GlobalFoundries rozšiřuje kapacity pro silicon photonics a SiGe, protože poptávka z AI a datových center převyšuje nabídku až do roku 2027. UMC zároveň hlásí silnější poptávku a růst spolupráce na 12nm procesu s Intelem.
Key Takeaways GlobalFoundries is expanding silicon photonics and SiGe capacity amid strong AI and data center demand.UMC is seeing stronger specialty technology demand while advancing 12-nanometer work with Intel.Both companies expect higher 2026 sales and earnings as foundry demand continues to improve. The global semiconductor foundry industry continues to benefit from rising demand for chips used in artificial intelligence, automotive electronics, industrial automation and connected devices. As chipmakers increasingly outsource manufacturing, foundries with advanced technologies, diverse customer bases and expanding production capacity are well positioned to capture long-term growth.
Against this backdrop, GLOBALFOUNDRIES Inc. (GFS - Free Report) and United Microelectronics Corporation (UMC - Free Report) stand out as two prominent players. While GlobalFoundries focuses on specialized process technologies and strategic manufacturing partnerships, UMC leverages its mature-node expertise and cost-efficient operations to serve a broad range of customers. Which semiconductor foundry stock offers the better investment opportunity today? Let's compare the two.
The Case for GFSGlobalFoundries is strengthening its long-term growth profile by capitalizing on rising demand from artificial intelligence and data center applications. The company reported robust double-digit growth in its Communications Infrastructure & Data Center and Automotive businesses during the first quarter, while highlighting strong momentum in silicon photonics and silicon-germanium (SiGe) technologies. Management noted that demand for its SiGe solutions has exceeded available capacity well into 2027, prompting capacity expansion. The company also expects its silicon photonics revenues to roughly double in 2026 and target a run rate exceeding $1 billion by the end of 2028, supported by increasing customer wins and new optical networking products.
Another positive is GlobalFoundries' improving profitability and expanding customer relationships. The company posted a record first-quarter gross margin of about 29%, up more than five percentage points year over year, reflecting a richer product mix, cost improvements and contributions from higher-margin technology services. Design wins climbed 50% from the prior-year period, while strategic partnerships with companies such as Renesas and Apple reinforce its position in automotive, industrial and U.S.-based semiconductor manufacturing. Management also emphasized that its diversified manufacturing footprint across the United States, Germany and Singapore is attracting customers seeking resilient supply chains amid ongoing geopolitical uncertainty.
Despite these strengths, GlobalFoundries continues to face headwinds in its Smart Mobile Devices business, which remains the largest revenue contributor. Management expects the segment to decline at a high-single-digit rate in 2026 as the broader smartphone market weakens, although it believes the business will outperform overall industry trends. The company also warned that geopolitical disruptions could raise supply-chain costs, with additional spending on critical materials expected to weigh on margins through the remainder of the year. These challenges suggest that sustained growth in AI, automotive and communications markets will be essential to offset weakness in mobile demand.
The Case for UMCUnited Microelectronics is benefiting from improving demand across its mature-node foundry business, supported by rising utilization and strong momentum in specialty technologies. During the first quarter, wafer shipments increased sequentially, lifting utilization to 79%, while 22-nanometer revenues reached another record and accounted for 14% of total sales. Management expects more than 50 customers to complete tape-outs on its 22-nanometer platform by the end of 2026, spanning applications such as display driver ICs, networking chips and microcontrollers. Looking ahead, UMC guided for high-single-digit shipment growth and low-single-digit ASP improvement in the second quarter, reflecting healthy demand across communications, consumer, industrial and AI-related markets.
UMC is also investing to expand its long-term growth opportunities beyond traditional mature-node manufacturing. The company continues to advance its 12-nanometer collaboration with Intel, which is expected to provide customers with U.S.-based manufacturing and pave the way for commercial production in 2027. At the same time, management highlighted growing traction in emerging businesses such as silicon photonics and advanced packaging, with more than 10 customer engagements and over 35 expected tape-outs in 2026. These initiatives, combined with disciplined pricing actions planned for the second half of the year and a strategy focused on higher-value specialty technologies, should strengthen UMC's competitive position over time.
On the downside, UMC's profitability continues to face cost pressures despite improving demand. Management cautioned that higher depreciation from the Singapore fab expansion, along with rising raw material, energy and logistics costs, is expected to offset much of the benefit from stronger utilization in 2026. While the company plans to implement wafer price increases in the second half, executives acknowledged that margin expansion is likely to remain constrained until depreciation expenses begin to ease, making sustained earnings growth dependent on continued demand recovery and successful execution of its higher-value technology roadmap.
How Does the Zacks Consensus Estimate Compare for GFS & UMC?The Zacks Consensus Estimate for GFS’ 2026 sales and earnings per share implies a 7.3% and 9.9%, respectively, year-over-year increase. Moreover, in the past 60 days, earnings estimates have witnessed upward revisions.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UMC’s 2026 sales and EPS implies year-over-year growth of 10.9% and 32.1%, respectively. Earnings estimates for 2026 have increased in the past 60 days.
Image Source: Zacks Investment Research
Price Performance & ValuationGFS stock has gained 140.2% in the past six months compared with its sector’s growth of 49.5%. Conversely, UMC’s shares have surged 247.9% in the same time frame.
Price Performance
Image Source: Zacks Investment Research
GFS is trading at a forward 12-month price-to-earnings ratio of 48.92X, above its median of 32.37X over the last year. UMC’s forward earnings multiple sits at 36.23X, above its median of 18.79X over the same time frame.
P/E (F12M)
Image Source: Zacks Investment Research
Which Stock to Buy Now?Both companies are well positioned to benefit from long-term semiconductor demand, but UMC appears to have the stronger investment case at this stage. The company is seeing broad-based improvement across core businesses, healthy momentum in the specialty technology portfolio and encouraging progress in emerging areas such as silicon photonics, advanced packaging and its collaboration with Intel.
In addition, analysts have become increasingly optimistic about UMC's earnings outlook, while it is expected to deliver faster growth than GlobalFoundries. Although both stocks trade at premium valuations after strong rallies, UMC's stronger earnings trajectory, improving demand environment and expanding technology roadmap give it an edge. This makes it the more compelling semiconductor foundry stock to buy now.
UMC currently has a Zacks Rank #2 (Buy), whereas GFS carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Kinder Morgan těží z rostoucího exportu LNG a vyšší poptávky po plynové elektřině v USA. Její objednávkový backlog ve výši 10,1 miliardy USD míří hlavně na LNG, výrobu elektřiny a utility.
Key Takeaways Kinder Morgan transports about 40% of U.S. natural gas and has stable, contracted cash flows.Rising LNG exports and gas-fired power demand are driving Kinder Morgan's natural gas growth story.A $10.1B project backlog targets LNG, power generation and utility demand to support cash flows. Kinder Morgan (KMI - Free Report) is a leading energy infrastructure company in North America that transports approximately 40% of U.S. natural gas. The company owns an extensive asset base, including approximately 78,000 miles of pipelines, 136 terminals and more than 700 billion cubic feet (Bcf) of working natural gas storage capacity. While KMI generates stable cash flows, supported by its highly contracted business model, its growth story is backed by the rising demand for natural gas and power consumption in the United States.
The rising demand for natural gas is driven by two major factors – growth in liquefied natural gas (LNG) exports and increasing gas-fired power demand in the U.S. Kinder Morgan’s assets. These assets are well-positioned to support LNG export growth, particularly at the export hubs in Texas and the Louisiana Gulf Coast. Additionally, the expansion of data centers, the retirement of coal-fired power plants, industrial reshoring, population migration and economic growth in the Southern U.S. are resulting in increased electricity consumption, boosting the need for reliable natural gas-fired power generation.
The company’s $10.1 billion project backlog is primarily focused on natural gas infrastructure, with more than 20% directed toward serving the growing LNG demand, whereas about 60% is directed toward power generation and utility demand. This should enable the midstream player to convert these demand trends into stable, predictable cash flows. These trends enhance the strategic value of KMI’s pipeline and storage assets and provide investors with a low-risk path to gain exposure to the structural growth in U.S. natural gas demand.
Energy Sector Players to Benefit From Rising Natural Gas DemandThe rise of data centers and higher gas-fired power demand presents an opportunity for Enbridge Inc. (ENB - Free Report) to capitalize on. Data centers require a huge amount of electricity, which is driving rapid growth in gas demand. The shift from coal to gas for power generation is increasing the demand for gas. Enbridgeis expected to gain from the expansion of its natural gas storage facilities.
Venture Global (VG - Free Report) is one of the largest U.S.-based exporters of liquefied natural gas (LNG) and is currently operating and developing multiple LNG export projects in Louisiana. The company anticipates that the total production capacity across its projects will account for approximately 68 million tons per annum, upon completion, with potential upside from optimization initiatives. Being an LNG export company, VG is expected to benefit from the rise in LNG demand, driven by the expansion of data centers, replacement of coal and the global shift toward lower-emission fuels.
KMI’s Price Performance, Valuation & EstimatesShares of KMI have jumped 14.2% over the past year compared with the 18.7% improvement of the composite stocks belonging to the industry.
Image Source: Zacks Investment Research
From a valuation standpoint, KMI trades at a trailing 12-month enterprise value to EBITDA (EV/EBITDA) of 14.47X. This is below the broader industry average of 15.2X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for KMI’s 2026 earnings hasn’t seen any revisions over the past seven days.
Image Source: Zacks Investment Research
KMI currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Quanta Services plánuje investovat 500–700 milionů USD do rozšíření kapacity transformátorů a výrobní stopy. Firma zároveň oznámila rekordní backlog 48,5 miliardy USD.
Key Takeaways PWR is expanding beyond construction to support utilities across engineering, manufacturing and supply chains.PWR plans to invest $500-$700 million to expand transformer capacity and manufacturing footprint.Quanta ended Q1 with a record $48.5 billion backlog, strengthening multiyear revenue visibility. Quanta Services, Inc. (PWR - Free Report) is increasingly aligning its business with one of the largest infrastructure opportunities in North America as utilities modernize aging power grids to meet rising electricity demand. The expansion of artificial intelligence, data centers, advanced manufacturing and electrification is placing greater pressure on transmission networks, making grid upgrades a long-term investment priority. This creates a favorable backdrop for companies with the expertise and scale to deliver complex infrastructure projects.
Grid modernization is becoming a key growth driver for Quanta because it has expanded well beyond traditional construction services. PWR now supports customers across engineering, procurement, construction, manufacturing and supply-chain solutions, allowing utilities to execute larger and more complex capital programs with greater certainty. The company is also working alongside customers much earlier in the planning process, strengthening its role in multiyear infrastructure investments.
Quanta is reinforcing this position through targeted manufacturing investments. The company plans to invest $500-$700 million over the next several years to double the power transformer manufacturing capacity while nearly doubling its off-site manufacturing, fabrication and logistics footprint to approximately 6.7 million square feet. These investments are designed to reduce equipment constraints, improve project execution and accelerate grid expansion as transmission demand grows.
The strategy is already translating into greater project visibility. Quanta ended the first quarter with a record backlog of $48.5 billion, up from $35.3 billion a year ago, including a 12-month backlog of $28.2 billion, up 45.4%, reinforcing strong multiyear revenue visibility. With utilities expected to invest heavily in transmission infrastructure for years to come, grid modernization has the potential to become one of Quanta's most durable long-term growth drivers.
How Does Quanta Compare With Infrastructure Peers?Quanta has established a leading position in North America's power infrastructure market, benefiting from growing investments in grid modernization, transmission expansion and electrification. As investors assess whether the company can sustain the long-term growth, comparisons with EMCOR Group, Inc. (EME - Free Report) and MasTec, Inc. (MTZ - Free Report) highlight its differentiated exposure to the evolving utility infrastructure landscape.
EMCOR is also benefiting from robust demand across electrical and mechanical construction, supported by data centers, manufacturing, health care and institutional projects. The company ended the first quarter with remaining performance obligations of $15.62 billion, reflecting strong project visibility. However, its growth remains more closely tied to building construction and facility-related services than utility transmission infrastructure.
MasTec is a closer peer, with exposure to power delivery, telecom, clean energy, pipeline and data center infrastructure. The company reported a record backlog of $20.3 billion and continues to benefit from investments in grid reliability, transmission expansion and AI-driven electricity demand. However, Quanta's integrated solutions platform, manufacturing investments and larger $48.5 billion backlog position it to capture a broader share of North America's multiyear grid modernization opportunity.
PWR’s Price Performance, Valuation & EstimatesPWR stock has surged 70.2% in the year-to-date (“YTD”) period, outperforming the Zacks Engineering - R and D Services industry, the broader Construction sector and the S&P 500 index.
PWR YTD Share Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, PWR trades at a forward 12-month price-to-earnings ratio of 47.53X, well above the industry’s 32.03X, as shown below.
PWR Valuation
Image Source: Zacks Investment Research
Quanta’s earnings estimates for 2026 and 2027 have decreased in the past 30 days. However, the revised estimates for 2026 and 2027 imply year-over-year growth of 30.5% and 17.3%, respectively.
Image Source: Zacks Investment Research
PWR’s Zacks RankQuanta currently flaunts a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Winnebago Industries má oporu v segmentu motorhome RV: tržby segmentu vzrostly o 10,1 % na 320,7 mil. USD a provozní marže se zlepšila na 3 % z -1,1 %.
Key Takeaways WGO's 2026 outlook hinges on whether Motorhome RV strength can offset towable RV and marine weakness.Motorhome RV revenues rose 10.1% to $320.7M, with operating margin improving to 3% from negative 1.1%.Affordability pressure, cautious dealer ordering and weak big-ticket demand still weigh on Winnebago. Winnebago Industries, Inc. (WGO - Free Report) is navigating a split 2026 backdrop. Motorhome improvement is helping, but the broader outdoor recreation market remains pressured.
The key question is whether product breadth and brand expansion can outweigh weak discretionary demand. For now, investors have to balance a visible bright spot against still-fragile towable RV and marine trends.
Winnebago's Segmental SplitWinnebago’s business is organized around three reportable segments: Towable RV, Motorhome RV and Marine. That mix matters because the company is not moving through the cycle evenly.
Towable RV represented 45.2% of fiscal 2025 revenues, while Motorhome RV accounted for 43.7%. Marine contributed 11.1%, making it smaller but still relevant to earnings quality, dealer demand and the company’s broader outdoor recreation identity.
Thor Industries, Inc. (THO - Free Report) remains a direct RV peer because it also competes across towable and motorized recreational vehicles. Patrick Industries, Inc. (PATK - Free Report) adds a supply-chain lens, since its component exposure to RV and marine markets makes it sensitive to the same production and dealer-order trends affecting Winnebago.
WGO Finds Support in New ProductsWinnebago continues to lean on new products to defend share and broaden price-point coverage. In towables, the Access and Thrive platforms under the Winnebago brand and Grand Design’s Transcend Lite are aimed at expanding participation among buyers who remain price conscious.
The company is also refreshing the higher end of its portfolio. The ARKA off-grid adventure truck, updated Newmar offerings and Grand Design’s Worry-Free Roof technology support product differentiation in motorhomes and towables.
Marine is part of the same strategy. Barletta’s Sanza line creates a more accessible entry point into the brand while Barletta continues to build share in the U.S. aluminum pontoon segment.
Winnebago Gets a Lift From MotorhomesThe Motorhome RV segment is the clearest support point in Winnebago’s latest results. Segment revenues rose 10.1% year over year to $320.7 million in the fiscal third quarter of 2026.
The profit improvement was more important than the sales gain. Motorhome RV generated operating income of $9.6 million and a 3% operating margin, compared with an operating loss of $3.2 million and a negative 1.1% margin in the year-ago quarter.
Higher unit volume and selective price adjustments helped the segment, partly offset by higher input costs. Management also cited traction at Grand Design Motorized, execution at Newmar and broader share gains across key motorhome categories.
WGO Still Faces Demand HeadwindsThe bullish case still runs into a difficult retail backdrop. Consumers remain interested in outdoor recreation, but affordability pressure, cumulative inflation, elevated interest rates and uncertainty around geopolitical events are delaying big-ticket purchases.
Dealer behavior is another drag. Management pointed to more deliberate ordering, with dealers focused on inventory quality, carrying costs and retail sell-through rather than adding wholesale volume.
These pressures are showing up outside motorhomes. Towable RV revenues fell 26.1% year over year in the fiscal third quarter of 2026, while Marine revenues declined 8.3%. Both segments also saw lower operating margins as volume deleverage, product mix and higher input costs weighed on performance.
What Winnebago’s Stock Signals Say NowThe bottom line is that Winnebago has one meaningful operating bright spot, but the stock still carries a weak short-term profile. Motorhome strength gives WGO a recovery argument, while towables, marine and consumer affordability keep that argument from looking clean.
WGO currently carries a Zacks Rank #4 (Sell). The Value Score of A supports the view that valuation screens well, and the Growth Score of B and VGM Score of B are not dismissive of the company’s broader financial profile.
Image Source: Zacks Investment Research
The Momentum Score of D keeps the signal mix cautious. Since Zacks Style Scores are designed to complement the Zacks Rank, the unfavorable rank makes it harder to treat WGO’s valuation as enough on its own. Investors may need clearer evidence that motorhome strength can spread across the portfolio before becoming more constructive.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Standard Commercial Lines je hlavním tahounem Selective Insurance Group: v roce 2025 tvořil 71 % tržeb a 79 % čistého předepsaného pojistného. Růst podporuje expanze do nových států a vyšší nové obchody i retence.
Key Takeaways The Standard Commercial Lines segment generated 71% of total revenues and 79% of net premiums written in 2025.Expansion into new states, including Kansas in 2025, supports premium growth and broader market presence.Higher new business, pricing, renewal exposure and retention continue to drive growth in the segment. Selective Insurance Group, Inc. (SIGI - Free Report) has a strong presence in the standard commercial lines market, focusing primarily on small and middle-market businesses. SIGI sells the Standard Commercial Lines property and casualty insurance products and services to commercial enterprises, typically businesses, non-profit organizations, and local government agencies, primarily in 36 states and the District of Columbia.
Selective Insurance continues to expand its Standard Commercial Lines footprint with the goal of a near national presence, while maintaining an agent-driven distribution model. Since 2017, SIGI has added 14 states to the Standard Commercial Lines footprint, including Kansas in 2025. In the first quarter of 2026, these expansion states produced $125 million in premiums, representing approximately 9% of total direct premiums written and 1% marginal total premium growth. SIGI expects to write new business in Montana and Wyoming by the end of 2026, pending regulatory approvals.
Standard Commercial Lines is the core revenue driver for Selective Insurance Group, making it the company's primary earnings engine. It generates the majority of the company's premium revenue, supplies the investment float that supports investment income, and serves as the foundation of the long-term growth strategy. This segment accounted for 71% of total revenues and 79% of total net premiums written in 2025. Higher new business, renewal pure price increases, exposure growth on renewal policies, and higher retention should continue to drive premiums in the segment.
Selective Insurance's standard commercial lines strategy centers on profitable underwriting rather than market-share expansion. By concentrating on well-understood industries, maintaining strong independent agency partnerships and exercising disciplined pricing, SIGI has consistently generated underwriting results that compare favorably with many peers across the commercial property and casualty insurance industry.
What About Its Peers?Axis Capital Holdings Limited (AXS - Free Report) , a global specialty underwriter, has a strategic focus on specialty products, including professional liability, cyber insurance, marine and aviation. AXS has been witnessing an increase in its top line over a considerable period of time on the back of higher net premiums. Its well-performing Insurance segment largely contributes to improving premiums. It continues to boost shareholder value through stock buybacks and dividend hikes.
Palomar Holdings, Inc. (PLMR - Free Report) has been displaying a good track record of net written premiums due to increased volume of policies written across the lines of business, driven by new business generated with existing partners, strong premium retention rates for existing business, expansion of its products’ geographic and distribution footprint, and new partnerships. Backed by a sustained operational performance, the company has maintained a solid capital position.
SIGI’s Price PerformanceShares of SIGI have gained 9.9% in the past year, outperforming the industry.
Image Source: Zacks Investment Research
SIGI’s Expensive ValuationThe stock is overvalued compared with its industry. It is currently trading at a price-to-book ratio of 1.67, above the industry average of 1.42. It carries a Value Score of A.
Image Source: Zacks Investment Research
Estimate Movement for SIGIThe Zacks Consensus Estimate for SIGI’s second-quarter 2026 EPS has moved up 2.4% in the past 60 days. The same for full-year 2026 and 2027 EPS has moved up 1.9% and 0.4%, respectively, in the past 30 days.
Ubiquiti ve 3. fiskálním čtvrtletí zvýšila výnosy o 18,7 % na 788,2 mil. USD, tažená růstem Enterprise Technology o 22,6 %. V Severní Americe výnosy stouply o 27 %.
Key Takeaways Ubiquiti's Q3 fiscal 2026 revenues rose 18.7% year over year, led by Enterprise Technology growth.UI's Enterprise Technology revenues climbed 22.6%, with North America revenues up 27% year over year.Ubiquiti expects product innovation and operations investments to support higher-value sales and expansion. Ubiquiti, Inc. (UI - Free Report) delivered impressive results in the third quarter of fiscal 2026, with revenues rising to $788.2 million from $664.2 million a year ago. The 18.7% year over year surge was driven by robust demand across its Enterprise Technology portfolio, while profitability also improved.
The Enterprise Technology segment generated $717.9 million in revenues, up from $585.7 million in the prior-year quarter, up 22.6% year over year. The company is benefiting from rising enterprise networking demand, increasing adoption of IoT-connected devices and continued deployment of unified IT infrastructure solutions. The North America region, which is Ubiquiti’s largest market, generated $410.2 million in revenues, up 27% year over year. Europe, the Middle East and Africa continued to post steady growth. Despite a lower market share, the company has witnessed improved traction in the Asia Pacific and South America regions.
The company continues to enhance the UniFi ecosystem and broaden its networking and unified IT management offerings. Management believes investments in product innovation, inventory management and operations will help maintain its competitive position while supporting higher-value product sales and long-term market expansion. Per our estimate, the company is set to report $2.83 billion in revenues from this segment in 2026, indicating a growth of 26% year over year.
How Are Competitors Faring?Ubiquiti faces competition from Cisco Systems (CSCO - Free Report) and Hewlett Packard Enterprise (HPE - Free Report) . Cisco enables enterprises and service providers to deliver highly secure connectivity from workplaces to data centers worldwide. During the recent quarter, the company’s total revenues increased 12% year over year, while networking revenues rose 25% year over year. Accelerating demand for Cisco’s switching and routing portfolio is driving this growth.
HPE reported revenue growth of 40.4% year over year. The Networking segment generated $2.7 billion in revenues in the second quarter of fiscal 2026, up 148.2% year over year. Management highlighted record campus and branch orders, with nearly 20% normalized growth in enterprise data center switching orders and nearly 30% normalized growth in routing orders. HPE also launched new autonomous, agentic AI operations capabilities and raised its cumulative Networks for AI order target to at least $2 billion by the end of fiscal 2026, reflecting confidence in AI-driven demand for high-performance networking.
UI’s Price Performance, Valuation and EstimatesUbiquiti has gained 36.7% in the past year compared with the Wireless Equipment industry’s growth of 42.5%.
Image Source: Zacks Investment Research
Going by the price/earnings ratio, the company’s shares currently trade at 34.57 forward earnings, higher than 31.44 for the industry.
Image Source: Zacks Investment Research
Earnings estimates for UI for 2026 have improved over the past 60 days.
Image Source: Zacks Investment Research
Ubiquiti carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
JPMorgan uvedl, že více než 60 % plánované kapacity datacenter pro rok 2027 ještě nezačalo a dalších 7 % projektů se zpožďuje kvůli dodavatelským řetězcům, povolování a nedostatku energie.
A popular saying in professional sports is that Father Time is undefeated. The clock stops for no professional athlete. The same can be true of the current data center buildout.
A recent JPMorgan Chase report states that more than 60% of the planned data center capacity for 2027 has not yet been started. An additional 7% of projects under construction are being delayed by supply chain bottlenecks, permitting hurdles, and power shortages.
Investors who focus on FUD (fear, uncertainty, and doubt) argue that the shift out of technology stocks, particularly hyperscaler stocks, is evidence that the data center story is falling apart.
Get Eaton alerts:
But the recent earnings season refuted that point of view. Demand is real. The money is committed. In the last quarter, the four major hyperscalers raised their combined AI-related capital expenditures to $750 billion for this calendar year. That demand is expected to reach $1 trillion in 2027.
But the one factor that investors can’t control is the time it takes to actually build the data centers. The story has gotten ahead of the shovels.
Data Center Backlog Stocks Could Be the Bigger AI TradeA more likely reason for the selloff is rotation into the stocks of companies that are essential to filling this backlog. The companies supplying the equipment needed to build new facilities stand to be the largest beneficiaries.
One option for investors is to look at exchange-traded funds (ETFs) tied to physical data center infrastructure. One example is the Global X U.S. Infrastructure Development ETF BATS: PAVE, which is up 22% in 2026 as of this writing.
However, investors may do better by investing in individual stocks within these funds. That can provide the opportunity for market-beating gains and, in some cases, dividends that can beat the performance of a single fund.
Eaton Is Turning AI Data Center Spend Into Backlog GrowthEaton Today
$403.94 -15.93 (-3.79%)
As of 11:43 AM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$311.92▼
$436.74Dividend Yield1.09%
P/E Ratio39.35
Price Target$420.95
Eaton NYSE: ETN sells the electrical guts inside an AI data center. Think of switchgear, UPS systems, busways, and power distribution units that connect the grid to the server racks. The Q1 2026 numbers tell the story. In Eaton’s Electrical Americas segment, data center orders surged roughly 240% year over year, while data center revenue in the segment grew about 50%.
That growth is likely to accelerate. Eaton closed the Boyd Thermal acquisition to expand into liquid cooling. The company is also collaborating with NVIDIA NASDAQ: NVDA on the Beam Rubin DSX platform for AI factories. Plus, a planned Reverse Morris Trust deal will spin off Eaton's Mobility Group. That leaves a more focused Electrical and Aerospace business aligned squarely with AI buildout demand.
ETN is up 28% year-to-date, which lands it within 5% of its consensus price target. However, since the company’s Q1 2026 earnings report, analysts have been aggressively raising their price targets.
Why Quanta Services Offers the Clearest Backlog VisibilityQuanta Services Today
PWR
Quanta Services
$701.12 -17.47 (-2.43%)
As of 11:43 AM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$363.01▼
$788.75Dividend Yield0.06%
P/E Ratio95.86
Price Target$733.87
Quanta Services NYSE: PWR does the physical work that turns a data center site plan into delivered power. The company builds high-voltage transmission lines, substations, and load centers. At its 2026 Investor Day, management outlined a $2.4 trillion addressable market through 2030.
The backlog supports that forecast. Quanta exited Q4 with a $44 billion backlog, up 27.5% year-over-year. Management now guides for 15% to 20% annual EPS (earnings per share) growth through 2030. Internal training programs have built a skilled-labor moat that smaller rivals struggle to match. That gives PWR pricing power as electricians and linemen become scarce.
PWR is up over 65% year-to-date, and like ETN, it’s within about 5% of its consensus price target. But analyst sentiment is bullish, and the chart is constructive, with support at the 50-day simple moving average (SMA) and a MACD on the cusp of reversing.
Vertiv Turns AI Heat and Power Demand Into Backlog GrowthVertiv Today
$306.74 -18.83 (-5.78%)
As of 11:43 AM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range$110.06▼
$379.93Dividend Yield0.08%
P/E Ratio76.48
Price Target$326.39
Vertiv NYSE: VRT sells the power and thermal infrastructure inside the building. Once Quanta finishes the grid work, Vertiv's UPS systems, switchgear, racks, and liquid cooling take over. Roughly 75% of revenue now comes from data center customers. Q1 2026 revenue grew 30% to $2.65 billion. Project backlog more than doubled to over $15 billion.
Management raised its full-year guidance to $13.5 to $14 billion in net sales. Recent acquisitions of Strategic Thermal Labs and ThermoKey extend Vertiv from chip-level cold plates to facility-scale heat rejection. Vertiv was also named a Tier 1 partner on Hut 8's NASDAQ: HUT gigawatt-scale Beacon Point AI campus. Each hyperscaler win reinforces the picks-and-shovels thesis.
VRT is up over 95% in 2026 and is also trading within 5% of its consensus price target. The company also has the most mixed analyst picture of the three stocks on this list. But investors willing to play the long game should consider VRT's potential for strong dividend growth in the coming years.
Should You Invest $1,000 in Eaton Right Now?Before you consider Eaton, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eaton wasn't on the list.
While Eaton currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Duolingo (DUOL) za poslední měsíc vzrostlo o více než 20 % a těží z AI, která výrazně zrychlila tvorbu obsahu. V 1. čtvrtletí zvýšilo čistý zisk o 24 % a tržby o 27 %.
It's been tough for long-term investors to hold Duolingo (DUOL +4.04%). The stock is down more than 70% over the past year, and while it was overvalued at over $400 per share, the current price is at bargain-basement levels, and some investors are finally noticing.
The stock has rallied more than 20% over the past month, and there are several reasons for Duolingo investors to feel optimistic that this is just the beginning.
Image source: Getty Images.
Duolingo isn't just for learning new languages Duolingo's original specialty was gamifying the language-learning experience. However, it is expanding into teaching other subjects, including chess, its fastest-growing subject.
Chess is a notable addition since it expands Duolingo's offerings beyond academic areas. The edtech company introduced math and music a few years ago and continues to expand its inventory. Duolingo is turning into an app that helps people master high-demand skills, not just new languages.
Its recent artificial intelligence (AI) investments also play a role here. Duolingo told investors in its Q1 shareholder letter that AI has "fundamentally changed how quickly we can create content." The company was able to publish 20,500 course units in Q1, compared to an average of 7,100 per quarter in 2025 and 1,800 per quarter in 2024.
Duolingo explained that this dramatic scaling helped it improve its popular Chinese, Japanese, and Korean courses. However, this same increase in content production makes it substantially easier for Duolingo to create new courses on high-demand skills that attract more users.
Today's Change
(
4.04
%) $
4.84
Current Price
$
124.78
Net income is still growing Almost tripling quarterly course unit production in a single year gives customers more options. That helps with revenue, but surprisingly, Duolingo's net income has marched higher as well. It truly demonstrates that Duolingo's AI efforts are cost-efficient, which makes the growth sustainable.
For instance, Duolingo delivered 24% year-over-year net income growth in Q1. Revenue was up by 27%, so there was a slight contraction in the net profit margin. Duolingo still walked away from the quarter with a double-digit profit margin, which has become the norm.
All of this financial growth is fueled by steady user acquisition. Duolingo's daily active users and paid subscribers were both up by 21% year over year. With 56.5 million and 12.5 million people, respectively, in those segments, Duolingo can still gain more market share. A side focus on hot, broader subjects like chess can expand Duolingo's footprint and keep users more engaged.
Intentional revenue slowdown is for long-term gains Although Duolingo's numbers were good, they were a downgrade from what investors have come to expect. Last year, Duolingo was exceeding 40% year-over-year revenue growth. A drop to 27% would explain the decline if Duolingo traded at over $400 per share then. However, Duolingo released Q1 results in early May, when almost all of the damage was already done.
Duolingo is aiming to become a company that will be around for 100 years and change how the world learns everything. This long-term vision comes with a medium-term goal of reaching 100 million daily active users in 2028.
The company could make more revenue by pushing its subscriptions or establishing a hard paywall, but Duolingo said its scale wouldn't be possible with a paywall model. Getting to 100 million daily active users with a freemium model will give Duolingo more options and financial growth in the future when it maximizes its average revenue per user.
In the meantime, Duolingo continues to improve its subscriptions so more people feel inclined to become paying customers. The company cited its subscription-only Video Call feature, which has more than doubled the average number of words spoken per user who takes advantage of it.
Duolingo anticipates 17.1% year-over-year revenue growth in Q2 and 16.1% in full-year 2026. The guidance figures imply deceleration and aren't glamorous for a growth stock, but Duolingo's correction is long overdue. Its efforts to attract 100 million daily active users in 2028 should pay off tremendously and give the company more opportunities to reignite revenue growth when the time calls for it.
Edwards Lifesciences na konferenci New York Valves 2026 představila nová data podporující její vedení v oblasti strukturální kardiologie. Studie PROGRESS, PARTNER 3, EARLY TAVR i registry PASCAL a SAPIEN M3 posilují důkazy pro platformu SAPIEN.
NEW YORK--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and innovating for patients. These new data – spanning aortic, mitral and tricuspid therapies – provide further understanding of the complexity of structural heart disease and the need for innovative treatment options.
Ahead of the planned full clinical presentation at TCT later this year, the baseline characteristics of the PROGRESS trial presented today provide new insights into the heterogeneous nature of moderate aortic stenosis (AS) patients. Research has shown that approximately half of moderate AS patients present with at least one at-risk feature, which includes symptoms, progressive cardiac damage, declining health and elevated risk of hospitalization. The PROGRESS trial is designed to evaluate whether patients with moderate AS and at least one risk factor may benefit from transcatheter aortic valve replacement (TAVR) earlier than current guidelines, which recommend clinical surveillance with echocardiographic follow-up every 1-2 years. Details of the PROGRESS trial design were recently published in the American Heart Journal and baseline characteristics of the PROGRESS trial are listed below:
More than 95% were symptomatic More than 70% had 2 or more at-risk features More than 90% had a normal left ventricular function Mean age was 78 ± 6 years Mean KCCQ score was 64 ± 24 Broad surgical risk distribution (46% low risk) Additional late-breaking clinical science presentations strengthen the evidence base for the SAPIEN 3 platform, including seven-year benchmark durability data from the PARTNER 3 trial, simultaneously published in JAMA Cardiology. Also presented were new findings from the EARLY TAVR trial, reinforcing the shift toward proactive disease management and providing continued long-term reassurance for physicians and patients. These data on Edwards’ SAPIEN platform underscore the benchmark valve performance and differentiated long-term durability of the therapy.
“Edwards remains focused on addressing the significant unmet needs of the many structural heart patients who remain untreated today,” said Bernard Zovighian, Edwards’ CEO. “Our expanding evidence base reflects Edwards’ clear and sustained commitment to advancing care through partnership with the physician community. From building a deeper understanding of the moderate AS population and advancing evidence about asymptomatic patients to demonstrating distinguished SAPIEN platform durability and strategies for lifetime disease management, we are strengthening confidence in long-term outcomes and increasing access for patients worldwide.”
Also at the meeting, new data highlighted clinical trial and real-world outcomes across Edwards’ mitral and tricuspid portfolio. Data from more than 4,500 patients treated with the PASCAL system in the STS/ACC Transcatheter Valve Therapy Registry helps highlight the sustained safety and effectiveness of the technology for patients with mitral regurgitation (MR). One-year data from the ENCIRCLE trial Mitral Annular Calcification (MAC) Registry support the safety, effectiveness and quality of life improvements with SAPIEN M3, the first and only transcatheter transseptal mitral valve replacement system, in patients with symptomatic valve dysfunction associated with MAC who are deemed unsuitable for surgery or TEER therapy by a heart team.
Zovighian added, “Together, our differentiated technology and world-class evidence reflect Edwards’ leadership in elevating the standard of care for structural heart patients and improving outcomes across the care continuum.”
About Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements made by Mr. Zovighian and statements regarding the benchmark performance and differentiated long-term durability of Edwards’ SAPIEN platform, elevating the standard of care, our leadership in advancing our growing body of high-quality scientific and clinical evidence, long-term reassurance for physicians and patients, our commitment to advance care through partnerships with the physician community, strengthen confidence in long-term outcomes and expanding access for patients, innovating for patients with structural heart disease, the safety and effectiveness and quality of life improvements of our products, and improving outcomes across the care continuum, and other statements that are not historical facts. Forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though they are inherently uncertain and difficult to predict. Our forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. Investors are cautioned not to unduly rely on such forward-looking statements.
Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those expressed or implied by the forward-looking statements based on a number of factors as detailed in the company's filings with the Securities and Exchange Commission. These filings, along with important safety information about our products, may be found at Edwards.com.
Edwards, Edwards Lifesciences, the stylized E logo, EARLY TAVR, ENCIRCLE, PARTNER, PARTNER 3, PASCAL, PROGRESS, SAPIEN, SAPIEN 3 and SAPIEN M3 are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.
Intuitive Machines rozšiřuje byznys prostřednictvím akvizic v oblasti navigace, výroby kosmických lodí a komunikací. Nejnověji plánuje koupit Goonhilly Earth Station a její dceřinou společnost COMSAT a přidat 44 antén i významnou deep-space komunikační infrastrukturu ve Spojeném království a USA.
Key Takeaways Intuitive Machines expanded through acquisitions in navigation, spacecraft manufacturing, and communications.LUNR agreed to acquire Goonhilly Earth Station, adding 44 antennas and deep-space communications assets.LUNR shares rose 7.5% in three months and trade at a forward P/S premium to the industry. Intuitive Machines, Inc. (LUNR - Free Report) has long been associated with lunar landers and NASA's Commercial Lunar Payload Services program. However, recent acquisitions suggest management is pursuing a much broader vision.
The acquisition strategy began to accelerate in 2025 when the company acquired KinetX Aerospace, a leader in deep-space navigation and flight dynamics services. It added expertise in spacecraft navigation, mission design, and constellation management. KinetX has supported numerous NASA planetary missions, giving LUNR valuable technical capabilities that complement its lunar operations.
LUNR’s most transformative transaction came in November 2025 when it announced the acquisition of Lanteris Space Systems, formerly Maxar Space Systems, from Advent International. The deal was valued at $800 million, and was closed in January 2026. The business brings decades of spacecraft manufacturing experience and serves national security, civil, and commercial customers.
Lanteris provides proven capabilities in satellite manufacturing, missile-warning systems, secure communications, Earth observation, and space-domain awareness missions. These capabilities position Intuitive Machines to compete for larger defense and civil-space programs while expanding its presence in rapidly growing national security markets.
Management continued its acquisition-driven expansion in May 2026 by announcing plans to acquire Goonhilly Earth Station and its COMSAT subsidiary. The acquisition is expected to add 44 antennas and substantial deep-space communications infrastructure across the United Kingdom and the United States.
Through targeted acquisitions, the company is building capabilities across navigation, manufacturing, communications, and operations. If management successfully integrates these assets, acquisitions could become one of the company's most important drivers of long-term growth.
Space Companies Using Acquisitions to Expand GrowthSeveral space companies have pursued similar acquisition-driven strategies to broaden capabilities and accelerate expansion:
Rocket Lab Corporation (RKLB - Free Report) has acquired businesses across spacecraft components, solar power systems, software, and satellite technologies, helping transform the company from a launch provider into a diversified space systems company.
Redwire Corporation (RDW - Free Report) has completed numerous acquisitions spanning in-space manufacturing, digital engineering, mission systems, and spacecraft technologies, creating a broad portfolio serving commercial and government customers.
LUNR Stock’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 earnings per share implies a decrease of 2.38% year over year.
Image Source: Zacks Investment Research
LUNR Stock Trades at a PremiumIn terms of valuation, LUNR’s forward 12-month price-to-sales (P/S) is 4.09X, a premium to the industry’s average of 2.59X.
Image Source: Zacks Investment Research
LUNR Stock’s Price PerformanceIn the past three months, the company’s shares have risen 7.5% compared with the industry’s 1.2% growth.
Alto Ingredients se v 1. čtvrtletí 2026 vrátila k ziskovosti a upravený EBITDA vzrostl na 4,7 milionu USD. Firma čeká zhruba 15 milionů USD ročních čistých výnosů z daňových kreditů 45Z.
Key Takeaways Alto Ingredients returned to profitability in Q1 2026 as adjusted EBITDA improved to $4.7 million.Alto Ingredients expects about $15 million in annual net proceeds from qualifying 45Z production volumes.Green Plains produced 174 million gallons of ethanol in Q1 2026 while operating at 97% of capacity. Alto Ingredients, Inc. (ALTO - Free Report) and Green Plains Inc. (GPRE - Free Report) are two prominent players in the U.S. biofuels industry, with business models centered on producing ethanol and other value-added agricultural products. While Alto Ingredients has increasingly diversified into specialty alcohols and essential ingredients for industrial and consumer applications, Green Plains has focused on transforming itself into a higher-margin producer of sustainable ingredients, renewable corn oil and low-carbon products.
The comparison between ALTO and GPRE is especially relevant as investors reassess the outlook for ethanol producers amid volatile corn prices, evolving renewable fuel policies and growing demand for low-carbon energy solutions. Both companies are navigating the same macroeconomic and regulatory environment but pursuing different strategic paths, making them an intriguing pair for evaluating growth potential, profitability and long-term positioning in the energy transition.
Let's discuss in detail.
The Case for Alto Ingredients StockAlto Ingredients operates as a diversified producer of renewable fuels, specialty alcohols and essential ingredients, supplying customers across health, beauty, food, beverage, industrial and agricultural markets. The company's diversified portfolio and focus on higher-value products are contributing to a meaningful improvement in operating performance. In the first quarter of 2026, Alto Ingredients returned to profitability with earnings of 5 cents per share, against a loss of 16 cents a year earlier, while adjusted EBITDA improved to $4.7 million from negative $4.4 million, reflecting the benefits of its strategic realignment, stronger export demand and improved crush margins.
Another major catalyst has been stronger industry fundamentals and a more favorable product mix. Robust export demand, higher export premiums relative to domestic renewable fuel sales and improving corn oil prices supported margins. The company's crush margins increased to 17 cents per gallon from just 2 cents a year ago, while essential ingredients returns improved to 53.4% from 48.2%. Management also remains optimistic about demand growth from export markets and year-round E15 adoption.
Operational improvements and expansion projects are further supporting the company’s long-term outlook. Alto Ingredients is investing in projects to improve reliability, increase utilization and expand capacity. A debottlenecking project at the Pekin dry mill is expected to raise annual production capacity by about 5 million gallons, while additional CO2 infrastructure investments are expected to enhance operational flexibility and support higher-value opportunities. The company is also evaluating carbon capture and sequestration initiatives that could provide additional earnings opportunities over time.
Alto Ingredients is benefiting from growing opportunities tied to Section 45Z tax credits and improving financial flexibility. The company recognized $3.9 million in tax-credit earnings in the first quarter and expects roughly $15 million in annual net proceeds from qualifying production volumes. Positive operating cash flow, lower debt and more than $94 million in borrowing capacity have further strengthened the company's balance sheet and financial flexibility.
The Case for Green Plains StockGreen Plains has established itself as a prominent player in the U.S. biofuels industry, operating a network of eight ethanol plants and maintaining a significant presence in domestic biofuel production. The company produced 174 million gallons of ethanol in the first quarter of 2026 while operating at 97% of capacity, underscoring the scale, utilization rates and efficiency of its production platform.
The business has evolved beyond conventional ethanol manufacturing into a diversified portfolio of value-added products and services. Alongside ethanol, Green Plains generates revenues from renewable corn oil, ultra-high protein ingredients, grain handling, commodity marketing and carbon-related activities. This broader product mix expands the company's exposure across agricultural, feed, energy and low-carbon markets.
Green Plains continues to focus on improving plant reliability, increasing processing yields and lowering carbon intensity across its facilities. The company is directing capital toward grain storage expansion, low-energy distillation upgrades and yield-enhancement technologies designed to improve efficiency and strengthen operating performance. Benchmarking initiatives and data-driven analytics are also helping identify productivity gains across the production network.
Green Plains is also benefiting from the growing contribution of its carbon platform and Section 45Z production tax credits. Net production tax credits contributed $55.2 million to adjusted EBITDA in the first quarter, supported by the first full quarter of carbon sequestration operations at its three Nebraska facilities. The company expects its carbon strategy to contribute between $200 million and $225 million of EBITDA in 2026, while strong liquidity provides additional financial flexibility.
Valuation & Price Performance of ALTO & GPREAlto Ingredients currently trades at a forward price-to-sales ratio of 0.38, representing a modest discount to Green Plains, which trades at 0.52.
P/S Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Over the last three months, Alto Ingredients has emerged as the stronger performer, rising 10.4% while Green Plains lost 11.8%.
Three Months Price Performance
Image Source: Zacks Investment Research
Bottom Line: ALTO Appears Better Positioned for GrowthBoth Alto Ingredients and Green Plains are evolving beyond traditional ethanol production, but the former currently offers a more compelling turnaround and valuation story. Its improving profitability, stronger crush margins, growing specialty alcohol and ingredients business, and exposure to Section 45Z incentives provide multiple avenues for earnings growth. While Green Plains continues to advance its low-carbon and carbon capture initiatives and benefits from greater scale, ALTO's improving operational execution, strengthening balance sheet and leverage to improve industry fundamentals could position the stock to deliver stronger upside potential over the near to medium term.
Both ALTO and GPRE sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
CoreWeave čelí rostoucím nákladům na datová centra, které mohou zkomplikovat plán zvýšit kapacitu zhruba z 1 GW na 8 GW do roku 2030. Její backlog meziročně vzrostl téměř o 300 % na 99,4 miliardy USD.
Cloud-computing specialist CoreWeave (CRWV 4.13%) has seen its order book grow nearly 300% year over year to a staggering $99.4 billion. At the same time, the capital required to build an artificial intelligence (AI) data center is rising, with costs estimated at $15 to $25 million per megawatt to build AI-ready facilities.
On a recent episode of the All-In Podcast, venture capitalist Chamath Palihapitiya remarked that building a modern 1-gigawatt (GW) AI data center now runs closer to $100 billion fully loaded.
As land fees rise and the scarcity of electrical engineers and components intensifies, specialized AI cloud providers like CoreWeave find themselves in a hyperinflationary infrastructure race to build scale.
Image source: Getty Images.
A purpose-built platform for AI CoreWeave operates a vertically integrated platform designed for the performance demands of AI workloads. The company buys the latest graphics processing units (GPUs) from its partner Nvidia and combines them with other computing hardware and its own software to deliver performance that general-purpose clouds often struggle to match.
CoreWeave acts as a middleman, renting the compute capacity to AI model companies and hyperscalers. This type of operation keeps capital costs down by leasing the physical data center facilities from third-party developers rather than owning them.
The specialization has made it a key partner to major AI labs, securing multi-year, take-or-pay contracts with clients such as Meta Platforms and OpenAI. CoreWeave's customer concentration is improving, with 10 customers committed to spending at least $1 billion each, and non-investment-grade AI labs now represent less than 30% of its backlog.
The cost of rapid expansion To fund its expansion, CoreWeave has taken on $25 billion in debt in the form of delayed-draw term loans (DDTLs). It signs a customer contract, uses it as collateral to borrow against future cash flows, and draws money only as capacity is deployed.
Lenders consider the credit-worthiness of the end customer, such as Meta, resulting in better terms. This structure has helped reduce its average borrowing rate from the mid-teens to just below 10% by the end of 2025.
Today's Change
(
-4.13
%) $
-4.08
Current Price
$
94.68
Capital expenditures are expected to exceed $30 billion this year, up from $15 billion last year. The company is on a capital-intensive campaign that is sustainable only as long as it can keep signing new deals and tapping capital markets.
The rising cost of data center construction could weigh on its ability to scale economically as it attempts to grow from around one gigawatt today to 8 GW of capacity by 2030. One factor that helps balance the risk of owning depreciating hardware is the rising demand for inference, which keeps older, less powerful GPUs more valuable for longer than usual.
If AI inference remains highly profitable for providers over the next three to five years, pricing for compute capacity should hold up well. If demand underwhelms or the world moves toward low-cost open-source models, it could put pressure on compute rates for future contracts.
While CoreWeave offers a unique and compelling way for investors to play the AI infrastructure build-out, there's still plenty of uncertainty around who the winners and losers will be over the long run. As the cost of memory chips and other inputs rises, the capital burden on neoclouds and its partners gets heavier. Given the wide range of potential outcomes, investors interested in this stock should keep in mind that taking a reasonable approach to position sizing can help reduce the risk involved with any single stock in a rapidly evolving industry.
Figma po IPO prudce klesla na 16 USD, zatímco tržby v 1. čtvrtletí vzrostly o 46 % na 334 milionů USD. Firma zároveň zvýšila výhled díky poptávce a růstu počtu uživatelů.
Figma's stock price has imploded since its initial public offering (IPO) last year as the exuberance that fueled its private-market valuation collided with the realities of life as a publicly traded company. FIG dropped to $16 on Thursday, down sharply from the all-time high of $142.
Figma is one of the best-known software companies in the corporate world. Over the years it has become a beloved name among designers because of the collaborative aspect.
This popularity surged before it became a publicly traded company. At its peak, it reached a $20 billion valuation when Adobe placed a bid. Adobe terminated the agreement after it faced opposition in the UK and the EU, forcing it to pay a $1 billion breakup fee.
Figma’s popularity helped its valuation to surge to over $60 billion following its IPO. Today, the figure has tumbled to $8.9 billion, and the situation is getting worse by the day.
The rise and fall of Figma is emblematic of what has been going on in the market today. It is common for highly valued companies to suffer a rude awakening when they go public. A good example of this is Klarna, whose valuation peaked at $17 billion following its IPO. Today, the company is valued at $7.2 billion.
Another example of this phenomenon is Circle Internet Group whose valuation peaked at $60 billion before plummeting to $17 billion today.
The main reason why the Figma stock price is imploding is known as SaaSpocalypse, a situation where investors are dumping software stocks in fear that their businesses will be disrupted by AI tools.
These fears explain why other companies in the software industry like Salesforce, Adobe, Intuit, and ServiceNow are in a freefall this year.
However, in reality, some popular individuals, including Jensen Huang, argues that the fear that AI will disrupt software companies is not backed by reality.
Instead, AI will improve these companies by helping them reduce their operational costs and improve their service offerings.
Indeed, the most recent results showed that Figma’s business is still firing on all cylinders this year. Its revenue surged by 46% in the first quarter to $334 million, with the management boosting its forward guidance citing demand and seat expansion.
The management now expects that its second-quarter revenue will jump by 40% to between $348 million and $350 million. For the year, the company is expected to make between $1.42 billion and $1.428 billion.
Therefore, there are signs that Figma is being punished unfairly, as the management is also predicting that profitability will happen soon. It is also showing that more companies are subscribing to its services.
FIG stock price chart | Source: TradingView
The daily chart shows that the FIG stock price has imploded and is now sitting at a crucial support level of $16.85. A closer look shows that this price coincides with the lowest swing in April this year. That is a sign that it has formed a double-bottom pattern whose neckline is at $27.80.
The double-bottom pattern suggests that a rebound is possible. However, the most likely scenario is where the stock continues falling for a while before bouncing back eventually. This view will be confirmed if it drops below the double-bottom level of $16.85.
Ondas přes Sentrycs navázala spolupráci s Lockheed Martin na integraci technologie Cyber-over-RF do protidronového systému Sanctum. Cílem je posílit detekci, sledování a neutralizaci bezpilotních hrozeb.
Ondas Inc. (ONDS - Free Report) recently announced that its subsidiary, Sentrycs, has collaborated with Lockheed Martin to integrate Sentrycs' Cyber-over-RF technology into Sanctum, Lockheed Martin's next-generation Counter-Unmanned Aerial Systems (C-UAS) solution. The deal is aimed at strengthening protection for military forces, homeland security and critical assets against evolving unmanned aerial threats.
Sanctum is designed to address complex drone threats, including coordinated swarms and rapidly evolving unmanned aerial system (UAS) tactics, by combining artificial intelligence, cloud-enabled data fusion and a modular defense architecture. The platform is built to detect, track, analyze and neutralize aerial threats in real time while integrating multiple sensors, effectors and command-and-control systems into a unified framework that supports interoperability, mission flexibility and scalable protection across a broad range of defense environments.
As part of the collaboration, Sentrycs' Cyber-over-RF technology will add a cyber-based detection and mitigation layer to Sanctum's multi-domain architecture. Operating directly at the communication protocol layer, the technology enables operators to detect, identify, track and take control of unauthorized drones without relying on jamming, spoofing or kinetic engagement, while avoiding collateral interference with surrounding communications and infrastructure. The capability also allows operators to safely guide unauthorized drones to a controlled landing, providing a targeted and non-disruptive mitigation option that enhances layered response capabilities and supports mission-adaptable counter-drone operations.
Management stated that modern defense against unmanned aerial threats requires integrated, layered solutions that combine advanced detection, rapid decision-making and precise mitigation capabilities. Management also stated that integrating Sentrycs' technology into Lockheed Martin's modular defense architecture creates a stronger and more comprehensive operational capability for countering evolving aerial threats. The collaboration represents another step toward more integrated and interoperable Counter-UAS architectures as defense organizations increasingly prioritize flexible, layered solutions to address rapidly evolving unmanned aerial threats.
Ondas is benefiting from robust demand for its ISR and counter-UAS solutions, supported by higher defense spending, growing investor interest and expanding market opportunities. Demand for its proven ISR platforms remains strong, while acquisitions have broadened its ISR capabilities, expanded its customer base and strengthened its multi-domain surveillance and reconnaissance portfolio. Its partnership with Palantir is further advancing layered ISR capabilities and expanding ISR-as-a-service opportunities.
Taking a Look at ONDS Competitors’Draganfly (DPRO - Free Report) is gaining from strong demand for its drone solutions, particularly in the military sector, supported by growing defense spending and expanding opportunities across domestic and international markets. The company is strengthening its position through strategic collaborations with partners such as Palladyne AI on swarming technologies, Global Ordnance and Babcock to expand its defense reach and multi-platform capabilities. Its interoperable, modular drone platform and partner-centric approach enable customers to integrate multiple payloads and mission requirements, while increasing adoption among military and public safety users. The company also continues to build relationships with key defense customers and strategic partners to support long-term growth.
Red Cat Holdings, Inc. (RCAT - Free Report) is benefiting from rising defense spending on drones, expanding demand for autonomous systems and a growing opportunity pipeline across military customers. The company expects annual revenues of $150-$180 million in the near to medium term, supported by strong demand for its Black Widow, Blue Ops and FlightWave platforms. It is also expanding its capabilities through the acquisition of Quaze Technologies, adding wireless power transfer technology for unmanned and autonomous systems. Management highlighted a nearly $700 million opportunity pipeline for Black Widow and expects its expansion into unmanned surface vessels through Blue Ops to create an additional revenue opportunity in 2026.
ONDS’ Price Performance, Valuation and EstimatesShares of ONDS have gained a whopping 338.6% in the past year against the Zacks Wireless-National industry’s decline of 11.8%.
Image Source: Zacks Investment Research
ONDS seems overvalued, as suggested by the Value Score of F. In terms of the forward 12-month Price/Sales ratio, ONDS is trading at 7.2, considerably higher than the industry’s multiple of 1.62.
Image Source: Zacks Investment Research
For ONDS, earnings estimates for the current year have been revised upwards in the past 60 days.
Image Source: Zacks Investment Research
ONDS currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
SpaceX Corp (NASDAQ:SPCX) is considering launching a Starlink-branded mobile phone service in the United States, according to a Financial Times report published on Friday, potentially expanding the company's role in the telecommunications market.
The report cited comments from SpaceX President Gwynne Shotwell during a recent investor roadshow, where she reportedly discussed plans for a direct-to-consumer wireless offering and the possibility of building a terrestrial mobile network in the US.
SpaceX currently works with T-Mobile to provide direct-to-cell satellite connectivity aimed at extending coverage to remote areas. A standalone mobile service would place the Elon Musk-led company in more direct competition with established wireless carriers including Verizon, AT&T and T-Mobile.
According to the Financial Times, SpaceX has told investors that a retail Starlink mobile product could allow the company to capture a larger share of customer revenue by combining satellite capabilities with terrestrial wireless infrastructure.
The company strengthened its wireless spectrum holdings through acquisitions of EchoStar licenses totaling about $19.6 billion, including a roughly $17 billion purchase in September 2025 and an additional $2.6 billion transaction in November.
Starlink has more than 10 million subscribers worldwide and has become a key contributor to SpaceX's record valuation.
Shares of SpaceX traded hands at $153 on Friday, after debuting at $135 per share on June 12.
Tesla (NASDAQ: TSLA | TSLA Price Prediction) and Google (NASDAQ: GOOGL) both reported Q1 FY2026 earnings that sharpened the autonomy debate in opposite directions. Tesla leaned on a global fleet streaming video into its training clusters. Alphabet leaned on Waymo collecting paid driverless miles across real city streets. Both want the robotaxi crown. Only one is already cashing fares.
Camera Fleet Funds Tesla. Cloud Demand Funds Alphabet. Tesla posted $22.39 billion in revenue, up 15.78% year over year, and EPS of $0.41, beating consensus by 14.14%. Automotive gross margin expanded to 21.1% from 16.2%, and active FSD subscriptions hit 1.28 million, up 51%. R&D climbed to $1.95 billion, much of it pointed at AI5 silicon and the unsupervised Robotaxi rides launched in Dallas and Houston.
Alphabet’s quarter was a different magnitude. Revenue reached $109.90 billion, EPS landed at $5.11 versus a $2.63 consensus, and Google Cloud jumped 63% to $20.03 billion with backlog nearly doubling to over $460 billion. CEO Sundar Pichai noted, “I’m pleased to see Waymo surpass 500,000 fully autonomous rides a week.” That is paid, unmonitored throughput.
Mass Market Fleet vs. Metro by Metro Rollout The strategic split is visible in how each company spends. Tesla pushed millions of customer-owned vehicles streaming real-world video directly into its Cortex training clusters, financed by its own auto margins and a $44.74 billion cash pile. Alphabet, meanwhile, guided 2026 capex to $175 to $185 billion, funded by Search and YouTube ads that still grew 19% and 11% respectively.
Lens Tesla Alphabet Autonomy data source Supervised consumer fleet 10 metro regions of Level 4 driverless Operating margin 4.6% 36.1% Free cash flow (Q1) $1.44B $10.12B Key vulnerability Robotaxi regulatory approval Capex compressing FCF Tesla’s vision-only approach scales cheaply per car. Waymo’s stack is expensive per car, but it is already booking fare revenue while Tesla’s Cybercab is still in pilot production at Gigafactory Texas.
The Next Test Is Commercial Driverless Miles Polymarket traders price a Tesla robotaxi launch in California by June 30 at just 2.3%, and assign a 46.9% probability to Q2 deliveries clearing 475,000 units. I will be watching whether Dallas and Houston unsupervised rides scale into recurring revenue, and whether Waymo’s 500,000 weekly rides keep doubling without safety setbacks.
Alphabet’s Commercial Lead in Context Alphabet currently presents the more commercially proven autonomy exposure. You get a Search and Cloud engine that already funds Waymo, a P/E around 15, and a Cloud backlog that signals demand visibility years out. TSLA is down 16.59% year to date while GOOGL is up 9.95%, a meaningful divergence in year-to-date performance. Tesla still suits investors betting on FSD v14, Optimus, and Cybercab economics arriving on schedule. The view would shift once Tesla demonstrates recurring, unsupervised fare revenue at Waymo’s scale.
Amazon tvrdí, že jeho vlastní čipy pro datová centra jsou jedním z největších byznysů v oboru a mají roční tempo tržeb 50 miliard USD. Trainium2 je už téměř vyprodaný a Trainium3 je téměř plně rezervovaný.
CANADA - 2026/06/19: In this photo illustration, the AWS (Amazon Web Services) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)
SOPA Images/LightRocket via Getty Images
This article was written by Doug Nathman, with research by his team at Trefis.
Worries in the market regarding Amazon's significant investment in AI might underestimate the impressive proprietary technology being developed to support it.
Despite a history of fast surges, Amazon has felt rather constrained as of late, trading sideways for nearly six months. A key question among investors is: will the company’s significant investment in artificial intelligence yield a substantial return, or will this expenditure not produce adequate returns?
However, concentrating on the spending overlooks the more critical narrative. Amazon’s approach in the fiercely competitive AI arena encompasses more than just simple purchases; the firm is constructing the vital infrastructure. In doing so, it is stealthily establishing itself as one of the most significant semiconductor manufacturers globally.
Is Amazon Among The Top Three Global Chip Firms?Buried within the most recent earnings call was a striking claim from management: if its custom silicon division operated independently, its yearly revenue run rate would be $50 billion. To provide context, the company asserts its “custom silicon segment is now one of the top three data center chip enterprises worldwide.” This isn’t merely a secondary endeavor. This is a strategic cornerstone slowly materializing in plain view, centered on two primary products: Graviton for general computing and Trainium for AI applications.
While the public perceives AWS primarily as a cloud service provider, it is swiftly transforming into a vertically integrated powerhouse. It has progressed from simply leasing server space to designing and implementing its own high-performance, cost-effective silicon to operate that space. And customers are eagerly awaiting their turn.
MORE FOR YOU
Demand Has Already Surpassed SupplyThis isn’t a theoretical edge; the demand is tangible and urgent. The company’s Trainium2 AI chip is already “primarily sold out.” Its successor, Trainium3, which has just commenced shipping, is “almost fully subscribed.” Most notably, Amazon reports that “a large portion of Trainium4, which is still approximately 18 months from widespread availability, has already been booked.”
When clients are reserving hardware that is set to be available in a year and a half, it indicates a strong demand for the unique price-performance ratio that Amazon is presenting. The customer base extends far beyond AI startups. Tech titan Meta recently “committed to utilizing tens of millions of Graviton cores” to advance its own AI initiatives, opting for Amazon’s custom CPU that delivers up to “40% superior price performance” compared to alternatives.
How Is This Addressing The Spending Concern?This is the vital connection. The bearish argument against Amazon is predicated on the massive cost of its AI expansion. However, creating its own chips fundamentally alters the cost dynamics of that investment. Management has been clear about the benefits, indicating that at scale, it anticipates Trainium will “save us tens of billions of dollars in capital expenditures every year.”
In addition to the cost savings, it establishes a robust competitive advantage. The company forecasts that its in-house silicon will “yield several hundred basis points of operating margin advantage compared to relying on external chips.” In a business as substantial as AWS, which currently operates at a $150 billion annualized revenue run rate, such margin enhancement is a powerful catalyst for profit.
While investors have been closely examining every dollar of capital spending, Amazon has been developing the very technology that could significantly enhance that capital's efficiency. It answers the market's most pressing question, suggesting that the company is evolving beyond mere participation in the AI revolution to construct a foundational, high-margin engine to sustain it for years ahead.
Where Will An Opportunity Like This First Manifest?An opportunity of this nature only counts once it begins to reflect in the financial figures, and the first concrete indication is in management’s outlook. The instant a company can actually anticipate new revenue, it adjusts its forecast, and an upward adjustment that the market is already rewarding serves as some of the clearest evidence that a narrative like this is becoming a reality.
A growth narrative this credible warrants action, but investing through a single stock means accepting all the fluctuations that one company experiences. A more intelligent strategy is to maintain a collection of stocks where the long-term perspective is equally robust, ensuring that the sustainable upside remains intact and no unexpected event can compromise it. This is how patient capital flourishes.
Differentiating the genuinely sustainable narratives from the merely appealing ones is the foundation of the Trefis methodology. The Trefis High Quality (HQ) Portfolio assesses the complete picture of quality across thousands of stocks, not just a single factor, retains the 30 strongest selections, and re-balances them with careful discipline. It possesses a track record of outperforming a benchmark that merges the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.
Nokia rozšiřuje spolupráci s AWS na autonomních sítích pro éru AI, s dostupností produktu později v letošním roce. Akcie v premarketu klesly o 3,79 % na 13,45 USD.
Nokia stock is among today’s weakest performers. Why is NOK stock falling? What Is Driving Nokia’s AWS Collaboration?Nokia’s latest catalyst is the expanded AWS collaboration aimed at "autonomous networks built for the AI era," with its Autonomous Networks Fabric set to run on AWS so telecom operators can move more of their operational stack into the cloud. The companies are positioning the integration around Level 4 autonomy using AI and cloud services, with product availability expected later this year.
Nokia’s pitch leans on unifying data management, agentic AI, digital twin simulations, and intent-based networking to drive "step-change efficiency," with the company’s CTO for AI and Autonomous Networks saying, "This is how telcos will compete in the AI era."
Nokia also has a separate AI-automation thread running through its Google Cloud partnership, where it’s building six specialized Gemini-powered agents for telecom workflows like event triage, anomaly detection, KPI analysis, and remediation recommendations. The companies said the system can cut troubleshooting times 50% to 80%, a concrete efficiency claim that can influence how investors model software-led margin upside.
Nokia Stock: Key Technical Levels To WatchEven with the premarket dip, the longer-term trend still leans bullish: the stock is up 170.93% over the past 12 months and remains well above its 100-day SMA ($10.75) and 200-day SMA ($8.39). The golden cross that formed in October 2025 (50-day SMA above the 200-day SMA) is still intact, which often keeps dip-buyers engaged as long as price holds near those longer averages.
Near-term, the chart looks more like a digestion phase than a breakdown, with price at $13.45 sitting just under the 50-day SMA ($13.49) and below the 20-day SMA ($14.69). That matters because the 20-day SMA is still above the 50-day SMA (a bullish alignment), but the stock needs to reclaim the short-term average to signal that buyers are taking control again.
RSI is the cleaner momentum read right now: at 48.90, it’s neutral and suggests the prior upside momentum has cooled rather than flipped into an oversold washout. In plain terms, RSI helps gauge whether a move is getting stretched, and this reading points to balance—neither panic selling nor overheated buying.
Key Resistance: $15.00 — a round-number ceiling that lines up with a nearby rebound-stall zone if the stock tries to bounce back above its short-term averages – Key Support: $13.00 — a nearby floor that sits close to the 50-day moving-average area where trend buyers often defend pullbacks
What Does Nokia Corporation Do?Nokia is a networking equipment vendor focused primarily on supporting wireless networks and, to a growing extent, Internet Protocol and optical systems. The firm operates three segments spanning mobile infrastructure (wireless core and related software), network infrastructure (IP routing/switching, optical, and fixed-network gear), and a portfolio bucket of businesses it views as less central longer term.
That mix is why the AWS tie-up matters to the stock narrative: it’s aimed at pushing more telecom operations into the cloud while layering in AI-driven automation (including agentic AI, digital twin simulations, and intent-based networking). If operators adopt that approach, it can support a more software- and services-oriented angle alongside the company’s traditional hardware footprint.
Nokia Earnings Preview: July 2026 EstimatesLooking further out, the next major catalyst for the stock arrives with the July 23, 2026 (confirmed) earnings report.
EPS Estimate: 7 cents (Up from 4 cents YoY) Revenue Estimate: $5.59 Billion (Up from $5.15 Billion YoY) Valuation: P/E of 87.8x (Indicates premium valuation relative to peers) Analyst Consensus & Recent Actions: The stock carries a Buy rating with an average price target of $14.67. Recent analyst moves include:
JP Morgan: Overweight (Raises Target to $21.00) (June 12) Argus Research: Upgraded to Buy (Target $15.00) (April 27) Morgan Stanley: Initiated with Overweight (Target $8.00) (Feb. 9) Nokia Benzinga Edge Rankings OverviewBelow is the Benzinga Edge scorecard for Nokia, highlighting its strengths and weaknesses compared to the broader market:
The Verdict: Nokia’s Benzinga Edge signal reveals a momentum-led setup with supportive quality, but a less forgiving valuation backdrop. For longer-term bulls, the key is whether the stock can hold the $13.00 area and rebuild strength back toward $15.00 without losing the 50-day trend zone.
Nokia Stock Price Action in Premarket TradingNOK Stock Price Activity: Nokia shares were down 3.79% at $13.45 during premarket trading on Friday, according to Benzinga Pro data.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
Citigroup prošla stresovým testem Fedu a plánuje zvýšit kvartální dividendu o 12 % na 67 centů na akcii. Spustila také víceleté zpětné odkupy akcií za 30 miliard USD.
Key Takeaways Citigroup cleared the Fed's 2026 stress test, reinforcing capital strength and shareholder return plans.C plans a 12% dividend increase to 67 cents and launched a $30B multi-year buyback program.C expects higher repurchases in 2026 than in 2025, backed by strong capital and liquidity positions. Citigroup Inc.'s (C - Free Report) successful completion of the Federal Reserve's 2026 stress test underscores the bank's financial resilience and strengthens its ability to reward shareholders. While passing the annual stress test is a regulatory milestone, the bigger takeaway for investors is the capital flexibility it creates. A strong capital position allows banks to return more cash through dividend payments and share repurchases while continuing to invest in growth initiatives.
Along with Citigroup, 31 banks like Wells Fargo (WFC - Free Report) and JPMorgan (JPM - Free Report) also cleared the Fed’s 2026 stress test.
C's Lower Capital Requirement Creates More Financial FlexibilityCitigroup’s Stress Capital Buffer remains unchanged at 3.6% after the Federal Reserve’s 2026 supervisory stress test. However, C stated that its latest stress-test results would have supported a lower SCB of 3.3% had the Fed not extended the existing requirements through Oct. 1, 2027. The Fed is maintaining current SCB levels while it finalizes updates to its stress-testing framework, enabling citigroup to continue operating under its existing capital buffer until the revised rules are implemented.
Even with the current requirement, Citigroup remains comfortably above regulatory minimums. As of March 31, 2026, its Standardized Common Equity Tier 1 capital ratio was 12.7%, 110 basis points above the required level of 11.6%. This excess capital provides a meaningful cushion against economic stress and highlights the progress the company has made in simplifying its operations, strengthening risk controls and improving earnings quality.
C’s liquidity position also remains solid. As of March 31, 2026, cash and due from banks, along with total investments, aggregated $467.8 billion, exceeding total debt, including short-term and long-term borrowings, of $379.6 billion.
This strength is translating directly into enhanced shareholder returns. Citigroup plans to raise its quarterly common stock dividend 12% to 67 cents per share from 60 cents, beginning in the third quarter of 2026, subject to board approval. The company has also initiated a $30-billion multi-year common stock repurchase program.
The broader banking sector is also moving to reward shareholders following the stress test results. JPMorgan plans to lift its quarterly dividend to $1.65 per share from $1.50 and authorized a $50-billion share repurchase program. Wells Fargo, meanwhile, plans to increase its quarterly dividend 11% to 50 cents per share, subject to board approval in July.
Coming back to Citigroup, its Investor Day financial overview reinforces this capital-return narrative. C has noted that it has returned roughly $45 billion of capital to shareholders since the beginning of 2022 and expects repurchases to be higher in 2026 than in 2025. This reflects disciplined capital deployment, improving profitability and continued progress in reshaping Citigroup into a simpler and more resilient company.
Final Words on Citigroup Capital StrengthIn conclusion, C’s stress test performance reinforces the strength of its franchise and the continued momentum in executing its transformation strategy. The results show that efforts to reshape the bank into a simpler and more resilient firm are translating into tangible progress, including stronger earnings capacity, enhanced capital resilience and a consistent reduction in its stress capital buffer.
Overall, Citigroup appears well-positioned to deliver steady long-term shareholder returns across varying economic conditions.
C’s Price Performance & Zacks RankCitigroup shares have surged 71.8% in the past year compared with the industry’s growth of 26.2%.
Image Source: Zacks Investment Research
The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
NVIDIA má objednávky na dodávky za 145 miliard USD, které mají zajistit výrobu čipů pro další čtvrtletí i rok 2027. Firma tím podporuje výhled na 1 bilion USD tržeb z Blackwell a Rubin do roku 2027.
A woman takes a picture at the NVIDIA booth during the China International Supply Chain Expo (CISCE) in Beijing on June 25, 2026. (Photo by Pedro PARDO / AFP via Getty Images)
AFP via Getty Images
This article was written by Doug Nathman, with research by his team at Trefis.
While investors concentrate on NVIDIA's staggering growth rate, an even more revealing figure resides in its supply commitments, illustrating a calculated strategy to satisfy demand that skeptics argue may not be viable.
Following a remarkable ascent, NVIDIA (NVDA) shares have cooled. The stock price has dipped below recent peaks, and discussions have transitioned from celebration to doubt. Is it possible for any corporation, even one at the forefront of the AI surge, to sustain this growth rate? While many analysts are examining the latest earnings figures or its trailing multiple, a crucial piece of information for an optimistic perspective is not found on the income statement at all.
The figure is $145 billion. This amount signifies NVIDIA’s overall supply, comprising existing inventory and, more critically, its future purchase commitments.
What Does $145 Billion In Commitments Represent?This amount signifies much more than merely a stockpile of chips stored away; it embodies a substantial, strategic commitment to future production. These pledges secure the necessary manufacturing capacity and raw materials required to create its upcoming generation of processors. Management has affirmed that this is a calculated initiative, reflecting the enhanced demand visibility we possess and a choice to secure capacity farther in advance than is normally standard. In a sector where a single shortage of components can disrupt production, NVIDIA is investing now to ensure it can manufacture the products it anticipates selling over the next several quarters, and even extending into the year 2027.
How This Assures Future RevenueThe underlying principle is straightforward: one cannot sell what cannot be produced. The primary physical limitation on NVIDIA's expansion is not demand, but rather the intricate supply chain necessary for its AI accelerators. By securing $145 billion worth of supply, the company is establishing the groundwork for its forecasts. This strategy is proactive, acting as the concrete basis for management's proclaimed confidence in achieving $1 trillion in Blackwell and Rubin revenue through 2027. That projection appears abstract until one observes the nine-figure commitments being undertaken to ensure the components needed for chip production.
MORE FOR YOU
The Resolution To The Major Concern?The foremost risk looming over the stock is its sustainability. The stock is currently facing pressure precisely because the market is questioning the duration of this level of growth. The company’s price-to-earnings multiple of 30.3, although high in relative terms, lies toward the lower end of its own 10-year spectrum of 19.6 to 143.1, indicating that investors are reluctant to factor in future growth at a rate comparable to the past. These purchase commitments represent a direct and significant response to that apprehension. A corporation that fears an approaching cyclical peak would not engage in long-term supply agreements of this magnitude. This indicates that management perceives a demand trajectory that justifies the undertaking of risk to secure capacity well in advance.
Of course, a commitment does not equate to a sale. The ultimate benchmark is converting that secured supply into revenue. However, for investors attempting to evaluate the resilience of NVIDIA’s market position, this $145 billion figure offers a concrete, forward-looking metric that the headline growth rates do not convey.
Typically, one figure does not drive a decision independently, but recognizing which number is crucial and the rationale behind it constitutes a significant portion of the challenge. Arriving at the aforementioned figure required looking beyond the surface level of fear to what was genuinely occurring beneath—an analysis that is difficult to perform once and exceedingly challenging to replicate consistently.
The Trefis High Quality (HQ) Portfolio is constructed on executing precisely that, continuously, across 30 quality enterprises, and then maintaining them with rule-based discipline so that no single entity dominates your outcome. You acquire a selection of well-researched advantages rather than a sole all-or-nothing gamble, with a proven record of surpassing a benchmark that aggregates the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. If a figure like this one merits action, that form of disciplined quality deserves serious consideration.
Nvidia vykázala tržby 81,61 miliardy USD za Q1 FY27 a těží z CUDA. Cerebras sice nabízí až 21násobně rychlejší inference, ale pro celý rok čeká provozní marže v rozmezí -28 % až -32 %.
NVIDIA (NASDAQ: NVDA | NVDA Price Prediction) and Cerebras Systems (NASDAQ: CBRS) just delivered earnings that frame the same question from opposite ends. Nvidia posted another blowout quarter built on its CUDA software stack. Cerebras, fresh off its May IPO, showed jaw-dropping inference speed yet guided full-year operating margins negative. The moat is developer gravity.
One Sells Platforms. The Other Sells Speed. Nvidia’s Q1 FY27 hit $81.61 billion in revenue, up 85.2% YoY, with Data Center alone reaching $75.25 billion on 92% growth. Networking soared 199% as InfiniBand, NVLink and Spectrum-X locked customers deeper into the stack. Jensen Huang told investors NVIDIA is “the only platform that runs in every cloud, powers every frontier and open source model, and scales everywhere AI is produced”, and the numbers back the claim.
Cerebras’ first report as a public company landed differently. Q1 GAAP revenue reached $193.4 million, up 94% YoY, with cloud services growing 178%. A multi-year, $20 billion-plus OpenAI inference deal covering 750 megawatts anchors near-term growth. Yet management guided full-year operating margins to negative 28% to negative 32%. Speed sells. Scaling it economically is harder.
Software Gravity Beats Wafer-Scale Throughput Independent benchmarks show Cerebras’ wafer-scale design delivering a 21x speed advantage over Nvidia hardware for latency-sensitive, low-batch inference. The catch is that every major LLM framework and enterprise developer stack is natively optimized for Nvidia architecture out of the box, while Cerebras requires specialized compilation and custom engineering support for anything off the well-trodden path.
Lens NVIDIA Cerebras Core Bet CUDA full-stack platform Wafer-scale inference speed Q1 Gross Margin 75.0% non-GAAP 44.6% GAAP Anchor Customers Meta, OpenAI, Anthropic, Google OpenAI, AWS, G42 Biggest Vulnerability OpenAI’s Jalapeño custom chip Negative operating margins Nvidia’s $119 billion in supply commitments and $80 billion added to its buyback authorization signal management is doubling down on the platform. Cerebras raised $5.6 billion at IPO and is funneling it into data center capacity for OpenAI’s decode workloads while AWS Trainium 3 handles prefill. That is a focused inference bet riding on one customer’s roadmap.
The Next Test Is Whether Developers Defect Two catalysts matter into the back half of 2026. For Nvidia, the OpenAI Jalapeño chip, built with Broadcom, is the most credible threat to CUDA stickiness. NVDA shares are already down 8.79% over the past month, even with the stock up 27.01% YoY. For Cerebras, the bar is executing the OpenAI ramp without further margin slippage. Q2 core gross margin guidance of 36% to 38% telegraphs how steep the infrastructure build will be.
Why The Setup Still Favors Nvidia For AI infrastructure exposure with a self-funding moat, Nvidia remains the cleaner expression of the thesis. The 75% gross margin, $48.55 billion in quarterly free cash flow, and the developer install base are tough to dislodge in a single product cycle. Cerebras has the faster chip and a marquee anchor customer. A forward P/E of 23 on NVDA already prices in some software erosion. If CUDA defections spread beyond OpenAI, my view changes.
JPMorgan Chase zvýší kvartální dividendu na 1,65 USD na akcii ve 3. čtvrtletí z 1,50 USD a spustí nový program zpětného odkupu akcií za 50 miliard USD s účinností od 1. července. Akcie se drží poblíž historického maxima.
JPMorgan Chase stock is trading near recent highs. Where is JPM stock headed? What Is JPMorgan’s New Capital-Return Plan?The board plans to raise the quarterly common dividend to $1.65 per share in the third quarter from $1.50, and it authorized a new $50 billion share repurchase program effective July 1. CEO Jamie Dimon framed the move as enabled by excess capital and liquidity, positioning the bank to keep returning cash while maintaining balance-sheet strength.
JPMorgan’s after-hours pop earlier in the week put the stock near its prior record around $338.09, reinforcing why traders are treating the payout reset as a near-term floor for sentiment. The bank also ended March 31 with $4.9 trillion in assets and $364 billion in stockholders’ equity, giving the capital-return plan more credibility than a one-off headline.
JPMorgan is also navigating tighter internal controls around AI tooling, after restricting Hong Kong staff access to Anthropic’s Claude models tied to export-control pressure on "Fable 5" and "Mythos 5." That operational friction sits in the background even as the stock pushes higher on a new $50B repurchase authorization.
JPM Stock: Critical Levels To WatchJPM is extended versus its trend gauges, trading 6.4% above the 20-day SMA ($316.41) and 9.4% above the 200-day SMA ($307.82), which keeps the longer-term uptrend intact but increases the odds of a pause or sideways digestion. The trend stack is still constructive, with the 20-day SMA above the 50-day SMA and the golden cross that formed in June (50-day SMA above the 200-day SMA) reinforcing the intermediate bullish regime after the death cross in March.
For momentum, MACD is the cleaner read here: it’s above its signal line with a positive histogram, which points to improving upside pressure versus the prior downswing. RSI previously entered overbought territory in June, so the setup can stay bullish while still being vulnerable to short, sharp pullbacks.
Key Resistance: $337.50 — a nearby pivot area just above the current price where breakouts can stall, especially with the stock pressing the top end of its 52-week range Key Support: $293.50 — a prior demand zone well below current levels that traders may treat as a larger "line in the sand" if the uptrend unwinds How JPMorgan Chase Operates GloballyJPMorgan is a leading global financial services firm with operations in 66 countries and over 318,000 employees as of year-end 2025. Under the JPMorgan brands, the bank holding company boasts a $4.9 trillion balance sheet and $2.68 trillion in deposits, as of March 2026.
JPM Earnings Preview: What Analysts ExpectLooking further out, the next major catalyst for the stock arrives with the July 14, 2026 (confirmed) earnings report.
EPS Estimate: $5.42 (Up from $4.96 YoY) Revenue Estimate: $48.61 Billion (Up from $45.68 Billion YoY) Valuation: P/E of 16.0x (Suggests fair valuation relative to peers) Analyst Consensus & Recent Actions: The stock carries a Buy rating with an average price target of $343.88. Recent analyst moves include:
Evercore ISI Group: Outperform (Raises Target to $340.00) (April 17) Jefferies: Hold (Raises Target to $320.00) (April 15) Truist Securities: Hold (Raises Target to $332.00) (April 15) JPMorgan Chase: Benzinga Edge Scorecard BreakdownBelow is the Benzinga Edge scorecard for JPMorgan Chase &, highlighting its strengths and weaknesses compared to the broader market:
The Verdict: JPMorgan Chase &’s Benzinga Edge signal reveals a growth-leaning profile with moderate momentum but a weaker quality score. For longer-term bulls, the setup works best if price can hold above the rising short-term averages while it digests gains near resistance.
JPM Stock Price ActivityJPM Stock Price Activity: JPMorgan Chase shares were down 0.80% at $332.44 at the time of publication on Friday, according to Benzinga Pro data.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
Chevron uvedl, že všichni zaměstnanci ve Venezuele jsou v pořádku a provoz po silných zemětřeseních pokračuje bez narušení. Normálně fungují i klíčové těžební projekty, rafinerie Paraguaná a exportní terminál José.
Key Takeaways Chevron confirmed employees are safe and Venezuelan operations continue without earthquake disruptions. CVX said key crude projects, refining and export facilities continue operating normally. Chevron is supporting communities while monitoring safety and recovery across Venezuela. Chevron Corporation (CVX - Free Report) has confirmed that its operations in Venezuela remain unaffected despite two powerful earthquakes that caused widespread destruction and significant loss of life, underscoring the company's commitment to employee safety, operational resilience and support for local communities during challenging times.
Employee Safety Remains the Top Priority for CVXChevron reported that all of its employees in Venezuela are safe and accounted for following the twin earthquakes, which measured 7.2 and 7.5 in magnitude. The company expressed solidarity with the Venezuelan people and reaffirmed its commitment to supporting employees, neighboring communities and maintaining safe operations.
With a long-standing presence in the country, Chevron emphasized that protecting its workforce remains its highest priority while continuing to monitor the evolving situation closely.
CVX's Operations Continue Without DisruptionDespite the severe impact of the earthquakes, Chevron, currently carrying a Zacks Rank #3 (Hold), confirmed that its Venezuelan assets continue to operate normally. The company's three onshore heavy crude projects in western and eastern Venezuela have not experienced operational disruptions.
Key oil infrastructure also remained functional following the seismic events. Venezuela's Paraguaná refining complex, located near the affected region, continued normal refining activities, while the José export terminal maintained regular crude export operations.
These developments demonstrate the resilience of critical energy infrastructure even under difficult circumstances.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Industry Maintains StabilityChevron was not the only energy company to report uninterrupted operations. Other international operators, including Eni S.p.A. (E - Free Report) and Repsol, S.A. (REPYY - Free Report) , also confirmed that their Venezuelan assets remain operational.
Eni continues supplying natural gas that supports approximately half of Venezuela's gas-fired power generation, while Repsol's projects, including its partnership with Eni in the Perla gas field, continue contributing to the country's energy supply.
Although operations have remained stable, authorities and industry operators like CVX, E and REPYY continue assessing petrochemical facilities located closer to the earthquake's epicenter to ensure long-term safety.
Recovery Efforts Continue Across VenezuelaEmergency response teams remain engaged in rescue and recovery efforts following one of the strongest earthquakes recorded in Venezuela in more than a century. Authorities continue evaluating damage to industrial facilities, public infrastructure and residential areas.
Meanwhile, the Morón Petrochemical Complex has begun restoring operations after temporarily suspending activities to complete safety inspections. The precautionary shutdown reflects the industry's emphasis on protecting personnel and ensuring facility integrity before resuming operations.
Chevron's Long-Term Commitment to VenezuelaChevron has maintained a presence in Venezuela through years of political and economic uncertainty. It is making major developments in Venezuela, where production from its joint ventures has been steadily rising, reinforcing its position as a critical partner to PDVSA. The company currently contributes roughly a quarter of the country’s total crude output, underscoring both its operational importance and long-term strategic interest in the region. Chevron's ability to continue operating safely following this natural disaster reflects its focus on operational excellence, risk management and responsible energy production.
By prioritizing employee safety while maintaining reliable operations, Chevron continues to support Venezuela's energy sector during a period of significant national hardship.
Chevron's Ongoing Commitment to Safety and RecoveryAs Venezuela continues recovery efforts, Chevron remains focused on safeguarding its workforce, supporting affected communities and ensuring the safe operation of its assets. The company's swift response and operational resilience demonstrate the importance of strong safety practices and infrastructure preparedness in the face of unexpected natural disasters.
With ongoing assessments across the country's energy sector, Chevron continues working alongside stakeholders to provide reliable energy while contributing to recovery efforts wherever possible.
Nebius zvýšil smluvní kapacitu napájení na více než 3,5 GW a do konce roku očekává přes 4 GW. Digital Realty hlásí rekordní leasing v oblasti AI a backlog ve výši 1,8 mld. USD.
Key Takeaways NBIS is expanding its AI infrastructure, targeting more than 4 GW of contracted power capacity by year-end. DLR is seeing record AI-driven leasing, expanding its data center pipeline through 2027 and beyond.Both NBIS and DLR are investing heavily in AI infrastructure, but differ in growth pace and business models. Nebius Group N.V. (NBIS - Free Report) and Digital Realty Trust, Inc. (DLR - Free Report) are benefiting from the rapid expansion of AI infrastructure as enterprises and hyperscalers accelerate investments in high-performance computing, AI cloud platforms and next-generation data centers. Growing demand for AI training and inference workloads is driving the need for large-scale GPU capacity, power-rich data center campuses and globally connected infrastructure, positioning both companies to capitalize on the ongoing buildout of the AI ecosystem.
While Nebius is expanding its AI-native cloud platform by adding GPU capacity, securing long-term customer commitments and investing heavily in new AI infrastructure, Digital Realty is scaling its global data center platform through record leasing activity, hyperscale developments and expanded connectivity to support increasingly AI-driven workloads. Both companies continue to invest aggressively to meet rising AI infrastructure demand, although they are executing through different business models within the AI infrastructure value chain.
Let’s evaluate their fundamentals, growth prospects, market challenges and valuations to determine which stock presents a stronger investment opportunity.
The Case for NBISNebius is rapidly scaling its AI infrastructure footprint by expanding data center capacity and strengthening its AI-native hyperscaler platform. Within the past three months, the company has increased its contracted power capacity from more than 2 gigawatts to over 3.5 gigawatts and now expects to exceed 4 gigawatts by year-end. It also announced a new data center site in Pennsylvania, which is expected to support 1.2 gigawatts of power at full build-out. More than 75% of the company's contracted power capacity is now owned, reflecting its strategy of building and operating an integrated AI infrastructure platform with greater control over long-term capacity.
The company continues to enhance its full-stack AI cloud platform by offering services across the AI lifecycle, including bare-metal infrastructure, multi-tenant cloud, inference and agentic capabilities. The acquisitions of Tavily, Eigen AI and Clarifai have strengthened its engineering capabilities while improving inference optimization and agentic search technologies. The company also expanded its collaboration with NVIDIA and achieved NVIDIA Exemplar Cloud status for GB300 training workloads, placing it among a limited number of cloud providers recognized across multiple GPU generations.
Demand for Nebius' AI infrastructure remains strong across a broad range of industries, with management stating that several customers typically compete for every GPU brought online. During the first quarter, pipeline generation increased 3.5 times sequentially, supported by growing demand from AI-native companies, enterprises and software vendors. Customers spanning fintech, physical AI, life sciences, manufacturing, energy and pharmaceuticals are increasingly adopting the company's AI cloud platform. Nebius also delivered a strong first-quarter financial performance, with group revenue rising 684% year over year and the AI business recording 841% revenue growth, reaching an annualized run-rate revenue of $1.9 billion.
For 2026, Nebius expects annualized run-rate revenue of $7 billion to $9 billion, group revenue of $3 billion to $3.4 billion and an adjusted EBITDA margin of around 40%. However, management expects quarterly EBITDA margins to fluctuate during the year as investments in infrastructure and capacity expansion are incurred ahead of revenue generation. Margins are expected to decline in the second quarter due to the back-half weighted deployment of new capacity before recovering to first-quarter levels in the third quarter and improving further in the fourth quarter.
The company has also raised its 2026 capital expenditure guidance to between $20 billion and $25 billion from the earlier range of $16 billion to $20 billion to support additional AI infrastructure capacity planned for 2027. The increased investment is backed by customer commitments but will require incremental financing through asset-backed structures, corporate debt and other funding alternatives. The company continues to evaluate multiple financing sources while maintaining a disciplined approach to funding its long-term data center expansion strategy.
The Case for DLRDigital Realty is gaining from robust AI infrastructure and data center demand, with enterprises and hyperscalers increasingly deploying AI workloads across its global PlatformDIGITAL ecosystem. The company said digital infrastructure has become foundational as AI adoption accelerates compute intensity, cloud demand remains resilient and enterprises continue investing in technology. This drove one of the strongest leasing quarters in the company's history, supported by rising demand for both interconnection services and large-scale hyperscale capacity.
The company continues to strengthen its position in AI-ready infrastructure through record leasing activity and an expanding global footprint. The company signed its largest-ever lease, a 200-megawatt AI inference deployment with a hyperscale customer in Charlotte, while also securing multiple 10-plus megawatt AI-related leases across major global markets. AI-oriented bookings represented a record share of the 0-1 megawatt category, reflecting growing enterprise adoption. To support future demand, the company expanded its development pipeline to 1.2 gigawatts under construction, increased investments in hyperscale campuses and added new connectivity hubs and land acquisitions across North America, Europe and the Asia-Pacific.
Digital Realty is also benefiting from strong long-term visibility supported by a record backlog and continued investments in AI-focused data center capacity. Management highlighted that customers are shifting AI deployments from pilot projects to production environments, particularly for inference workloads, while enterprise AI demand continues to expand. Record bookings lifted the backlog to $1.8 billion, with lease commencements extending into 2027 and beyond. Digital Realty is simultaneously scaling its private capital platform, expanding hyperscale development funding and securing additional land and power resources to meet customers' long-term AI infrastructure requirements.
However, the rapid expansion of AI infrastructure continues to face industry-wide execution challenges. Management noted that limited power availability, labor shortages, supply chain constraints and community opposition are restricting the pace at which new data center capacity can be delivered. These factors are widening the gap between customer demand and deployable capacity, while utilities, equipment availability and construction timelines remain key variables across major markets.
Digital Realty is also navigating higher development costs as inflation in land values, construction expenses, supply chains and liquid-cooling infrastructure increases capital requirements for new AI data centers. The company acknowledged elevated operating expenses during the quarter and expects continued investment spending to support hyperscale growth. While management believes market rental rates are strong enough to offset rising development costs and preserve targeted returns, higher capital intensity and ongoing infrastructure investments remain important considerations.
Share Performance for NBIS & DLRIn the past three months, NBIS stock has surged 154.5% while DLR gained 10.4%.
Image Source: Zacks Investment Research
Valuation for NBIS & DLRIn terms of Price/Book, NBIS shares are trading at 8.97X, higher than DLR’s 2.93X.
Image Source: Zacks Investment Research
How Do Estimates Compare for NBIS & DLR?Over the past 60 days, analysts have significantly revised estimates for NBIS’ bottom line for the current year.
Image Source: Zacks Investment Research
For DLR, estimates have been revised marginally upward over the past 60 days.
Image Source: Zacks Investment Research
NBIS or DLR: Which Stock is the Better Investment?Both NBIS and DLR currently carry a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
While Digital Realty provides a more established and stable data center platform supported by strong leasing activity and long-term backlog, Nebius' faster growth profile, improving earnings outlook and expanding AI-native platform make it the more compelling choice for investors seeking higher upside in the AI infrastructure space.
SSR Mining dokončila prodej 80% podílu v dole Çöpler společnosti Cengiz Holding za 1,49 mld. USD v hotovosti. Výnosy chce použít na reinvestice, návrat kapitálu akcionářům a růst.
Key Takeaways SSR Mining closed the sale of its 80% stake in the Copler Mine to Cengiz.SSRM received $1.49B in cash and plans to reinvest, return capital and pursue growth.SSR Mining expects its 2026 gold equivalent output of 450,000-535,000 ounces from four mines. SSR Mining Inc. (SSRM - Free Report) announced that it closed its previously announced sale of 80% stake in the Çöpler Mine to Cengiz Holding A.S. Along with the prior announced sale of the 20% stake in the Hod Maden development project, the sale of the Çöpler Mine is consistent with SSR Mining's refocusing toward an Americas platform.
Details of SSR Mining’s Deal to Sell Çöpler Mine StakesOn March 4, 2026, SSR Mining inked a binding memorandum of understanding to sell its majority stake in the Çöpler Mine and related properties in Türkiye. Çöpler was a key contributor to SSRM’s output, which stopped operations on Feb. 13, 2024, following a significant slip on the heap leach pad.
SSR Mining worked toward the restart of the Çöpler Mine while securing the necessary regulatory approvals from Turkish authorities over the past two years. During this time, the company determined a strategic review to be the optimal path for the mine to maximize shareholder value.
SSR Mining received $1.49 billion in cash from the transaction, which it plans to use for continued business reinvestment, capital returns and accretive growth initiatives. SSRM expects the sale to yield immediate value for shareholders by exceeding current market expectations for the mine's net asset value and cash flow.
SSRM’s recent strategic actions, including the acquisition of the Cripple Creek & Victor Mine, position it as a leading producer in the United States focused on free cash flow and capital return. The company currently operates four active mines across the United States, Canada and Argentina. SSR Mining expects gold-equivalent ounces to be 450,000-535,000 for 2026.
SSRM Stock Price PerformanceThe SSRM stock has appreciated a whopping 125.2% in a year compared with the industry’s return of 40.8%.
Image Source: Zacks Investment Research
SSR Mining’s Zacks Rank & Stocks to ConsiderThe Zacks Consensus Estimate for Dow's current-year earnings is pegged at $2.61 per share, indicating a 377% year-over-year surge. Dow’s shares have gained 13.6% in a year.
Albemarle has an average trailing four-quarter earnings surprise of 74.5%. The Zacks Consensus Estimate for the company’s 2026 earnings is pegged at $12.45 per share, indicating year-over-year growth from a loss of 79 cents. ALB shares have skyrocketed 124% so far this year.
Avino Silver has an average trailing four-quarter earnings surprise of 125%. The Zacks Consensus Estimate for Avino Silver’s 2026 earnings is pegged at 39 cents per share, indicating 34.5% year-over-year growth. Its shares have surged 62.7% in a year.
Jefferies potvrdila pro AstraZeneca doporučení koupit a označila ji za Franchise Pick před klíčovým čtením dat ze studie CARDIO-TTRansform ve druhé polovině roku 2026. Cílová cena 18 000 p znamená asi 30% růst.
Jefferies has reiterated its 'buy' rating on AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) and named the drugmaker a Franchise Pick, framing an approaching late-stage trial readout as the next major catalyst for the shares.
The broker holds a price target of 18,000p, implying upside of around 30% to the current price.
At the centre of the call is CARDIO-TTRansform, a phase III study of eplontersen, marketed as Wainua, in transthyretin amyloidosis, a progressive condition in which misfolded proteins build up in the heart.
Data is due in the second half of 2026, and Jefferies argues a positive result could de-risk around $5 billion in future sales while adding a low single-digit percentage to its net present value estimate.
The analysts see the trial as well placed to succeed, citing a large patient population and the ability to test the drug both alone and alongside existing stabiliser therapies such as tafamidis.
A favourable outcome would validate eplontersen as a competitive silencing treatment and open the door to combination use, where Jefferies sees the larger long-term prize.
The broker frames the opportunity within a transthyretin amyloidosis market it expects to reach around $18 billion by 2030, driven by earlier diagnosis and a shift towards disease-modifying therapies in a condition that remains widely underdiagnosed.
Jefferies also points to AstraZeneca's broader pipeline, including the amyloid-clearing antibody cliramitug, as evidence of a multi-mechanism franchise rather than a single-product bet.
On the longer-term question of growth beyond 2030, the analysts estimate AstraZeneca must de-risk roughly $12.5 billion of incremental revenue by 2034 to sustain forecast top-line growth of about 3% a year, a target they consider achievable.
The price target places the stock at a premium of around 40% to the European pharmaceuticals sector on 2027 earnings, a valuation Jefferies says is justified.
Intel v 1. čtvrtletí vykázal non-GAAP EPS 0,29 USD při tržbách 13,58 mld. USD a divize Data Center a AI vzrostla meziročně o 22 %. TSMC zároveň zvýšila tržby o 21,4 % a čistý zisk o 43,82 %.
Intel (NASDAQ:INTC | INTC Price Prediction) and Taiwan Semiconductor Manufacturing (NYSE:TSM) both posted Q1 2026 results that frame the same question from opposite sides: who builds the world’s most advanced chips, and where. TSMC remains the engine of AI silicon. Intel is the Western alternative hyperscalers are quietly funding. Geography matters more than the numbers.
Foundry Bets Lift Intel. AI Wafers Carry TSMC. Intel’s Q1 came in at $0.29 in non-GAAP EPS on $13.58B revenue, with Data Center and AI up 22% YoY and Foundry up 16% YoY. CEO Lip-Bu Tan stated: “The next wave of AI will bring intelligence closer to the end user… This shift is significantly increasing the need for Intel’s CPUs and wafer and advanced packaging offerings.” A $4.07B Mobileye-related restructuring charge dragged GAAP results into a loss.
TSMC’s quarter was cleaner. Q1 revenue hit NT$1,134.10B, up 21.4% YoY, and net income jumped 43.82% to NT$572.48B. Gross margin reached 66.2%, a profitability profile Intel cannot match today. April monthly revenue rose 17.5% YoY, confirming AI wafer demand is accelerating.
Western Subsidies vs. Taiwanese Scale Intel’s foundry roadmap anchors a politically insulated U.S. manufacturing base: $8.9B in CHIPS Act funding, a $5.0B NVIDIA equity investment, $2.0B from SoftBank, and Intel 18A ramping at Fab 52 in Arizona. Xeon 6 was selected as the host CPU for NVIDIA’s DGX Rubin NVL8 systems. Intel joined the Terafab project alongside SpaceX, xAI, and Tesla. Hyperscalers are realizing that relying on a single island for over 90% of advanced chip fabrication is an unsustainable operational risk.
TSMC is diversifying with fabs in Arizona, Japan, and Germany, with its Arizona tax credit rate raised from 25% to 35%. Customer concentration is striking: the top 10 customers represent 84% of accounts receivable. Most leading-edge research stays in Hsinchu.
Lens Intel TSMC Core Bet U.S. foundry as secure second source Taiwan-anchored leading-edge dominance Key Vulnerability Execution on 18A yields and customer wins Geopolitical concentration risk Profit Engine Xeon, advanced packaging, foundry ramp 3nm and 2nm AI wafers The Next Test Is Intel 18A Customer Wins Watch whether Intel converts its Google ASIC partnership and NVIDIA wafer relationship into named 18A foundry customers before management decides on the Intel 14A go-ahead. For TSMC, monitor whether the 2D transistor and CoPoS packaging roadmap stays on schedule while Arizona expansion absorbs more capex. Intel guided Q2 to $13.8B-$14.8B in revenue with non-GAAP EPS of $0.20, so the margin path matters more than the headline.
Why Intel Offers Asymmetric Upside Intel fits investors seeking exposure to the structural reshoring trade, even with restructuring noise and a CFO who trimmed shares at $109.82. The stock is up 256.78% YTD, so the easy money is gone, but the foundry thesis has years to play out. TSMC remains the better business by every operating metric, with 46.5% profit margin proving it. TSMC may appeal to investors prioritizing quality compounding. If China-Taiwan tensions cool meaningfully, the relative case for TSMC strengthens. Until then, Intel’s political insulation is the edge the market is still underpricing.
DexCom potvrdil výhled růstu tržeb na rok 2026 o 11 % až 13 % a dál rozšiřuje adopci CGM díky novým produktům a širšímu pokrytí. Abbott naopak čelí slabosti diagnostiky, nejistotě v Číně a ředění EPS po akvizici Exact Sciences.
Key Takeaways Abbott faces Diagnostics weakness, China uncertainty and EPS dilution from the Exact Sciences deal.DXCM is expanding CGM adoption through new products, broader coverage and global market growth.DXCM reiterated 2026 revenue growth guidance of 11%-13% and expects wider G7 15 Day adoption. With the rising prevalence of diabetes worldwide, the demand for more efficient and real-time glucose monitoring solutions has intensified. Abbott (ABT - Free Report) and DexCom (DXCM - Free Report) are among the leading players in the continuous glucose monitoring (CGM) device market, valued at $13.4 billion in 2025 by Grand View Research.
Healthcare giant Abbott’s businesses span cardiovascular care, diagnostic testing, nutrition, pain and movement disorders, with Diabetes Care being a consistent top-line driver for the past several quarters. On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 diabetes using insulin therapy, as well as certain non-insulin users who struggle with hypoglycemia.
Here’s a closer look at both companies to determine which stock offers the more compelling investment opportunity today.
The Case for Abbott
Abbott’s flagship, sensor-based CGM system, FreeStyle Libre, has quickly established global leadership across both Type 1 and Type 2 diabetes. CGM sales reached $2 billion in the first quarter of 2026, up 7.5% year over year, though growth was affected by a delay in an international tender renewal and a difficult prior-year comparison tied to shelf restocking dynamics. CGM growth is forecasted to return to double-digits in the second quarter.
Abbott’s CEO also remains bullish on the long-term CGM opportunity, estimating that 70-80 million people globally should be using CGMs compared with the current market of roughly 10-12 million users. Recently, the company secured CE Mark for the first-ever dual glucose-ketone sensing technology for people with diabetes, branded as Libre Duo and Libre Duo 10 Day. The systems continuously measure glucose and ketone levels every minute and will integrate with the Libre digital health ecosystem.
Beyond Diabetes Care, Abbott’s Core Lab Diagnostics business is seeing robust demand across the United States, Europe and Latin America. However, Core Lab trends were flat in China, with the company continuing to expect a weaker market for the full year despite lapping prior pricing actions.
The March 2026 acquisition of Exact Sciences added a Cancer Diagnostics business, expanding presence in one of the fastest-growing areas of healthcare. Even so, the deal introduces a $0.20 dilution to the 2026 adjusted EPS guidance of $5.38 to $5.58.
Abbott’s Rapid and Molecular Diagnostics business suffered from lower demand for respiratory virus testing due to a much weaker respiratory season compared to last year. Management is taking a cautious view and is not assuming the shortfall will recover later in the year. The Established Pharmaceuticals Division benefits from branded generics positions in faster-growing geographies. Abbott is focused on restoring a healthier balance between price and volume over time in Nutrition, while its Medical Devices segment is gaining from scale advantages and new product cycles across the franchises.
Take a look at how analysts are projecting Abbott’s bottom line.
Image Source: Zacks Investment Research
The Case for DexCom
DexCom is benefitting from broader access to its CGM product portfolio, continued active base growth and new product launches. The company has partnered with several insulin delivery systems manufacturers to integrate its CGM products, with more than one million CGM users now connected to an automated insulin delivery (AID) system worldwide.
Internationally, DexCom’s 2026 first-quarter growth was widespread across core markets, with notable strong performance in countries such as France and Canada, where access has recently expanded. Management outlined a targeted international strategy aimed at gaining share through reimbursement progress and a portfolio tailored to local channels, including DexCom One+ in Europe.
In the quarter, DexCom made an expanded rollout of the G7 15 Day sensor across all U.S. channels. The platform is now available with all U.S. pump partners, helping minimize friction for AID users who upgrade within the installed base. DexCom expects nearly 50% conversion of the U.S. base to the 15-day sensor by year-end 2026, with an international launch expected to begin in the second half of the year. The company also introduced its next-generation G8 roadmap, designed to deliver a step-change improvement in glucose performance with a smaller form factor and self-adapting sensor.
DexCom continues to build out its software ecosystem, adding engagement tools for Stelo, including enhanced Smart Meal Logging features, and it has been expanding provider-facing capabilities through Direct EHR Integration. More than 320 health systems have already integrated or are in the process of onboarding this capability across the United States and international markets.
The company also continues to expand insurance coverage for its CGM sensors, particularly among Type 2 diabetes patients. The three largest U.S. Pharmacy Benefit Managers now cover DexCom CGM for all people with diabetes, including those with type 2 not using insulin.
ABT also reiterated its 2026 revenue guidance, calling for 11% to 13% growth over 2025 levels. Take a look below at how the company’s earnings estimates are shaping up.
Image Source: Zacks Investment Research
ABT & DXCM: Price Performance and Valuation
Year to date, ABT shares have declined 25.6%, whereas DexCom shares have climbed 4.1%.
Image Source: Zacks Investment Research
Abbott is trading at a forward, five-year Price/Sales (P/S) of 2.99X, below its median of 4.63X. Meanwhile, DXCM sits with a five-year P/S of 4.88X, also lower than its median of 9.93X.
Image Source: Zacks Investment Research
Conclusion
Both companies are poised to benefit from the long-term growth trends of the CGM market. However, Abbott continues to face respiratory testing volatility in Diagnostics, dilution risk following the Exact Sciences acquisition and ongoing uncertainty in China. DexCom is gaining from elevated CGM demand worldwide, new product launches and expanding coverage for its sensors.
While DexCom trades at a premium to Abbott, it remains well below its historical median. The stock has also delivered stronger YTD performance relative to Abbott. Coupled with positive earnings estimate revisions, existing DXCM holders may find it prudent to stay invested to enjoy growth prospects. Meanwhile, those holding ABT stock may find it wise to sell for now until the short-term operating visibility improves.
DXCM carries a Zacks Rank #3 (Hold), while ABT has a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Morgan Stanley Wealth Management rozšířila přístup k PMAX - Balanced, odstranila požadavek na akreditovaného investora a spustila PMAX - Growth. Minimální investice je 10 000 USD.
NEW YORK--(BUSINESS WIRE)--Morgan Stanley Wealth Management announced that it has expanded access to the Morgan Stanley Private Markets and Alternatives Fund ("PMAX") by registering it as PMAX - Balanced. This change removes the accredited investor requirement, lowers minimum investment amounts, and introduces daily subscriptions, making private market strategies accessible to a broader range of clients through a simplified, professionally managed investment vehicle.
Morgan Stanley Wealth Management is also adding to its PMAX product suite with the launch of PMAX - Growth, a fund with a growth-focused allocation, and plans to introduce additional strategies with targeted investment objectives.
Historically, access to private markets was primarily limited to institutions and ultra-high-net-worth investors, but the PMAX fund platform now broadens access to institutional-quality private market investment managers for more clients.
This expansion comes as private markets continue to gain momentum. Global Alternatives AUM is expected to exceed $30 trillion in 2030, up from less than $10 trillion a decade ago, driven by companies staying private longer and increasing investor demand for opportunities beyond public markets.1 Over the same period, the number of public companies has declined significantly, while 84% of companies generating $100 million or more in revenue remain private.2
Morgan Stanley Wealth Management continues to see substantial growth in alternative investments, with over $300 billion in client assets under management.3 This achievement positions the Firm as a leading provider of alternative investment solutions in the wealth management sector and underscores its 45-year history of excellence in this space, extensive resources, and a dedicated team of nearly 350 alternatives professionals.
“Our PMAX platform reflects our commitment to broadening access to private markets through innovative products designed to meet a wider range of client needs,” said Alison Nest, Head of Investment Solutions Products. “By expanding the platform and making it easier to invest, we are giving clients and advisors more ways to build diversified portfolios aligned with their investment objectives.”
PMAX platform overview
PMAX - Balanced, with currently over $1B in AUM4, is a multi-manager portfolio offering diversified exposure across private equity, private credit, real estate and infrastructure through a simplified, single-ticket evergreen vehicle. With a diversified allocation across these strategies, it seeks to offer the potential for risk-adjusted higher returns, income and lower correlation relative to traditional investments.
PMAX - Growth is a growth-oriented private markets approach for clients seeking increased exposure to long-term capital appreciation opportunities. The fund provides diversified exposure to private equity through a curated, multi-manager portfolio across sectors, geographies and vintages, combining growth‑oriented and buyout strategies that seek to pursue long‑term capital appreciation while providing diversification.
The funds require a $10,000 initial investment and $5,000 for subsequent contributions. The funds permit daily purchases and allow clients to benefit from consolidated tax reporting and fully funded exposure without capital calls. Additionally, the streamlined investor experience removes the need for subscription documents, making the process simpler and more efficient for clients.
The funds are closed-end investment companies and do not offer daily redemptions. Liquidity is anticipated only through limited quarterly repurchase offers that occur at the discretion of each fund's Board of Trustees.
“The PMAX platform brings together Morgan Stanley Wealth Management’s scale, alternatives expertise and manager access in a way that is designed to make private markets investing more accessible and more flexible for clients,” said Brian Holzer, Head of Alternative Investments Distribution. “With these offerings, we are continuing to build a differentiated platform that helps advisors deliver institutional-quality private market strategies.”
Investment approach
The funds utilize the intellectual capital of Morgan Stanley Wealth Management’s Global Investment Committee for asset allocation and Global Investment Manager Analysis team for manager selection and due diligence.
PMAX - Balanced targets allocations to private equity, private credit and real assets. This calibrated mix is designed to pursue higher risk-adjusted returns, income and diversification across private market strategies that may have lower correlation to public markets. The strategy also seeks diversification across sub-strategy, geography, sectors and managers, while retaining flexibility to incorporate additional strategies as opportunities arise.
PMAX - Growth targets allocation ranges that emphasize buyout strategies, as a core component, complemented by growth equity and venture capital and other opportunistic strategies. Overall, the approach focuses on diversification within private equity through manager selection, asset allocation, and periodic rebalancing, with the goal of seeking attractive risk‑adjusted returns over time.
About Morgan Stanley Wealth Management
Morgan Stanley Wealth Management, a global leader, provides access to a wide range of products and services to individuals, businesses and institutions, including brokerage and investment advisory services, financial and wealth planning, cash management and lending products, annuities and insurance, retirement and trust services.
About Morgan Stanley
Morgan Stanley (NYSE MS) is a leading global financial services firm providing investment banking, securities, wealth management and investment management services. With offices in more than 41 countries, the Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For more information, visit www.morganstanley.com.
Important Information
This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy any securities, nor does it constitute investment advice or a recommendation of any kind.
The PMAX funds are closed-end investment companies with limited to no liquidity. Shares are not listed on any securities exchange and no secondary market is expected to develop. Shareholders do not have the right to require the funds to redeem their shares. The funds may offer to repurchase shares on a quarterly basis in an amount not to exceed 3% of each fund's net asset value, subject to the discretion of each fund's Board of Trustees. No assurances can be given that a fund will conduct a repurchase in any given quarter and investors should not expect to be able to sell their shares regardless of how a fund performs.
The funds invest primarily in private market strategies for which valuations are generally provided on a quarterly basis by the underlying portfolio fund managers, while the funds calculate their net asset value and offer shares on a daily basis. Accordingly, the daily net asset value of a fund's shares may not fully reflect the current fair value of the fund's underlying investments and may be subject to adjustment as updated valuations become available.
Investing in the funds involves a high degree of risk, including the possible loss of the entire investment. The funds invest in non-traditional, alternative strategies, including private equity, private credit and real assets, that are subject to risks not typically associated with traditional investments, including but not limited to illiquidity, limited transparency, leverage, valuation uncertainty and potential for significant price volatility. Past performance is not indicative of future results, and there can be no assurance that the funds will achieve their investment objectives.
Investors should carefully read the applicable prospectus before investing for a more complete description of the risks involved. Copies of the prospectus may be obtained by contacting your Morgan Stanley Financial Advisor.
The sole purpose of this material is to inform, and it is in no way intended to be an offer or solicitation to purchase or sell any security, other investment or service, or to attract any funds or deposits. Products mentioned herein may not be appropriate for all investors and may be purchased only after an eligible investor has carefully reviewed the Fund’s offering materials and executed any applicable subscription documents. MSWM has not considered the actual or desired investment objectives, goals, guidelines, or factual circumstances of any investor in any fund(s). Before making any investment, each investor should carefully consider the risks associated with the investment, as discussed in the applicable offering materials, and make a determination, based upon their own particular circumstances, that the investment is consistent with their investment objectives and risk tolerance.
Past performance is no guarantee of future results. Actual results may vary. Diversification does not assure a profit or protect against loss in a declining market.
Alternative investments involve complex tax structures, tax inefficient investing, and delays in distributing important tax information. Individual funds have specific risks related to their investment programs that will vary from fund to fund. Clients should consult their own tax and legal advisors as MSWM does not provide tax or legal advice.
Interests in alternative investment products are only made available pursuant to the terms of the applicable offering materials, are distributed by MSWM and certain of its affiliates, and (1) are not FDIC-insured, (2) are not deposits or other obligations of MSWM or any of its affiliates, (3) are not guaranteed by MSWM or any of its affiliates, and (4) involve investment risks, including possible loss of principal. MSWM is a registered broker-dealer, not a bank.
RedStone nyní dodává cenový feed pro JupUSD na Solaně, aby stablecoin mohl fungovat jako kolaterál v DeFi. Jupiter tím zpeněžuje nevyužitý kolaterál z perpetuals.
Launching a stablecoin used to mean building the whole stack: reserves, attestation, custody, redemption, distribution. Stablecoin-as-a-Service from Ethena removes that work. What is left for the issuer is the price feed that lets the token work as collateral in DeFi. For JupUSD, that feed comes from RedStone.
TL;DR: Stablecoin-as-a-Service lets any app launch a branded stablecoin on rented reserve infrastructure. Ethena runs the reserves and the machinery, and the partner brings the name and the distribution. Jupiter launched JupUSD stablecoin, monetizing $400 to $500 million of idle perps collateral. The current stablecoin circulating supply sits at $51 million. RedStone now delivers the price feed for JupUSD on Jupiter’s Solana platform. Stablecoin-as-a-Service: Ethena’s Reserve Model Ethena Whitelabel is a Stablecoin-as-a-Service product that allows partners to launch a branded stablecoin on rented reserve infrastructure, the same infrastructure that also backs USDtb, Ethena’s BUIDL-backed dollar.
When a partner launches a branded stablecoin, Ethena runs the reserves and the mint and redemption process, allowing the issuer to focus on the branding and distribution.
Ethena’s whitelabel offering covers multiple chains and protocols, with partners choosing between Ethena’s underlying reserve models depending on the product they want.
For JupUSD, that reserve asset is USDtb, which has grown to a circulating supply of roughly $889 million as of June 2026, according to DeFiLlama. Partners building on this infrastructure plug into a reserve mechanism already operating at scale.
Why JupUSD Needs Reliable Pricing Data Jupiter is Solana’s largest DeFi platform by total value locked. Founded in October 2021 as a swap aggregator routing trades across Solana DEXs, it has since expanded into a full onchain finance suite providing perpetual futures trading, lending, prediction markets, and a mobile trading app. Jupiter processed over $1 trillion in spot and perpetuals volume in 2025.
JupUSD was launched in January 2026, initially backed entirely by USDtb before the reserve mix shifted to its current 90/10 split with USDC. For Jupiter, the stablecoin solved a balance sheet problem: its perpetuals venue was sitting on roughly $400 to $500 million of idle collateral, and JupUSD puts that capital to work.
It is monetization infrastructure, not a savings account for users. Because USDtb flows through to BlackRock’s BUIDL fund, the yield accrues to Jupiter’s reserves rather than to JupUSD holders. As of June 12, 2026, JupUSD’s circulating supply sits around $51 million, published live on the project’s transparency page with broader metrics on DeFiLlama.
JupUSD is the default stablecoin powering the Jupiter superapp, which means that every venue using it needs reliable pricing data to run smoothly. Perps need it to value collateral, Jupiter Lend needs it to trigger liquidations, and Jupiter Predict needs it to settle markets. RedStone now provides that price feed for JupUSD on Solana.
The RedStone approach for whitelabeled stablecoins A whitelabeled stablecoin arrives with its reserves handled but cannot be used as collateral until a price feed makes it usable. Lending markets, perps, and prediction markets all need a fast, manipulation-resistant feed before they will take it as collateral or settle against it. The more venues the stable reaches, the bigger demand for price feed is.
RedStone’s modular architecture treats each feed as a configuration change rather than a bespoke build, so coverage expands at the pace these stablecoins now launch. On Jupiter that is already live: RedStone provides the JupUSD feed on Solana today, currently serving Jupiter’s perpetual markets.
Ethena handles reserve management as a service. RedStone provides the pricing data that makes each one usable.
Frequently Asked Questions What is Stablecoin-as-a-Service?
A model where the reserve and issuance infrastructure for a stablecoin is provided as a service, so an app can launch its own branded stable without building custody, attestation, and redemption from scratch. Ethena offers it through Ethena Whitelabel, and JupUSD is built on it.
Why does a service-issued stablecoin still need an oracle?
Reserves back the token’s value, but they do not make it usable in DeFi. Lending markets and perpetual venues need a manipulation-resistant price feed to accept it as collateral. Without one, the stablecoin remains a simple coin rather than a productive asset.
What type of price feed is RedStone running for JupUSD?
A push-model market feed for JupUSD on Solana that aggregates the spot price from exchanges and pushes updates onchain on deviation 0.2% or 24h heartbeat triggers.
Freeport-McMoRan rozšiřuje projekty v Chile, Arizoně a Indonésii, aby zvýšil kapacitu a produkci mědi. Konsensus ohledně EPS společnosti FCX pro roky 2026 a 2027 počítá s růstem o 6,1 % a 44,6 %.
Key Takeaways FCX is advancing expansion projects in Chile, Arizona and Indonesia to boost copper capacity and output.Freeport's organic growth pipeline positions itself well to benefit from future demand growth.Estimates for 2026 and 2027 for FCX point to 6.1% and 44.6% growth, trending higher over the past 60 days. Freeport-McMoRan Inc. (FCX - Free Report) remains committed to disciplined execution and the development of its organic growth projects. The company’s expansion efforts are designed to enhance production capacity, supported by solid financial strength.
FCX has completed the evaluation of a large-scale expansion at El Abra in Chile to define a large sulfide resource that could potentially support a major mill project similar to the large-scale concentrator at Cerro Verde, with an estimated resource of approximately 20 billion recoverable pounds of copper.
In Arizona, FCX is progressing with pre-feasibility studies at its Safford/Lone Star operations, with completion targeted for 2026, to assess a sizable sulfide expansion opportunity. It has expansion opportunities at Bagdad in Arizona that can more than double the concentrator capacity of the operation. Technical and economic studies have revealed the potential to build concentrating facilities to boost copper production by 200-250 million pounds annually.
PT Freeport Indonesia (PT-FI) is developing the Kucing Liar ore body within the Grasberg district with a targeted ramp-up to commence in 2030. FCX completed studies in 2025 that showed an opportunity to increase Kucing Liar’s design capacity to 130,000 metric tons of ore per day and reserves by roughly 20% at low costs.
FCX’s organic growth pipeline, designed to expand capacity and output, positions it well to benefit from future demand growth. Effective execution of these projects will strengthen its ability to drive shareholder value.
Among FCX’s peers, Southern Copper Corporation (SCCO - Free Report) has a strong pipeline of world-class copper greenfield projects and various other promising opportunities. Southern Copper continues to build its presence in Peru as the country is the second-largest producer of copper. The company’s key growth catalysts include the Tía María, Los Chancas and Michiquillay projects in Peru, along with El Pilar and El Arco in Mexico, all of which underpin SCCO’s long-term expansion pipeline.
BHP Group Limited (BHP - Free Report) continues to reshape its portfolio toward commodities such as copper and potash, allocating nearly 70% of its medium-term capital expenditure to these areas. This strategy positions BHP to benefit from decarbonization, electrification, population growth and rising living standards in emerging markets. BHP, in March 2026, submitted the Environmental Impact Declaration permit for the Escondida New Concentrator to replace the aging Los Colorados plant as it nears the end of operations, a move that backs its growth strategy while addressing asset longevity. With an estimated investment of $4.4-$5.9 billion, the project targets new capacity to produce 220-260 kt of copper annually.
The Zacks Rundown for FCXShares of Freeport-McMoRan have rallied 22% in the past six months compared with the Zacks Mining - Non Ferrous industry’s growth of 6.8%.
Image Source: Zacks Investment Research
From a valuation standpoint, FCX is currently trading at a forward 12-month earnings multiple of 20.82, a modest 3.2% premium to the industry average of 20.17X. It carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for FCX’s 2026 and 2027 earnings implies a year-over-year rise of 6.1% and 44.6%, respectively. The EPS estimates for 2026 and 2027 have been trending higher over the past 60 days.
Biogen uvedl, že jeho růstové produkty v 1. čtvrtletí vygenerovaly tržby 851 milionů USD, což je meziročně o 12 % více. Nové léky ale zatím nestačí kompenzovat pokles tržeb z franšízy na roztroušenou sklerózu.
Key Takeaways Biogen's newer drugs are growing but remain insufficient to offset declining MS franchise sales.Leqembi's subcutaneous autoinjector and blood-based diagnostics may support growth from 2027 onward.Biogen's growth products generated $851 million in Q1 sales, up 12% year over year. Biogen (BIIB - Free Report) is in the midst of a major portfolio transition. The company is seeing declining sales of its key multiple sclerosis (“MS”) drugs like Tecfidera and Tysabri and spinal muscular atrophy (SMA) treatment, Spinraza, due to generic erosion, increasing competition from newer therapies and pricing headwinds.
To combat the pressure on key drugs, Biogen has been aggressively building a new growth engine around recently launched products, Eisai-partnered Leqembi for Alzheimer’s disease, Skyclarys for Friedreich’s ataxia, Qalsody for amyotrophic lateral sclerosis (ALS) and Supernus Pharmaceuticals (SUPN - Free Report) -partnered Zurzuvae for depression.
The key question for investors is whether these products can eventually compensate for the erosion of blockbuster drugs like Tecfidera, Tysabri and Spinraza. Let us discuss.
Key Multiple Sclerosis Drugs, Spinraza Face Increased CompetitionBiogen’s MS sales are declining due to generic competition for Tecfidera globally, biosimilar competition for Tysabri in Europe and rising competitive pressure in the MS market.
In 2026, Biogen expects revenues for MS products, excluding Vumerity, to decline by a mid-teen percentage versus 2025 due to increased competitive pressure on the ex-U.S. MS business, particularly accelerating generic competition for Tecfidera in Europe.
Spinraza’s sales are also declining due to lower demand amid increasing competitive pressure from newer SMA treatments, including gene therapies and oral medicines that offer greater convenience. Spinraza faces competition from Novartis’ (NVS - Free Report) gene therapy, Zolgensma, and Roche and PTC Therapeutics’ (PTCT - Free Report) Evrysdi (risdiplam), which comes as either a liquid solution or an oral tablet.
BIIB’s New Drug Contributing to Top-Line GrowthAmid declining demand for MS drugs and Spinraza, Biogen believes its new products, Leqembi, Skyclarys and Zurzuvae have the potential to return the company to revenue growth.
The largest opportunity in Biogen's new portfolio is arguably Leqembi. Leqembi/lecanemab gained approval for early Alzheimer’s disease in the United States in 2023. Though the Leqembi launch was slow, it picked up in 2024 and 2025. Leqembi has also been launched in Japan, China, the EU and some other countries. Leqembi commands over 60% of the anti-amyloid therapy market share in the United States.
A less frequent maintenance intravenous dosing version of Leqembi was approved by the FDA in January 2025. A subcutaneous autoinjector for maintenance dosing called Leqembi Iqlik was launched in October 2025, while a supplemental filing seeking approval of the Leqembi Iqlik subcutaneous autoinjector for initiation dosing has been granted priority review by the FDA, with a decision expected in August. Biogen and Eisai believe that the introduction of blood-based diagnostics (which can help earlier detection of Alzheimer’s) and the subcutaneous autoinjector for maintenance and initiation should drive Leqembi’s growth from 2027 onward.
Other new products, Qalsody, Biogen/Supernus’ Zurzuvae and Skyclarys (added from the 2023 acquisition of Reata Pharmaceuticals) are also seeing strong demand trends in the United States.
Skyclarys is seeing strong demand trends in the United States as well as the EU. Biogen expects Skyclarys’ future growth to come from ex U.S. markets as the launches advance. Zurzuvae’s launch also exceeded the company’s internal expectations, with sales more than doubling in 2025. Skyclarys and Zurzuvae’s sales are expected to continue to rise in 2026.
Biogen’s growth products (Skyclarys, Qalsody, Zurzuvae, Vumerity and Spinraza plus Alzheimer’s revenues from the Leqembi collaboration) generated sales of $851 million in the first quarter, rising 12% year over year.
In April, Biogen closed its acquisition of Apellis Pharmaceuticals, adding the commercialized medicines Empaveli and Syfovre for immune-mediated retinal disease and nephrology to its commercial portfolio. These drugs should also contribute to Biogen’s growth in future quarters.
Can BIIB’s New Drugs Offset Key Drugs’ Erosion?After declining for several years, Biogen’s revenues have somewhat stabilized since 2024 due to contributions from newer products and pipeline progress. However, its newer drugs, Leqembi, Skyclarys, Qalsody and Zurzuvae, are currently insufficient to offset the near-term top-line decline of the MS franchise. Though all these new drugs are showing signs of growth, replacing lost revenues from Tecfidera, Tysabri and Spinraza will likely take time.
BIIB’s Price Performance, Valuation and EstimatesBiogen’s stock has risen 14.8% so far this year compared with an increase of 5.4% for the industry.
Image Source: Zacks Investment Research
From a valuation standpoint, Biogen is reasonably priced. Going by the price/earnings ratio, the company’s shares currently trade at 13.44 forward earnings, which is lower than 17.72 for the industry. The stock is trading above its five-year mean of 13.17.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for earnings has declined from $15.04 per share to $13.99 per share for 2026 over the past 60 days. For 2027, the consensus mark for earnings has declined from $16.61 to $16.22 per share over the same time frame.
Image Source: Zacks Investment Research
Biogen has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Vaxart vyzvala akcionáře, aby na výroční schůzi hlasovali pro všech šest kandidátů do představenstva na základě bílé plné moci. Firma zároveň uvedla, že její vývoj vakcín pokračuje a má zajištěné financování i pokračující podporu BARDA.
Details Strategic Actions Taken by the Board to Advance the Company’s Pipeline and Drive Value Creation
Vaxart’s Purpose-Built Board Brings the Proven Expertise Needed to Oversee its Next Phase of Growth
Dissident Nominees Lack Relevant Clinical-Stage Biotech Expertise, Misrepresented Their Qualifications
and Offered No Credible Ideas for Value Creation
Vaxart Has Made Multiple Settlement Offers to the Dissident Shareholder Group – Daniel Houle Insists on Making This Proxy Contest About Winning a Seat for Himself
Visit Vote.Vaxart.com for Additional Information and Voting Resources
SOUTH SAN FRANCISCO, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, today published a presentation urging shareholders to vote “FOR” ALL six of the Company’s highly qualified director nominees on the WHITE proxy card in connection with its upcoming Annual Meeting of Stockholders scheduled to be held on July 16, 2026.
Highlights of the presentation include:
Strategic Execution at a Pivotal Moment
Vaxart is developing game-changing oral vaccines with the potential to redefine vaccine delivery and immune responses:
Vaxart is advancing multiple vaccine programs across high-value markets, including COVID-19, norovirus and influenza.Management is pursuing a disciplined development strategy that prioritizes programs with the strongest scientific rationale, commercial opportunity and funding pathways.Through its Phase 2b COVID-19 trial, Vaxart is working toward topline 12-month safety and immunogenicity data from the approximately 400-participant Sentinel Cohort.Vaxart is also targeting a full efficacy and safety readout from its approximately 5,100-participant Main Cohort, representing a significant clinical and value-creation milestone.
Vaxart’s Board has taken prudent steps to enable Vaxart to continue advancing its programs in a challenging environment:
Vaxart has been executing through immense industry pressures brought upon by significant regulatory, funding and policy disruption, including two BARDA stop-work orders that impacted Vaxart and many other vaccine companies.Through CEO Steven Lo’s leadership and negotiations with government stakeholders, the Company secured the continuation of BARDA funding for its lead COVID-19 program.Vaxart entered into a $25 million share purchase agreement, providing flexible access to capital, if needed, to support continued execution toward key milestones.The Board’s decision to raise $40 million in 2025 extended the Company’s runway, enabling it to enter key partnerships and advance its programs.
The Right Board to Oversee the Path Forward
The Board is purpose-built to guide Vaxart through its next phase of value creation. The Board is aligned with the Company's evolving strategic priorities, with substantial expertise across biotech, vaccine development, clinical trials and regulatory affairs.The Board’s experience has helped secure continued BARDA funding, establish the Dynavax partnership and enable additional financing flexibility through the Lincoln Park Capital agreement.Mr. Lo, Dr. Elaine J. Heron and Dr. David Wheadon are instrumental to Vaxart's success and have the judgment, credibility and relationships needed to oversee the Company’s most important future opportunities. The Board is responsive to shareholder feedback and acts in shareholders’ best interests: The Board has added two new independent directors — Dr. James B. Breitmeyer and Kevin Finney — over the last 18 months as part of its ongoing refreshment efforts, resulting in an average director tenure of approximately 2.3 years.In 2025, the Board further strengthened independent oversight through the appointment of W. Mark Watson as Lead Independent Director.The Board maintains an active dialogue with shareholders and withdrew its reverse split proposal for this upcoming Annual Meeting following feedback. The Dissident Campaign is Risking Vaxart’s Momentum
Replacing ANY of Vaxart’s highly qualified directors with the dissident nominees is not in shareholders’ best interests: None of the dissident nominees has experience leading a public clinical-stage biotech company or with vaccine development, regulatory affairs and clinical trial oversight.The dissident nominees have drastically exaggerated their qualifications, and Daniel Houle’s reckless public statements show that he should not serve on Vaxart’s Board.Collectively, they present unacceptable risk for a company approaching critical inflection points like Vaxart. Vaxart has made good-faith efforts to resolve the proxy contest: Vaxart has made multiple settlement offers to the dissident shareholder group in an effort to resolve the proxy contest.The Board’s proposals are highly reasonable and reflect what it has heard other independent shareholders want to see.Mr. Houle is waging a self-interested campaign primarily focused on “winning” a Board seat for himself rather than reaching a constructive resolution that would benefit all Vaxart shareholders. Vote “FOR” ALL 6 of Vaxart’s highly qualified director nominees on the WHITE proxy card TODAY!
If you have questions or require assistance with voting your shares, please call Vaxart’s proxy solicitor:
Additional shareholder resources and voting information can be found at Vote.Vaxart.com.
About Vaxart
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the Company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus, and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Cautionary Language Concerning Forward-Looking Statements
This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” provisions created by those sections, that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this communication regarding Vaxart’s strategy, prospects, plans and objectives, results from preclinical and clinical trials, commercialization agreements and licenses, and beliefs and expectations of management are forward-looking statements. These forward-looking statements may be accompanied by such words as “should,” “believe,” “could,” “potential,” “will,” “expected,” “anticipate,” “plan,” “target,” “seek,” “intend,” “may,” “predict,” “project,” “would,” and other words and terms of similar meaning. Examples of such statements include, but are not limited to, statements relating to Vaxart’s ability to develop and commercialize its product candidates, including its vaccine booster products; Vaxart’s expectations regarding clinical results and trial data, and the timing of receiving and reporting such clinical results and trial data; Vaxart’s expected timing for future clinical trials; and Vaxart’s expectations with respect to the effectiveness of its product candidates; expectations regarding collaborations, including the collaboration with Dynavax; expectations regarding the pursuit of strategic partnerships and external funding opportunities for Vaxart’s programs; expectations regarding government funding; and expectations regarding Vaxart’s capital resources and funded runway. Vaxart may not actually achieve the plans, carry out the intentions, or meet the expectations or projections disclosed in the forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations, and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Vaxart makes, including uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates, and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from the clinical studies; decisions by regulatory authorities impacting labeling, manufacturing processes, and safety that could affect the availability or commercial potential of any product candidate, including the possibility that Vaxart’s product candidates may not be approved by the FDA or non-U.S. regulatory authorities; that, even if approved by the FDA or non-U.S. regulatory authorities, Vaxart’s product candidates may not achieve broad market acceptance; that a Vaxart collaborator may not attain development and commercial milestones; that Vaxart or its partners may experience manufacturing issues and delays due to events within, or outside of, Vaxart’s or its partners’ control; difficulties in production, particularly in scaling up initial production, including difficulties with production costs and yields, quality control, including stability of the product candidate and quality assurance testing, shortages of qualified personnel or key raw materials, and compliance with strictly enforced federal, state, and foreign regulations; that Vaxart may not be able to obtain, maintain, and enforce necessary patent and other intellectual property protection; that Vaxart’s capital resources may be inadequate; Vaxart’s ability to resolve pending legal matters; Vaxart’s ability to obtain sufficient capital to fund its operations on terms acceptable to Vaxart, if at all; the impact of government healthcare proposals and policies; competitive factors; and other risks and uncertainties described in the “Risk Factors” sections of Vaxart’s most recent Annual Report on Form 10-K, including amendments thereto, and Quarterly Reports on Form 10-Q filed with the U.S. Securities and Exchange Commission. Vaxart undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.
Important Additional Information and Where to Find It
Vaxart has filed a definitive proxy statement and form of white proxy card with the U.S. Securities and Exchange Commission (the “SEC”) in connection with its solicitation of proxies for the 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Stockholders are able to obtain the Company’s proxy statement, any amendments or supplements to the proxy statement and other documents filed by the Company with the SEC at no charge at the SEC’s website at www.sec.gov. Copies are also available at no charge at the Company’s website at https://investors.vaxart.com/financials-filings/sec-filings.
Paramount Skydance prodloužila lhůtu pro nabídky na výměnu a odkup dluhopisů do 15. července 2026. K 25. červnu bylo nabídnuto 24,38 % dluhopisů určených k odkupu a 44,27 % dluhopisů určených k výměně.
, /PRNewswire/ -- Paramount Skydance Corporation (NASDAQ: PSKY) ("Paramount") today announced the extension of the Expiration Dates in connection with the previously announced (i) offers to purchase (the "Tender Offers" and each, a "Tender Offer") for cash, upon the terms and subject to the conditions set forth in the related offer to purchase (the "Offer to Purchase"), any and all of the identified notes in each series of the Existing Tender Offer Notes (defined by reference to the table set forth below) issued by Discovery Global Holdings, Inc. (formerly WarnerMedia Holdings, Inc.) (the "DGH Issuer") and Discovery Communications, LLC (the "DCL Issuer" and together with the DGH Issuer, each a "WBD Issuer" and collectively the "WBD Issuers"), as applicable, and (ii) offers to exchange (the "Exchange Offers" and each, an "Exchange Offer" and, together with the Tender Offers, the "Offers" and each, an "Offer"), upon the terms and subject to the conditions set forth in the related exchange offer memorandum (the "Offering Memorandum"), any and all of the identified notes in each series of the Existing Exchange Offer Notes (defined by reference to the table set forth below) (together with the Existing Tender Offer Notes, the "Offer Notes") issued by the applicable WBD Issuer for notes to be newly issued by Paramount.
The Expiration Dates for the Tender Offers and Exchange Offers (as defined in each of the Offer to Purchase and Offering Memorandum, respectively) have been extended to 5:00 p.m., New York City time, on July 15, 2026, unless further extended. The Settlement Dates for the Tender Offers and Exchange Offers (as defined in each of the Offer to Purchase and Offering Memorandum, respectively) will occur promptly after the Expiration Date and are currently anticipated to occur in the third quarter of 2026. Paramount anticipates extending the Expiration Date for such Tender Offers and Exchange Offers until such time that would result in the Settlement Dates occurring on the closing date of the proposed acquisition (the "Acquisition") by Paramount of Warner Bros. Discovery, Inc. ("WBD") or within one business day thereof. Tenders of the Offer Notes in the Offers may be withdrawn at any time prior to the Expiration Date. The aforementioned extensions further extend the Expiration Dates previously extended by Paramount on June 12, 2026.
As of 5:00 p.m., New York City time, on June 25, 2026, approximately 24.38% and 44.27% of the aggregate principal amount of the Existing Tender Offer Notes and Existing Exchange Offer Notes, respectively, have been validly tendered in the applicable Offers. As Paramount previously announced that it anticipates extending the Offers to align with the closing date of the Acquisition, Paramount does not view these figures to be representative of the final results of the applicable Offers.
Information about each series of Offer Notes eligible to participate in the Offers is summarized below.
Type of Offer
Offer Notes to be Tendered
or Exchanged, as
Applicable
Issuer of Offer Notes
CUSIP No. / Common Code
/ ISIN Eligible to
Participate in the Offers (1)
Aggregate Principal
Amount of Offer Notes
Eligible to Participate in the
Offers (2)
Tender Offer
3.950% Senior Notes due 2028
DCL Issuer
25470D CP2
US25470DCP24
$1,234,458,000
Exchange Offer
4.125% Senior Notes due 2029
DCL Issuer
25470D CQ0
US25470DCQ07
$655,825,000
Exchange Offer
3.625% Senior Notes due 2030
DCL Issuer
25470D CR8
US25470DCR89
$914,183,000
Exchange Offer
5.000% Senior Notes due 2037
DCL Issuer
25470D CS6
US25470DCS62
$453,281,000
Exchange Offer
6.350% Senior Notes due 2040
DCL Issuer
25470D CT4
US25470DCT46
$438,102,000
Exchange Offer
4.950% Senior Notes due 2042
DCL Issuer
25470D CU1
US25470DCU19
$130,366,000
Exchange Offer
4.875% Senior Notes due 2043
DCL Issuer
25470D V91
CV9US25470DC
$141,584,000
Exchange Offer
5.200% Senior Notes due 2047
DCL Issuer
25470D W74
CW7US25470DC
$3,161,000
Exchange Offer
5.300% Senior Notes due 2049
DCL Issuer
25470D X57
CX5US25470DC
$247,860,000
Tender Offer
3.755% Senior Notes due 2027
DGH Issuer
254948 AH5
US254948AH58
254948 AN2
US254948AN27
U25483 AA3
USU25483AA38
$1,189,336,000
Exchange Offer
4.054% Senior Notes due 2029
DGH Issuer
254948 AJ1
US254948AJ15
254948 AP7
US254948AP74
U25483 AB1
USU25483AB11
$1,353,828,000
Exchange Offer
4.279% Senior Notes due 2032
DGH Issuer
254948 AK8
US254948AK87
254948 AQ5
US254948AQ57
$2,691,764,000
Exchange Offer
5.050% Senior Notes due 2042
DGH Issuer
254948 AL6
US254948AL60
254948 AR3
US254948AR31
U25483 AD7
USU25483AD76
$4,104,687,000
Exchange Offer
5.141% Senior Notes due 2052
DGH Issuer
254948 AM4
US254948AM44
254948 AS1
US254948AS14
$949,883,000
Exchange Offer
4.302% Senior Notes due 2030
DGH Issuer
XS3393993285
339399328
€234,382,000
Exchange Offer
4.693% Senior Notes due 2033
DGH Issuer
XS3393994507
339399450
€316,641,000
__________
(1) No representation is made as to the correctness or accuracy of the identifiers listed in this press release or printed on the Offer Notes. Such identifiers are provided solely for the convenience of the holders.
(2) Represents the aggregate principal amount of Offer Notes outstanding that are eligible to participate in the Offers.
The Exchange Offers are being made pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended (the "Securities Act"), and the rules and regulations of the Securities and Exchange Commission (the "SEC") promulgated thereunder, and are also not being registered under any state or foreign securities laws. Any securities offered pursuant to the Exchange Offers may not be offered or sold in the United States or to any U.S. persons (as defined below) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Exchange Offers will only be made, and the securities offered pursuant to the Exchange Offers are only being offered and issued, to holders of applicable Existing Exchange Offer Notes who are (a) reasonably believed to be "qualified institutional buyers" as defined in Rule 144A under the Securities Act or (b) not "U.S. persons," as defined in Rule 902 of Regulation S under the Securities Act (such holders, "Eligible Holders"), and only Eligible Holders who have completed and returned the eligibility certification are authorized to receive or review the Offering Memorandum or to participate in the Exchange Offers. The eligibility certification is available electronically at: https://gbsc-usa.com/eligibility/paramount.
General
Each Offer is a separate offer, and each may be individually consummated, amended, extended, terminated, or withdrawn, subject to certain conditions and applicable law, at any time in Paramount's sole discretion, and without also consummating, amending, extending, terminating, or withdrawing any other Offer with respect to any other series of Offer Notes. Paramount may terminate an Offer if any of the conditions of such Offer described in the Offer to Purchase or Offering Memorandum, as applicable, are not satisfied or waived by the applicable Expiration Date, subject to applicable law. In addition, Paramount may waive the conditions to an Offer without extending such Offer in accordance with applicable law.
The Offers are being made solely by Paramount and are not being made by WBD or the WBD Issuers. None of Paramount, WBD, the WBD Issuers, the Dealer Managers, the Exchange Agent (as defined below), the Information Agent (as defined below), the trustees under each of the indentures governing the Offer Notes, the trustee or collateral agent under the indenture that will govern the notes to be issued in the Exchange Offers, or any affiliate of any of them makes any recommendation as to whether any holder of Offer Notes should tender or refrain from tendering all or any portion of the principal amount of such holder's Offer Notes for cash or notes to be issued in the Exchange Offers. No one has been authorized by any of them to make such a recommendation. Holders must make their own decision whether to tender Offer Notes in any Offer and, if so, the amount of Offer Notes to tender.
Only Eligible Holders may receive a copy of the Offering Memorandum and participate in the Exchange Offers. Paramount has engaged Global Bondholder Services Corporation to act as the exchange agent (in such capacity, the "Exchange Agent") and information agent (in such capacity, the "Information Agent") for the Offers. Questions concerning the Offers, or requests for additional copies of the Offer to Purchase or Offering Memorandum or other related documents, may be directed to Corporate Actions by telephone at (855) 654-2014 (U.S. toll-free) or (212) 430-3774 (banks and brokers) or by email at [email protected]. Holders should also consult their broker, dealer, commercial bank, trust company or other institution for assistance concerning the Offers. The Exchange Offer documents and the Tender Offer documents can be accessed at the following link: https://gbsc-usa.com/paramount.
Paramount has engaged BofA Securities and Citigroup as dealer managers (in such capacity, the "Dealer Managers") for the Offers. Holders with questions regarding the Offers should contact BofA Securities, Inc. at +1 (888) 292-0070 (toll-free) or +1 (980) 388-3646 (collect) or [email protected] or Citigroup Global Markets Inc. at +1 (800) 558-3745 (toll-free) or +1 (212) 723-6106 or [email protected]. Latham & Watkins LLP is serving as legal counsel to Paramount and Cahill Gordon & Reindel LLP is serving as legal counsel to the Dealer Managers.
This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security, and does not constitute an offer, solicitation, or sale of any security in any jurisdiction in which such offer, solicitation, or sale would be unlawful.
About Paramount, a Skydance Corporation
Paramount, a Skydance Corporation is a next-generation global media and entertainment company, comprised of three business segments: Studios, Direct-to-Consumer, and TV Media. PSKY's portfolio unites legendary brands, including Paramount Pictures, Paramount Television, CBS, CBS News, CBS Sports, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount+, Pluto TV, and Skydance Animation, Film, Television, Interactive/Games, and Paramount Sports Entertainment.
This communication contains "forward-looking statements" regarding the Acquisition and the other transactions referred to herein. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Paramount. Risks and uncertainties include, but are not limited to: the risk that the closing conditions for the Acquisition will not be satisfied, including the risk that clearances under applicable antitrust or regulatory laws will not be obtained or will be obtained subject to conditions that are not anticipated; the possibility that the transactions described herein will not be completed in the expected timeframe or at all; the occurrence of any event, change or other circumstances that could give rise to the termination of the Acquisition; potential adverse effects to the businesses of Paramount or WBD during the pendency of the Acquisition, such as employee departures or distraction of management from business operations; negative effects of the announcement or the consummation of the Acquisition on the market price of WBD or Paramount stock; the risk of stockholder litigation relating to the Acquisition, including resulting expense or delay; the potential that the expected benefits and opportunities of the Acquisition, if completed, may not be realized or may take longer to realize than expected; risks related to the streaming business of the post-Acquisition combined business (the "Combined Company"); the adverse impact on the Combined Company's advertising revenues as a result of changes in consumer behavior, advertising market conditions, and deficiencies in audience measurement; risks related to operating in highly competitive and dynamic industries; the unpredictable nature of consumer behavior, as well as evolving technologies and distribution models; risks related to the Combined Company's decision to invest in new businesses, products, services, and technologies, and the evolution of the Combined Company's business strategy; the potential for loss of carriage or other reduction in, or the impact of negotiations for, the distribution of the Combined Company's content; damage to the Combined Company's reputation or brands; losses due to asset impairment charges for goodwill, content and long-lived assets, including finite-lived intangible assets; liabilities related to discontinued operations and former businesses; increasing scrutiny of, and evolving expectations for, sustainability initiatives; evolving business continuity, cybersecurity, privacy and data protection and similar risks; challenges in protecting and maintaining the Combined Company's intellectual property rights; domestic and global political, economic and regulatory factors affecting the Combined Company's business generally or the Acquisition; the inability to hire or retain key employees or secure creative talent; disruptions to the Combined Company's operations as a result of labor disputes; risks and costs associated with the integration of, and Paramount's ability to integrate, the businesses of Paramount Global, Skydance Media, LLC, and WBD successfully and to achieve anticipated synergies, including in the amounts or on the timelines anticipated to realize such synergies; litigation related to the Acquisition and other matters or transactions; risks associated with the Combined Company's holding company structure, including its dependence on distributions from its subsidiaries to meet tax obligations and other cash requirements; risks related to our indebtedness, including our substantial outstanding debt obligations, our ability to incur substantially more debt and our ability to meet the financial and other covenants contained in the agreements governing the indebtedness of Paramount, WBD, or the Combined Company. A further list and description of these risks, uncertainties and other factors and the general risks associated with the respective businesses of Paramount and WBD can be found in Paramount's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 25, 2026, including in the sections captioned "Cautionary Note Concerning Forward-Looking Statements" and "Item 1A. Risk Factors," Paramount's most recently filed Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 4, 2026, including in the sections captioned "Cautionary Note Concerning Forward-Looking Statements" and "Item 1A. Risk Factors," and Paramount's subsequent filings with the SEC, and in WBD's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 27, 2026, including in the section captioned "Item 1A. Risk Factors," WBD's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 6, 2026, and WBD's subsequent filings with the SEC. Neither Paramount nor WBD undertakes to update any forward-looking statement as a result of new information or future events or developments, except as required by law.
Šéf Rivian varuje, že automobilky soustředěné na zisk z benzinových aut budou na konci dekády technologicky pozadu. Klíčová je podle něj investice do softwaru a elektromobilů.
Carmakers that focus on selling fossil fuel engines are at risk of being “woefully behind” on technology by the end of the decade, according to the boss of Rivian, an Amazon-backed US electric carmaker.
RJ Scaringe, Rivian’s founder and chief executive, said the car industry has reached a “fork in the road” in the choice between short-term profits and the heavy investments, particularly in software, that will be required to survive.
In an interview this month in London, he said many have chosen profits, ramping up the production of petrol or hybrid pickup trucks and SUVs in the US and Europe.
Much of the automotive industry in the US and Europe has lobbied to slow the transition to electric vehicles, favouring instead polluting but profitable cars with internal combustion engines.
The retreat has been particularly striking in the US, where Donald Trump’s administration has gutted incentives to produce and buy EVs. Ford, General Motors, Honda, Stellantis and Volkswagen, all of which have large US operations, have collectively written off more than $70bn (£53bn) from their previous EV investments, according to Reuters.
Workers on the production line at Rivian’s headquarters in California. Photograph: Bloomberg/Getty ImagesScaringe said the decisions to focus on profitable petrol cars could come back to haunt manufacturers.
He said: “That looks really good financially for 2026, 2027, maybe even 2028. But as you get to the end of the 2020s and into the 2030s, I think we’re going to find a lot of companies are unfortunately woefully behind in terms of their technology.”
The turn against EVs has led to uncertainty over demand for Rivian, which has just started deliveries of its R2 SUV in the US. The car is “make or break” for the company as it tries to turn a profit for the first time, Scaringe said.
RJ Scaringe says focusing on the profitable petrol cars could come back to haunt manufacturers. Photograph: Kimberly White/Getty Images for RivianRivian was founded in 2009, and delivered its first electric vehicle in 2021, the same year as it floated on the stock market.
Rivian lost $3.6bn in 2025 amid heavy investment in the R2 and in autonomous driving abilities. After its market value soared above $100bn at its initial public offering, the carmaker has dropped back to $21bn – although Scaringe could be in line for share awards worth as much as $5bn if he can push the share price to targets well above its all-time high.
Rivian lost $3.6bn in 2025 amid heavy investment in the R2 and in autonomous driving abilities. Photograph: RivianScaringe said the “the more damaging and more dangerous aspect” of the turn against EVs was not the delayed transition from petrol engines to batteries but rather the failure to develop the software that increasingly controls every aspect of the vehicle.
He said petrol cars were stuck with a design that scatters computer chips throughout the car – from the engine to the seats and wing mirrors – rather than a centralised architecture that can be easily modified. Relying instead on a single computer reduces production costs by “thousands of dollars”, Scaringe said.
Rivian’s heavy investment in digital technology and software has at least partly paid off. Alongside the Amazon investment, which includes a deal for up to 100,000 delivery vans, Rivian and Germany’s Volkswagen agreed a $5.8bn electric tech and software joint venture in 2024, and Uber invested $1.25bn in a deal that could also lead to the sale of 50,000 robotaxis.
Scaringe said Rivian could help to increase the take-up of EVs in the US despite the White House backlash. Electric cars made up 7.8% of all US car sales in 2025, and Scaringe said the R2 alone could eventually increase the market share by three or four percentage points.
“The objective is to be a very large company” with annual sales in the millions, Scaringe said.
Scaringe said he was sceptical of carmakers’ claims that buyers do not want EVs, but rather that the dominance of Tesla’s Model 3 saloon car and Model Y SUV in the US was a “sign of a market starved for great choices”. Chinese carmakers dominate the global EV industry but are locked out of the US by prohibitive tariffs.
Rivian is also aiming to sell the R2 in the UK and mainland Europe, although that will not happen for at least a year.
MAS zařadila Hyperliquid na seznam Investor Alert List a uvedla, že platforma není v Singapuru licencovaná ani autorizovaná. Hyperliquid tvrdí, že nikdy netvrdila opak.
Singapore’s top financial watchdog just put Hyperliquid on notice. The Monetary Authority of Singapore (MAS) added the high-speed trading platform to its Investor Alert List on June 26, flagging it as neither licensed nor authorized to operate in the city-state.
The move doesn’t ban Hyperliquid outright. But it does tell Singaporean users something important: if things go sideways on the platform, MAS protections won’t be there to catch you.
What the Investor Alert List actually means MAS launched the list back in 2004 as a public warning tool. Its purpose is straightforward: inform residents when a financial service provider hasn’t obtained the proper licenses to operate within Singapore’s jurisdiction.
Advertisement
Being on the list doesn’t mean Hyperliquid is fraudulent. It means the platform hasn’t gone through Singapore’s regulatory gatekeeping process, which covers things like capital requirements, anti-money laundering compliance, and consumer safeguards.
Singapore’s MAS has also placed Bybit Fintech Ltd. on its Investor Alert List as part of its efforts to strengthen oversight of crypto platforms operating without local authorization.
In response, Bybit said it is seeking clarification from MAS and noted that it has long implemented measures, including contractual restrictions and IP blocking, to prevent Singapore users from accessing its platform.
Hyperliquid says it never claimed to be licensed by MAS In a statement, Hyperliquid said that as permissionless infrastructure, it is not, and has never claimed to be, licensed or authorized by MAS.
Hyperliquid has been added to the MAS's Investor Alert List (IAL). IAL listing does not constitute a ban, an enforcement action, or a finding of wrongdoing. The IAL provides a list of entities that, based on information available to MAS, may be wrongly perceived as being licensed…
— Hyperliquid (@HyperliquidX) June 26, 2026
The team added that nothing about the network or its operation has changed. Users always maintain self-custody, and all transactions are settled transparently and fully onchain.
Hyperliquid said the ecosystem will continue to engage constructively with regulators and institutions around the world in support of clear, effective frameworks that enable the continued development of onchain finance.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Strategy navýšila dolarové rezervy o 300 milionů USD na celkových 1,4 miliardy USD a koupila dalších 520 BTC za 35 milionů USD, čímž potvrdila pokračující akumulaci i při poklesu Bitcoinu.
Under the leadership of Michael Saylor, Strategy has reaffirmed its commitment to Bitcoin, even as the cryptocurrency experiences a sharp pullback. On Thursday, the price of Bitcoin fell to as low as $58,000—its lowest level since October 2024. This decline means Bitcoin has now dropped about 52% from its all-time high above $126,000 reached last year.
Strategy stands firm as Bitcoin downturn continuesAccording to recent data, Bitcoin repeatedly found support around the $60,000 mark throughout the year. After rebounding from this level in February and again in the first half of June—reaching as high as $67,000—the latest wave of selloffs has once again put this threshold under pressure. As of publication time, Bitcoin was down 3.95% over the past 24 hours to $59,729, and had dropped 4.16% for the week.
Michael Saylor emphasized that volatility tests every capital structure, and he underscored that Strategy remains steadfast in its Bitcoin focus, disciplined capital allocation, credit integrity, and commitment to long-term value creation.
Strategy has emerged as one of the most prominent companies regularly adding Bitcoin to its balance sheet since 2020. Originally a software firm, Strategy has become well-known in recent years for its institutional approach to acquiring Bitcoin. Saylor has made this strategy central to the company’s corporate identity.
Balance sheet pressure and growing criticismAs cryptocurrency market losses deepened, Strategy has faced more than $13 billion in unrealized losses on paper. Nonetheless, the company’s management remains convinced that the current volatility is not reason enough to alter its core investment strategy. The company’s statements have consistently highlighted its focus on transparency and unwavering execution.
However, this approach is not without its critics. Crypto analytics firm CryptoQuant argued that Strategy should temporarily pause its Bitcoin purchases and focus on strengthening its reserves. According to CryptoQuant, adopting a more systematic purchasing schedule—rather than buying only when new capital is raised—would represent a more cautious strategy.
CryptoQuant believes that it would be more prudent for Strategy to first rebuild its reserves and then adopt a more structured timing model for its future Bitcoin acquisitions.
Strategy boosts reserves and maintains Bitcoin buying policyMost recently, Strategy increased its dollar reserves by $300 million, bringing the total to $1.4 billion. The company reported that these additional funds would continue to back the credit quality of its digital debt securities.
During the same period, Strategy acquired an additional 520 BTC for $35 million, raising its total Bitcoin holdings to 847,363 coins. This demonstrates that, even amid significant price declines, Strategy has not abandoned its accumulation policy.
Supporters argue that the losses currently remain unrealized and that the outlook could improve dramatically if Bitcoin finds a bottom and begins to climb again. Nonetheless, as market pressure persists, attention remains fixed on Strategy’s debt structure, reserve management, and the timing of its new acquisitions.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.
Michael Saylor hájí Strategy a říká, že firma zůstává zaměřená na Bitcoin, i když akcie spadly na několikaletá minima. Analytici zároveň varují před dalším nákupem a doporučují obnovit hotovostní rezervy.
ToplineBillionaire Michael Saylor on Friday defended his Strategy’s approach to bitcoin even as shares of the cryptocurrency’s largest institutional holder fell to multi-year lows, and as analysts warned against the company buying more amid a broader decline in the crypto market.
Shares of bitcoin’s largest institutional holder have plummeted 80% from their all-time high.
Getty Images
Key FactsSaylor, in a post on X, wrote that “volatility tests capital structure” and reaffirmed that Strategy “remains focused on bitcoin, disciplined capital allocation, credit quality and long-term value creation.”
Shares of Strategy plunged by more than 9% on Thursday to their lowest level since February 2024, and shares are down more than 8% from their record intraday high ($543) in November 2024, while its preferred stock has dropped nearly 25% since Jan. 13 to a new record low.
The price of bitcoin briefly stumbled to a 21-month low on Thursday, hitting an intraday low of $58,131, and the world’s leading cryptocurrency has shed more than half of its value since peaking above $126,000 in October 2025.
Crypto analytics firm CryptoQuant wrote in a report Thursday that Strategy should halt its bitcoin purchases and instead rebuild its cash reserves, arguing the company’s strategy of buying during bitcoin price dips has resulted in “rapid unrealized loss growth.”
JPMorgan analysts issued a similar warning in a note earlier this month, concluding Strategy’s dollar reserves should be rebuilt to “restore confidence and reduce investor concerns that the company would sell more bitcoins to cover dividend payments.”
forbes valuationSaylor founded Strategy, then known as MicroStrategy, in 1989, and his net worth has swelled to $3 billion as of market close on Thursday. He emerged as a top executive during the dot-com bubble, after which Saylor’s fortune plummeted, but Strategy’s bitcoin investments made him a billionaire once again, as Saylor has directed the firm to shift its corporate coffers into bitcoin.
big number845,256. That’s Strategy’s total bitcoin holdings, which the company priced at an aggregated market value of $63.9 billion, or roughly $75,680 per token, according to a regulatory disclosure earlier this month. Strategy most recently purchased 1,550 bitcoin for $101.3 million on June 8 at an average price of $65,332 per coin.
key backgroundStrategy’s cash reserves totaled $1.4 billion as of Friday, representing just a fraction of its bitcoin holdings. The company’s bitcoin transactions have shifted broader views of the crypto market, including its first bitcoin sale in years late last month, sparking a selloff that erased the cryptocurrency’s record-setting surge. Billionaire hedge fund executive Philippe Laffont said earlier this week he was a “little bit more worried” about bitcoin, arguing there were more attractive investment opportunities, like SpaceX, that he would “rather bet” on. Bitcoin’s latest slide also comes as $10 billion in options is set to expire Friday on Deribit, the world’s largest crypto options venue.
further readingForbesBillionaire Saylor’s Strategy Buys Bitcoin Worth $101 Million—After Earlier Sale Sparked Sell-OffBy Ty Roush
Strategy tvrdí, že pokles ceny $BTC ani akcií $MSTR neohrožuje její bitcoinové rezervy. Většina dluhu je v dlouhodobých konvertibilních dluhopisech se splatností do roku 2032 a dále, obvykle s úrokem mezi 0 % a 1 %, bez margin maintenance covenants navázaných přímo na cenu Bitcoinu.
An "Indestructible" Balance Sheet@Strategy executive @CJ_Bitcoin has moved to reassure investors that neither a drop in $BTC's price nor a slide in the company's equity can threaten its Bitcoin reserves. In comments shared on June 26, he described the balance sheet as an "indestructible" digital fortress, capable of absorbing significant market drawdowns without triggering forced liquidations or margin calls.
The confidence is rooted in how Strategy structures its debt. Unlike retail traders or hedge funds that use margin loans, Strategy does not rely on high-leverage facilities with automatic liquidation thresholds. Most of its debt consists of long-dated convertible notes, with maturities extending to 2032 and beyond, typically carrying low interest rates between 0% and 1%, with no margin maintenance covenants tied directly to Bitcoin's price. That means a falling $BTC price does not automatically force the company's hand. If Bitcoin appreciates, the value of the company's holdings rises, strengthening its balance sheet. If Bitcoin declines, the debt does not automatically trigger asset sales.
Analysts have broadly echoed that view. No margin calls can be triggered by a price decline in the coin, and forced liquidation probably would not even become a realistic possibility until Bitcoin fell to around $8,000. Absent a "Black Swan" event, involuntary Bitcoin sales remain highly unlikely before debt maturities arrive in 2028, leaving insolvency rather than margin calls as the only plausible risk scenario.
Scale and ContextStrategy's conviction has been tested before. During the 2022 crypto winter, pressure was intense. Critics questioned whether the company could survive its leveraged Bitcoin bet, and calls for forced liquidation circulated widely. Strategy did not sell a single coin. Instead, it held its position and began planning the capital raises that would define the next three years.
As of May 25, 2026, Strategy holds 843,738 Bitcoin, giving it 220,900 Bitcoin per share (in sats), alongside $6.7 billion in aggregate principal of convertible notes and $15.5 billion in aggregate notional preferred stock outstanding. According to data from BitcoinTreasuries.net, Strategy now controls approximately 4% of Bitcoin's fixed 21 million supply.
The picture is not without complications. In early June, Strategy disclosed in an SEC filing that it sold 32 Bitcoin at an average price of $77,135 per coin to help meet obligations tied to its preferred stock. The transaction was tiny relative to its overall holdings, but the symbolism was enormous, as a line that investors once assumed would never be crossed just got crossed. Critics, including gold advocate Peter Schiff, continue to argue that the firm's leverage structure creates latent risks, though Strategy has not indicated any intention to sell its Bitcoin holdings, and Saylor has repeatedly stated his commitment to holding the asset long-term.
For now, @CJ_Bitcoin's message is clear: short-term price volatility in either $BTC or $MSTR is not a strategic threat to the reserve itself.
Sources:
CCN: Strategy Has No Liquidation Risk Until Bitcoin Falls to $8,000
Strategy Inc: Q1 2026 Financial Results (Official Press Release)
Strategy Form 8-K, May 2026 (SEC Filing)
Michael Saylor broke his public silence on June 26 with a post on X reaffirming Strategy’s commitment to Bitcoin, as the company faces a securities investigation and widening pressure across its capital structure.
Rosen Law Firm launched the probe, examining whether Strategy executives made materially misleading statements across five linked securities. The company has issued no formal response.
Saylor Doubles Down on Bitcoin FocusOn X, Saylor offered no direct comment on the probe. Instead, he framed volatility as a structural test. He signaled continued commitment to credit quality and long-term value creation.
Volatility tests every capital structure. Strategy remains focused on Bitcoin, disciplined capital allocation, credit quality, and long-term value creation. We appreciate our investors and will continue to execute with transparency and resolve. $MSTR
— Michael Saylor (@saylor) June 26, 2026 Michael Saylor. Source: XThe statement is notable for what it omits. It makes no mention of the class action interest gathering around the firm or the sharp declines across Strategy’s preferred securities. Saylor focuses on capital discipline, a message directed at both equity holders and creditors.
Strategy holds 847,363 Bitcoin (BTC), more than 4% of all Bitcoin that will ever exist. Its average acquisition cost sits near $75,500 per coin, well above current prices. That gap compressed the MSTR premium investors once paid for leveraged Bitcoin exposure. It also sharpened scrutiny on how the company continues to fund new purchases.
Strategy built much of that position through multiple classes of publicly traded preferred stock. Those instruments now sit under pressure as Bitcoin prices weaken and investor confidence in the dividend model erodes.
Market Pressure Tests That ConvictionThe day before Saylor posted, critic Peter Schiff escalated his criticism of Strategy’s declining market performance.
He argued MSTR has fallen 84% from its all-time high. Schiff also noted that STRC dropped 25% from par, now carrying an implied yield of 15.3%. Saylor’s post served as an indirect rebuttal to those attacks without addressing them directly.
Questions about STRC’s long-term sustainability have grown sharper. The preferred stock’s dividend structure costs an estimated $1.2 billion annually. Strategy disclosed a $1.4 billion cash reserve on June 22, barely a year of cover at current rates.
Whether Saylor’s reaffirmation steadies investor confidence or the probe escalates into a formal complaint may define Strategy’s near-term trajectory.
X Money od Elona Muska se začíná zpřístupňovat vybraným uživatelům a jako bankovní infrastrukturu používá Cross River Bank, dlouholetého partnera Ripple. To znovu rozdmýchalo spekulace o možné budoucí integraci XRP.
Elon Musk’s X Money begins rolling out to some of Premium+ users today, with “everything app” payments feature gaining momentum. X Money is using Ripple’s long-term partner Cross River Bank as banking infrastructure for its services, sparking speculation over XRP and other crypto integration in the future.
Elon Musk Launches Digital Payments Service X Money X Money, the payments and digital wallet system integrated into Elon Musk’s X platform, is rolling out to select users with features like peer-to-peer transfers, a Visa debit card, and high-yield savings options.
pic.twitter.com/6Zi3pmHwPN
— Elon Musk (@elonmusk) June 25, 2026
While currently fiat-focused and backed by traditional rails, its banking infrastructure provider Cross River Bank is a long-standing partner with Ripple since 2014.
FDIC member Cross River Bank serves as the primary banking partner for X Money, holding user deposits and offering up to $10M in FDIC insurance through the X Cash Sweep Program. It would power key elements like card issuance and payment processing.
This brings XRP into the spotlight, sparking speculation about future cross-border efficiency, stablecoin support, or even direct token integration. Cross River uses XRP Ledger to enable faster and lower-cost cross-border transfers.
The XRP Army claimed a likely infrastructure overlap for deposits and instant settlement. Meanwhile, Elon Musk’s X Money launch coincided with Ripple’s push to provide tradFi with payments and tokenization infrastructure. XRP’s strengths in liquidity and speed could prove valuable.
While X Money remains primarily a fiat-based service in its early public access phase, Elon Musk earlier hinted about potential crypto integration.
As CoinGape reported earlier, Elon Musk’s X launched Big Charts for stocks and crypto, expanding its Smart Cashtags feature. Users can see larger real-time charts and posts for BTC, ETH, XRP, HYPE, DOGE, TSLA, MSTR, COIN, and others.
Will XRP Price Rebound? XRP price pared gains after rebounding more than 3% after the crypto market crash. The price is currently trading at $1.03, with a 24-hour low and high of $1.01 and $1.08, respectively. Furthermore, trading volume has increased by 25% in the last 24 hours, indicating a rise in interest among traders.
Analyst Ali Martinez pointed out that XRP is testing a major volume block at $1.06. On-chain data from the UTXO Realized Price Distribution (URPD) showed over 830 million XRP changed hands at the price.
It makes it a key support level to watch. If XRP plunges, the next support levels based on volume are $0.80, $0.62, and $0.51.
CoinGlass data showed selling in the derivatives market amid crypto options expiry. The total XRP futures open interest dropped 1.83% to $2.31 billion in the last 4 hours.
XRP UTXO Realized Price Distribution. Source: Ali Martinez
A conditional national trust bank charter, a pending Federal Reserve master account, and a string of acquisitions in brokerage, payments, and treasury. Ripple is assembling a full regulated-finance stack. The benefits flow first to its stablecoin and the company itself. What is left for XRP is the question.
Summary
Ripple has assembled a full regulated-finance stack: a conditional national trust bank charter, a pending Federal Reserve master account bid, and acquisitions in prime brokerage, payments, and treasury services. The charter and master account primarily benefit RLUSD, Ripple’s stablecoin, whose reserves would sit under federal and state oversight, not XRP directly. A national trust bank cannot take ordinary deposits or carry federal deposit insurance, so the real prize is direct access to Federal Reserve payment rails and custody of its own stablecoin reserves. For XRP, the benefit is indirect: a more legitimate, bank-grade Ripple strengthens the whole ecosystem and XRP’s role as a bridge asset, but it creates no direct token-demand mechanism. This is the same pattern that defined XRP through 2026, in which Ripple’s wins flow first to the company and RLUSD, with the token benefiting slowly, if at all. Ripple is turning itself into a bank, or something very close to one, and it is doing it methodically.
Over the past year the company won conditional federal approval to operate a national trust bank, applied for a Federal Reserve master account that would give it direct access to the central bank’s payment systems, and bought its way into prime brokerage, payments, and corporate treasury services through a series of acquisitions.
Add the dollar stablecoin it already issues, the 70-plus regulatory licenses it holds around the world, and a fresh European license that lets it passport services across 30 countries, and the picture is unmistakable.
A company once known mainly for a cross-border payments network and a controversial token is assembling the full apparatus of a regulated financial institution.
For XRP holders, who have watched the token grind sideways near a dollar through a year of Ripple triumphs, the natural question is what all of this means for them.
The honest answer is more complicated, and more sobering, than the headlines suggest, because almost every piece of Ripple’s banking build benefits the company and its stablecoin first, and the token only indirectly.
This piece works through Ripple’s transformation into a regulated financial institution and what it actually delivers for XRP. It covers the banking stack Ripple is assembling, what a national trust bank can and cannot do, the real prize of a Federal Reserve master account, why the charter is mostly a stablecoin story, what genuinely accrues to XRP, the bull case within the bank build, and what holders should watch.
The goal is to separate the real significance of Ripple becoming a bank, which is considerable for the company, from the wishful assumption that everything good for Ripple is automatically good for the token, which 2026 has repeatedly shown to be false.
A payments company is turning into a financial institution Take the full measure of what Ripple has built, because the strategy only becomes clear when you see the pieces together.
The foundation is a conditional charter to operate a national trust bank, granted by the Office of the Comptroller of the Currency, the federal regulator that supervises national banks. The OCC conditionally approved Ripple National Trust Bank alongside other crypto firms in a broader wave of national trust bank approvals.
That federal approval matters because it moves Ripple deeper into the regulated banking perimeter without turning it into an ordinary retail bank.
A subsequent rule expanded what such trust banks are allowed to do, turning what would have been a narrow custody license into something with real operational scope, including digital-asset custody, stablecoin reserve management, and certain payment services.
On top of the charter, a Ripple subsidiary applied for a Federal Reserve master account, the account that would connect Ripple directly to the central bank’s payment rails.
And around that regulatory core, Ripple has been buying capabilities: a prime brokerage, a payments business, and a corporate treasury-services firm, each acquisition adding a piece of the institutional-finance stack.
Layer in the rest and the ambition is obvious. Ripple issues a dollar-pegged stablecoin that has grown past $1 billion in market value.
It holds dozens of regulatory licenses across jurisdictions, and it recently secured preliminary European authorization that lets it offer regulated services across the entire European Economic Area.
That is where Ripple’s European license fits into the larger build. The company is not only chasing U.S. banking access; it is trying to make its regulated-finance stack portable across major markets.
Taken individually, any one of these is a notable corporate step. Taken together, they describe a single, coherent strategy: to become the institutional infrastructure layer for crypto-native finance.
Ripple wants to be a regulated entity that banks and corporations can trust to custody assets, manage stablecoin reserves, settle payments, and connect to both the traditional financial system and the blockchain world.
Ripple is not dabbling in banking. It is building a bank-grade financial institution deliberately, piece by piece.
The question for a token holder is where, in all of this carefully assembled machinery, XRP actually fits.
What a national trust bank is, and what it is not Before assessing what the charter means for XRP, it is worth being precise about what a national trust bank actually is, because the word “bank” carries connotations the charter does not deliver.
A national trust bank is not a retail bank. It cannot take ordinary deposits, cannot offer checking or savings accounts, and does not carry federal deposit insurance, the protection that backs ordinary bank deposits.
What it can do is custody assets, provide fiduciary and trust services, manage reserves, and, under the expanded rule, handle digital-asset custody and certain payment-related functions.
Headlines that say “Ripple becomes a bank” are gesturing at something real, but they compress away an important distinction.
That distinction matters for understanding the charter’s purpose. Ripple’s trust bank exists primarily to serve Ripple’s stablecoin business.
Its core planned function is to custody and manage the reserve assets that back the stablecoin, which today are held through a separate trust entity, and to provide custody to institutional clients.
By bringing reserve management in-house under a federal charter, Ripple gains tighter control, removes reliance on third-party custodians, and obtains a regulatory standing that few stablecoin issuers can match: oversight at both the federal level, through the national chartering regulator, and the state level, through New York’s financial regulator.
That dual supervision is a genuine selling point to institutions weighing whether to trust Ripple’s rails.
This is also why the fight over trust charters matters. Senator Elizabeth Warren and banking groups have challenged the idea that crypto firms with OCC trust charters should be treated like bank-grade institutions, arguing that they could act like crypto banks without the same restrictions.
NEW: Sen. Elizabeth Warren joins banks to challenge Ripple and other crypto firms with OCC trust charters. Claims they act as crypto banks avoiding regulatory obligations pic.twitter.com/ojuHDUd73U
— crypto.news (@cryptodotnews) May 28, 2026 The crypto industry has pushed back. The Digital Chamber called on the OCC to uphold crypto trust bank charters for firms including Coinbase, Ripple, Circle, and BitGo, arguing that the charters are part of bringing digital assets into regulated finance rather than keeping them outside it.
NEW: Digital Chamber calls on OCC to uphold crypto trust bank charters for Coinbase, Ripple, Circle and BitGo against Sen. Warren’s claim of banking law violations pic.twitter.com/qBLrmTOD14
— crypto.news (@cryptodotnews) May 27, 2026 But notice what the trust bank does not do. It does not custody XRP for the benefit of XRP holders, does not create any obligation to buy or hold the token, and does not make XRP a bank deposit or a regulated bank instrument.
It is, at its heart, infrastructure for the stablecoin, which is the recurring theme of Ripple’s entire banking build.
The real prize: a Federal Reserve master account The most consequential piece of Ripple’s banking strategy is the one furthest from being secured: a Federal Reserve master account.
A master account is the account a financial institution holds directly with the central bank, and it is the gateway to the core of the financial system.
It allows direct settlement through the central bank’s payment networks, the same rails the largest banks use, and direct access to base money rather than balances held at a commercial bank.
For a stablecoin issuer, the prize is enormous. With a master account, Ripple could hold the reserves backing its stablecoin directly at the central bank, the safest possible place, eliminating the counterparty risk of relying on private banks and giving institutions far greater confidence in the stablecoin’s solvency and redemption safety.
That is why custody and reserve safety matters so much in this story. Stablecoins are only as trusted as the assets backing them, the institutions holding those assets, and the transparency around redemption.
The catch is that no crypto-native firm has ever received full access of this kind on ordinary terms, and the bar is extraordinarily high.
The central bank has historically been reluctant to extend master accounts to non-traditional institutions. Uninsured trust banks face the most stringent levels of review, and previous attempts by crypto-adjacent firms to win access have often failed or taken years.
Ripple’s subsidiary has applied, and the application remains pending, with no public timeline and no clear signal of when or whether the central bank will act.
Approval would be genuinely transformative. It would mark a deeper integration between a crypto-native company and the core U.S. financial system, and it would dramatically strengthen the institutional credibility of RLUSD.
Ripple, Circle receive conditional national bank charter approvals from OCC
— crypto.news (@cryptodotnews) December 12, 2025 But it is far from assured. Even in the optimistic case, the direct beneficiary is again the stablecoin and the company’s settlement capabilities, not the token.
A master account would let Ripple hold stablecoin reserves at the central bank and settle through its rails. It would not, by itself, create demand for XRP.
The prize is real, and the prize is mostly about everything except the token.
Why this is mostly a stablecoin story Step back and a clear pattern emerges from every piece of Ripple’s banking build: it is, overwhelmingly, a stablecoin story.
The trust charter exists primarily to custody and manage stablecoin reserves. The master account, if granted, would primarily benefit the stablecoin by letting its reserves sit at the central bank.
The European license primarily expands where Ripple can offer regulated payment and stablecoin services. The acquisitions in brokerage, payments, and treasury primarily build out an institutional settlement and services business in which the stablecoin is the natural cash leg.
Ripple’s dollar stablecoin has grown past $1 billion, expanded across multiple blockchains, and won approvals in multiple jurisdictions. The banking apparatus is being constructed largely to support and legitimize it.
That is why the RLUSD the bank serves is the center of the story. A stablecoin is useful to institutions precisely because it is designed to hold a steady dollar value while moving across crypto rails.
Ripple’s own reserve-transparency page also shows why this matters. The company is trying to make RLUSD look less like an experimental crypto product and more like a regulated dollar instrument with transparent backing, regular attestations, and bank-grade custody.
This is the same dynamic that defined XRP through 2026, when Ripple’s marquee bank deals and settlement milestones ran through its stablecoin and ledger while the token captured little beyond a negligible network fee.
As previously reported, this is why Ripple wins bypass the token. Ripple can deepen its institutional footprint while XRP still waits for direct, measurable token demand.
The banking build is that dynamic taken to its logical conclusion. Ripple is constructing a regulated financial institution whose central purpose is to make its stablecoin the most trusted, most institutionally credible dollar token in the market, and to build a settlement and custody business around it.
XRP is part of the broader ecosystem, but it is not the thing the bank is for.
A holder hoping that the charter, the master account bid, and the acquisitions would translate into direct demand for the token is, once again, watching the wrong variable.
The value of all this machinery flows first to Ripple the company and to the stablecoin it is built to serve, exactly as Ripple’s own communications have acknowledged in noting that the banking progress is unlikely to move the token’s price directly or immediately.
So what do XRP holders actually get? If the bank build is mostly about the stablecoin, the fair question is whether XRP holders get anything at all.
The honest answer is yes, but indirectly and slowly. The benefit to XRP runs through legitimacy and ecosystem strength rather than any direct mechanism.
As Ripple becomes a regulated, bank-grade financial institution, the entire ecosystem it anchors gains credibility in the eyes of the banks and corporations Ripple wants as customers.
A more trusted Ripple makes every part of its stack, including the ledger on which XRP lives and the role XRP can play, more palatable to institutional users.
The argument, which Ripple and many holders make, is that demand for one asset in an ecosystem can lift others in the same stack, and that a Ripple wired into the core of the financial system is a Ripple better positioned to drive real-world use of XRP as a bridge asset over time.
This indirect benefit is not nothing, and it would be a mistake to dismiss it. XRP’s most plausible long-term role is as a bridge asset that moves value between currencies in settlement.
A Ripple with a federal charter, a master account, and a credible institutional settlement business is a Ripple with more opportunities to route that kind of settlement in ways that touch the token.
But the benefit is conditional, gradual, and unguaranteed, three qualities that make it very different from the direct, immediate boost holders often hope for.
XRP does not become a bank deposit, a stablecoin, or a regulated instrument through any of this. It remains a separate, volatile asset whose demand depends on whether Ripple’s growing institutional infrastructure eventually channels real settlement volume through it.
The competing path is obvious: the same settlement volume could instead keep flowing through RLUSD, which is better suited to settlement precisely because it does not move in price.
The banking build improves the odds that Ripple can win regulated institutional business someday. It does not make that business flow through XRP now, and it does not create token demand on its own.
The bull case within the bank build In fairness to the optimistic view, there is a coherent bull case for XRP buried inside Ripple’s banking transformation, and it deserves a clear statement.
The strongest version goes like this: Ripple is methodically removing every reason an institution might hesitate to build on its rails.
The charter answers the custody and reserve-management question. The master account, if granted, answers the reserve-safety question at the highest possible level.
The acquisitions answer the brokerage, payments, and treasury questions. The licenses answer the regulatory question across jurisdictions.
As those barriers fall one by one, Ripple becomes a place where serious institutions can conduct serious volume. In a world where Ripple is running large-scale regulated settlement, the case for using XRP as the neutral bridge asset between currencies strengthens, because the infrastructure to do it at scale finally exists and is trusted.
Pair that with the token’s other tailwinds, including the regulatory clarity from its resolved legal status, the spot exchange-traded funds gathering assets, and the prospect of federal legislation codifying its commodity classification, and the bull case becomes clearer.
That is where the legislation that could codify XRP fits in. If the CLARITY Act turns XRP’s commodity treatment into durable federal law, it could make institutions more comfortable using the token where it has a genuine settlement role.
In that version of the future, XRP sits inside a maturing, increasingly bank-grade ecosystem at exactly the moment that ecosystem becomes capable of institutional-scale activity.
If even a fraction of the settlement flowing through a fully built-out Ripple touches XRP as a bridge, the demand could be meaningful, and it would arrive on top of a token that has already cleared its regulatory hurdles.
This is a real argument, and it is why the banking build is truly good news for the long-term XRP thesis even though it is not a direct catalyst.
The caveat, as always, is the word “if.” The bull case depends on Ripple choosing and managing to route settlement through the token rather than through the stablecoin, and the entire pattern of 2026 suggests the stablecoin keeps winning that role.
The infrastructure being built is real. Whether XRP is wired into it is the open question.
What XRP holders should watch For a holder trying to judge whether Ripple’s banking transformation will ever translate into token demand, the analysis points to a few specific signals worth tracking, none of which is another charter or acquisition headline.
The first is the Federal Reserve master account decision.
If granted, it would be a landmark for Ripple and the stablecoin, and it would mark the company’s deepest integration into the financial system. Over time, that expands the surface area where XRP could be used.
If denied, a key piece of the institutional thesis stalls.
Either way, it is the most consequential pending item, and its outcome shapes everything downstream.
The second and more important signal is whether XRP actually appears in the settlement flows of Ripple’s bank-grade business, as opposed to the stablecoin doing all the work.
This is the variable that decides the entire question. If Ripple’s institutional settlement increasingly routes through XRP as a bridge asset, generating real, recurring token demand, then the banking build will finally have reached the token.
If, as has been the pattern, the stablecoin carries the settlement while XRP captures only a fee, then the bank is a Ripple and stablecoin story with XRP riding the halo of legitimacy but not the flows.
The third signal is the broader regulatory picture, particularly whether federal legislation codifies XRP’s status, which would compound the legitimacy the banking build provides.
The honest synthesis is that Ripple becoming a bank is a major, genuine achievement that strengthens the company, the stablecoin, and the long-term credibility of the whole ecosystem.
For XRP specifically, it improves the odds without delivering the goods.
The token’s payoff depends on a future choice, to run regulated settlement through XRP, that Ripple has not yet shown it will make.
Until it does, the bank is being built for everything except the token, and the token, as it has all year, waits.
Frequently asked questions Is Ripple actually becoming a bank? Sort of, but with important caveats. Ripple won conditional federal approval to operate a national trust bank and applied for a Federal Reserve master account, and it has acquired prime brokerage, payments, and treasury businesses. But a national trust bank is not a retail bank: it cannot take ordinary deposits, offer checking or savings accounts, or carry federal deposit insurance. It is a specialized institution for custody, fiduciary services, and reserve management. So Ripple is building a bank-grade regulated financial institution, but one focused on custody and stablecoin reserves instead of traditional deposit-taking banking.
What is the Federal Reserve master account and why does it matter? A master account is an account held directly with the central bank, giving direct access to its payment rails and to base money, the same access the largest banks have. For Ripple, it would let the company hold its stablecoin’s reserves directly at the central bank, the safest possible location, eliminating reliance on private banks and boosting institutional confidence in the stablecoin. No crypto-native firm has ever been granted full access of this kind on ordinary terms, the review is stringent, and Ripple’s application is pending with no timeline. Approval would be transformative for the company and stablecoin, though not a direct catalyst for XRP.
Does Ripple’s banking push help XRP? Indirectly and gradually, not directly. The charter and master account primarily benefit Ripple’s stablecoin, whose reserves they would custody and secure. XRP does not become a deposit, a stablecoin, or a regulated instrument. The benefit to XRP runs through legitimacy: a bank-grade Ripple strengthens the whole ecosystem and improves the odds that XRP is eventually used as a bridge asset in regulated settlement. But that is conditional and slow, not the direct demand boost holders often hope for, and Ripple itself has acknowledged the banking progress is unlikely to move the token’s price immediately.
Why does the stablecoin benefit more than XRP? Because the entire banking build is designed around the stablecoin. The trust charter exists mainly to custody and manage stablecoin reserves. The master account, if granted, would let those reserves sit at the central bank. The acquisitions build a settlement business in which the stablecoin is the natural cash leg. A stablecoin is suited to settlement precisely because it holds a steady value, while XRP’s volatility makes it less suitable for that role. So Ripple’s regulated infrastructure naturally channels value to the stablecoin, with XRP benefiting only as part of the broader, more credible ecosystem.
What is the bull case for XRP in all this? The bull case is that Ripple is methodically removing every reason an institution might hesitate to use its rails, through the charter, the master account bid, the acquisitions, and the licenses. As those barriers fall, Ripple becomes capable of large-scale regulated settlement, and the case for using XRP as a neutral bridge asset between currencies strengthens because the trusted infrastructure to do it finally exists. Combined with XRP’s regulatory clarity, its ETFs, and possible federal legislation, the bull case is that XRP sits inside a maturing, bank-grade ecosystem just as that ecosystem becomes capable of institutional-scale activity. The caveat is whether settlement actually routes through XRP instead of the stablecoin.
What should XRP holders watch next? Three things. First, the Federal Reserve master account decision, which would mark Ripple’s deepest integration into the financial system and expand where XRP could be used, or stall a key part of the thesis if denied. Second, and most important, whether XRP actually appears in the settlement flows of Ripple’s institutional business, generating real token demand, as opposed to the stablecoin doing all the work. Third, the broader regulatory picture, especially whether federal legislation codifies XRP’s commodity status. The token’s payoff depends on Ripple choosing to route regulated settlement through XRP, a choice it has not yet shown it will make.
This article is information, not investment advice. Cryptocurrency is volatile, and regulatory approvals, corporate plans, and figures reflect reporting available as of June 26, 2026, which can change quickly. Verify current data from primary sources before making any decision.
XRPL získá Lending Protocol v1.1 jako samostatné rozšíření, které v1.0 nenahrazuje ani neodkládá jeho použití. SOIL zároveň plánuje jako první aplikace využít nativní lending na XRPL.
The XRP Ledger (XRPL) is poised to welcome a new generation of lending and yield products as its decentralized finance (DeFi) ecosystem continues its rapid expansion.
Ripple executive J. Ayo Akinyele has provided a detailed clarification regarding the upcoming Lending Protocol v1.1.
Akinyele explicitly stated that v1.1 is an enhancement to the existing protocol, rather than a replacement for v1.0, and emphasized that developers have no reason to hold off on utilizing v1.0 today.
HOT Stories
"The protocol works as designed," Akinyele noted, explaining that the v1.1 update simply introduces refinements and added flexibility driven by feedback from the ecosystem and the long-term vision for lending on the XRPL.
Version 1.1 will ship as a separate amendment that extends the existing protocol. The previous will not be deprecated, meaning supporting it now allows institutions and developers to deploy lending applications and use cases directly on the mainnet.
"The protocol works as designed. v1.1 enhances it: refinements and added flexibility driven by ecosystem feedback and where we want lending on XRPL to go. It ships as a separate amendment that extends the existing protocol. v1.0 will not be deprecated, and supporting it now will enable institutions and developers to deploy lending applications and use cases on mainnet," he said.
The activation of v1.1 will follow the standard amendment process, meaning there is no dependency requiring users to wait for it before acting on v1.0. Each amendment will be reviewed on its own merits by validators on their normal cadence.
SOIL eyes first application After the news of the protocol's development, another Ripple executive confirmed that a new wave of lending and yield products is officially coming to the network.
SOIL, a prominent protocol known for offering institutional lending services using USDC, RLUSD, and XRP, has officially announced its plans to integrate the XRPL Lending Protocol alongside SAV. The firm is positioning itself to become the first application to leverage these native features, which could potentially introduce an entirely new category of yield-generation products directly to the XRP Ledger.
To facilitate this new phase of lending services, the firm has proposed the activation of specific technical standards in the near future. Most notably, this includes the XLS-65 and XLS-66 standards, which are expected to be activated as soon as possible to ensure the lending upgrade is effectively deployed across the network.
Na XRP Ledgeru vyskočil denní platební objem na zhruba 926 milionů XRP, ale počet aktivních adres zůstal téměř beze změny. To naznačuje spíš velké převody než širší adopci.
Cover image via depositphotos.com Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.
Transaction activity on the XRP Ledger has increased dramatically, with payment volume close to 1 billion XRP in a single day.
XRP's payments volume surgeRecent network data shows that on June 25, payment volume increased to about 926 million XRP, one of the biggest spikes seen in recent weeks. Such a sharp rise seems extremely bullish at first glance. High transaction volumes are frequently seen as a sign of increasing institutional involvement, expanding network utility, or rising demand for the underlying asset.
XRP/USDT Chart by TradingViewThe overall picture, however, indicates that investors should exercise caution when analyzing the data. One crucial detail is the fact that payment volume increased without a corresponding increase in active users. The number of active addresses stayed comparatively constant throughout the month, varying between 100,000 and 150,000, despite transaction volume surging toward 1 billion XRP. This divergence suggests that rather than broad network adoption, the spike might have been caused by a comparatively small number of significant transactions.
HOT Stories
The XRP Ledger frequently exhibits this kind of behavior. Hundreds of millions of XRP can be moved between wallets by large organizations, exchanges, payment processors, and institutional players, momentarily inflating transaction metrics without necessarily indicating a significant change in retail demand.
In the meantime, XRP's market performance continues to be challenged. The asset recently broke below a multi-month support zone that had held since March and is still trading within a wider downtrend. According to technical indicators, XRP is trading below all significant moving averages, and the price structure continues to form lower highs and lower lows.
XRP's market performance There is a substantial gap between price action and network activity. In the past, persistent bull markets have typically been accompanied by concurrent increases in market demand, active addresses, and transaction volume. In this instance, only one of those metrics has demonstrated significant acceleration.
You Might Also Like
Strong network utilization frequently provides a stronger long-term foundation, as opposed to speculative trading alone. The market may start to see the recent spike as proof of real adoption growth, rather than isolated whale activity, if active users begin to track transaction volume higher in the upcoming weeks.
For the time being, the billion-XRP payment spike shows how active the XRP Ledger is, but before interpreting it as a clear bullish signal, traders will probably need confirmation from user growth and price performance.
Binance u XRP hlásí téměř neutrální Z-Score 0,17, což ukazuje na běžné derivátové pozice bez výrazného pákového nárůstu. XRP mezitím za 24 hodin klesl o více než 4,4 % při širším výprodeji krypta.
TLDR: Binance’s XRP Perpetual-Spot Volume Imbalance Z-Score sits near neutral at 0.17, within normal historical range. XRP dropped over 3.3% in 24 hours to $1.049 as tech stock declines triggered over $1 billion in crypto liquidations. Ripple’s RLUSD stablecoin launched on SBI VC Trade in Japan, becoming the first regulated listing with zero fees. Spot XRP ETFs recorded $31.32 million in June net inflows, well below May’s record high of $132 million. Binance’s XRP Perpetual-Spot Volume Imbalance Z-Score is holding near neutral at approximately 0.17, according to the latest on-chain data.
The reading reflects that the gap between perpetual and spot trading volumes remains within a historically normal range.
XRP is trading near $1.02 as of this writing, down over 4.4% in 24 hours amid a broad crypto market selloff. Despite the price drop, derivatives market activity has not shown signs of excessive speculative buildup.
Z-Score Stability Points to Measured Derivatives Positioning The Volume Imbalance indicator on Binance measures the difference between perpetual and spot trading volumes for XRP.
The current reading stands at approximately 0.51, with the 30-day Z-Score sitting near 0.17. That figure places the current imbalance well within the range of normal activity relative to the past month.
Source: CryptoQuant
Perpetual trading continues to dominate XRP market activity, but the margin of dominance remains unremarkable.
The Z-Score has moved through notable swings over the past several months. During price rallies in April and May, perpetual volumes expanded sharply, widening the gap above spot market activity on several occasions.
As XRP’s price retreated and speculative interest eased, the indicator pulled back toward balanced levels. The 30-day Z-Score then stabilized near zero before settling at its current modest positive reading.
A Z-Score of 0.17 indicates the present level of perpetual dominance is not exceptional. It falls broadly in line with average derivatives activity recorded over the past month.
There is no evidence of the kind of leverage buildup that typically precedes sharp price swings or large-scale liquidation events. At the same time, the reading does not suggest any notable drop in trader participation across derivatives markets.
The data paints a picture of cautious, measured positioning in XRP derivatives at this stage. Traders appear to be adjusting exposure gradually rather than piling into directional bets.
That behavior is consistent with a market navigating a broad selloff without taking on outsized risk. The Z-Score’s proximity to neutral reflects that restraint across Binance’s XRP derivatives market.
Market Context: Selloff and Ecosystem Developments XRP’s decline of over 4.4% in 24 hours came alongside a broader crypto market selloff driven by falling technology stocks.
Over $1 billion in crypto positions were liquidated during the period across the market. The price pressure pushed XRP to approximately $1.02, compounding recent weakness in the token.
Despite the turbulence, Binance’s derivatives data has not shown a corresponding spike in speculative activity.
Ripple’s RLUSD stablecoin launched in Japan through SBI VC Trade, the first Japanese exchange to list the asset. The listing is fully regulated and carries zero fees, going live immediately upon approval.
X Finance Bull noted on X that the Japan listing continues opening regulatory doors for the broader Ripple ecosystem.
JUST IN 🚨 RLUSD on Japan now.
Is $XRP for settlement next?
SBI VC Trade became the first Japanese exchange to list Ripple's stablecoin, fully regulated, zero fees, live today.
Japan keeps opening doors for the Ripple ecosystem one piece at a time.pic.twitter.com/IT9nYBpz1g https://t.co/SfemaHq3N2
— X Finance Bull (@Xfinancebull) June 24, 2026
RLUSD also surpassed Ethereum in circulating supply, adding to the milestone’s weight despite subdued XRP price action.
Spot XRP ETFs recorded $31.32 million in net inflows during June, per SoSoValue data. That figure trails May’s record of $132 million in net inflows by a wide margin.
Still, the ongoing institutional interest reflected in ETF flows contrasts with the short-term price weakness. Cumulative inflows into spot XRP ETF products have exceeded $1.43 billion since their November 2025 launch.
The combination of a neutral Z-Score, modest ETF inflows, and active ecosystem expansion gives a layered picture of XRP’s current market state.
Price performance has weakened amid macro-driven selling pressure. However, derivatives positioning on Binance remains measured, and the broader Ripple infrastructure continues to grow.
The Z-Score’s stability near 0.17 suggests traders are not amplifying the selloff through excessive leveraged exposure.
Bývalý člen Ethereum Foundation Trent Van Epps varoval, že Ethereum může během 3 až 9 měsíců čelit kritické mezeře ve financování vývoje. Zároveň uvedl, že ETH je po prudkém poklesu v přeprodaném pásmu.
Former Ethereum Foundation member Trent Van Epps warned on Thursday that Ethereum (CRYPTO: ETH) faces a critical funding gap within 3 to 9 months.
Why The Foundation Is Pulling Back On PurposeVan Epps, who spent five years at the Ethereum Foundation before recently stepping away, explained in an interview with Coindesk that the organization is deliberately pushing legitimacy and funding power out into the broader ecosystem rather than holding onto it.
The Foundation’s treasury, built from the network’s earliest days, has funded critical shared resources like client development and the move from proof of work to proof of stake, but that treasury is shrinking by design.
Core development funding needs sit at roughly $30 million per year, a small figure against Ethereum’s $200 billion market cap and the trillions in stablecoin settlement the network handles.
The problem isn’t a lack of need. It’s that as the Foundation steps back, no clear institution has stepped up to fill the gap, even as the Foundation recently cut its workforce by 20% and saw executives depart.
Protocol Guild Raised $40 Million In Four Years, But It Isn’t EnoughVan Epps built Protocol Guild, a collective funding mechanism for Ethereum’s core developers, distributing nearly $40 million over four years.
“We’ve had some good success,” he said, “but ultimately it’s not sufficient.”
He pointed to the free-rider problem as the core obstacle to fixing it.
“If somebody donates, but their competitor doesn’t, all of a sudden they have a distinct advantage over somebody who’s parted with some of their resources to fund the shared resource,” he said, calling coordination among large stakeholders genuinely hard even when most understand what’s at stake.
Beyond the funding question, Van Epps argued ETH as an asset needs fresh, confident storytelling that connects the token directly to the EVM’s dominance, the engine underpinning roughly 90% of total value locked across crypto including layer-2 networks.
ETH’s Chart Shows Oversold Conditions After A Sharp Trendline BreakETH broke a rising trendline that had held since February, triggering a fast move down through $1,900, then $1,800, into the $1,557 level.
The death cross from November 2025 remains intact across all major moving averages.
RSI sits at 28.98, an oversold reading that often precedes bounce attempts even within a larger downtrend.
The 20-day EMA at $1,707.57 and 50-day EMA at $1,864.11 sit overhead as the first levels traders will watch for any recovery to either fail or gain real traction.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
Charles Hoskinson testuje chytrý kontrakt pro obnovu peněženek po exploitu SecondFi, který odčerpal zhruba 16 milionů ADA. Ověřoval by držení 24slovné seed phrase pomocí zero-knowledge proof bez jejího zveřejnění na blockchainu.
A Smart Contract Approach to Wallet RecoveryCardano founder Charles Hoskinson (@IOHK_Charles) is experimenting with a smart contract designed to help users recover funds from wallets compromised in the recent SecondFi exploit. According to Hoskinson, the contract would use a zero-knowledge proof to verify that a claimant possesses the 24-word seed phrase associated with an affected wallet, without requiring that phrase to be exposed on-chain. If verified, the contract would vend $ADA and Cardano native tokens from a dedicated recovery pool to the confirmed owner. Hoskinson said he plans to coordinate with the Midnight team and key developers on the findings before any wider rollout.
The Midnight network, Cardano's privacy-focused sidechain, is a natural fit for this kind of work. Hoskinson has previously described Midnight as deeply connected to zero-knowledge systems , and the project's cryptographic tooling makes it a practical base for building proof-based recovery mechanisms.
The SecondFi Exploit: What Happened SecondFi, the Cardano wallet formerly known as Yoroi, confirmed a major exploit that drained roughly 16 million $ADA, worth approximately $2.4 million, from 374 user wallets across three separate attacks. SecondFi's team traced the breach to a vulnerability in its proprietary wallet generation software, which gave attackers access to funds across multiple user wallets. Critically, Cardano's base protocol was not the entry point.
The team rescued a further 129 million $ADA before attackers could reach it, routing funds to a third-party custodian, but blockchain security firm SlowMist estimates total losses could still exceed $20 million pending an independent audit. Users cannot protect themselves by simply moving their seed phrase to another wallet. The vulnerability activates at the address level when a transaction is signed, and affected users must submit claims directly to SecondFi.
SecondFi was built on the foundations of Yoroi, a wallet created by EMURGO, one of the three founding entities behind Cardano. That history makes the breach sting harder for the community. The team says it is working with IOG, Cardano Foundation, IntersectMBO, and SundaeSwap to limit damage across the wider ecosystem.
Hoskinson's proposed recovery mechanism remains experimental, and no timeline has been confirmed. Its viability will depend on the technical findings from his coordination with the Midnight team and core developers. For now, affected users have been advised to wait for official guidance from SecondFi before taking any independent action.
Sources:
CoinDesk: SecondFi loses $2.4 million in Cardano wallet exploit, up to $20 million at risk
CryptoNewsZ: SecondFi fixes Cardano wallet flaw that led to 16M ADA theft
CoinGabbar: SecondFi Cardano Wallet Exploit: User Impact and Recovery Plan
USDt od Tether se podle tržní kapitalizace stal druhou největší kryptoměnou, když Ether po denním propadu o 5,2 % klesl na 1 510 USD a jeho kapitalizace spadla pod 185 miliard USD. USDt měl kapitalizaci 186 miliard USD.
Tether stablecoin USDt has become the second-largest cryptocurrency by market capitalization as Ether fell to its lowest price of the year on Friday
Ether’s market capitalization dropped below $185 billion following a 5.2% price crash over 24 hours, sending the asset tumbling to $1,510 on Coinbase, according to TradingView. This allowed USDt, with a $186 billion market capitalization, to surpass the cryptocurrency.
“[The] stablecoin overtake really highlights how the market still favors stability over ETH’s volatility right now,” Andri Fauzan Adziima, research lead at Bitrue Research Institute, told Cointelegraph.
The development reflects accelerating stablecoin growth, which currently represents almost 15% of the entire crypto market capitalization. Stablecoin supply contracted more than 30% in the last bear market, but they’re hitting record highs this time, wrote 21Shares on Thursday, adding:
“To us, that is the strongest evidence yet that stablecoins are one of crypto’s defining use cases – demand that no longer depends on the cycle.”USDt flipped ETH in market capitalization. Source: CoinGecko
Alvin Kan, chief operating officer of Bitget Wallet, told Cointelegraph that the flip is a “notable milestone that highlights the explosive growth and dominance of stablecoins in today’s crypto ecosystem.”
“It demonstrates strong demand for reliable, liquid on- and off-ramps during periods of volatility, while serving as a reminder that ETH must continue delivering compelling utility and narrative momentum to maintain its position.” Kan said the development is positive for the broader market, as deeper stablecoin liquidity supports higher trading volumes and ecosystem innovation.
ETH prices are back at crucial support levels last visited in October 2023 and April 2025.
The Ethereum ecosystem has also faced internal changes recently, following several executive departures and a 20% workforce reduction at the Ethereum Foundation.
However, a new nonprofit organization called Ethlabs was launched this week by key EF developers and researchers and backed by Ether treasuries Bitmine and Sharplink.
ETH prices are at a critical long-term support level. Source: TradingView
Not all are bearish Some have taken Ether's decline as an opportunity.
Ether treasury company Sharplink bought the dip, making its first purchase in eight months, scooping up 5,000 ETH on Thursday. Bitmine, chaired by Tom Lee, has also been accumulating at these low prices, adding a further 76,881 ETH last week.
Meanwhile, Circle’s USDC (USDC) also flipped Ripple’s XRP (XRP) in market capitalization as XRP fell back towards $1, its lowest level since November 2024, leaving XRP with a market capitalization of $64 billion compared with USDC's $73.6 billion.
Magazine: AI is banking the unbanked in Africa... faster than crypto
Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently.
DOMA Perpetual Capital Management odmítá nabídku na odkup InMode za 16,20 USD za akcii a plánuje hlasovat proti obchodu. Tvrdí, že cena společnost podhodnocuje.
DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual) DOMA ASSERTS THAT THE $16.20 PER SHARE OFFER MATERIALLY UNDERVALUES INMODE AND ITS LONG-TERM POTENTIAL
DOMA BELIEVES THE BID EXPLOITS THE DEPRESSED VALUATIONS CREATED BY YEARS OF CEO-LED UNDERPERFORMANCE
DOMA EXPLICITLY REJECTS THE CURRENT TERMS AND URGES THE BOARD TO UPLHOLD ITS FIDUCIARY DUTIES
, /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board").
The letter can be downloaded here
The full text of the letter follows:
June 26, 2026
To the Board Member of InMode:
As of the date of this letter, DOMA Perpetual Capital Management LLC ("DOMA") and its affiliates beneficially own approximately 4.63% of the outstanding ordinary shares of InMode Ltd. ("InMode" or the "Company").
We are writing as a concerned shareholder regarding the recently proposed acquisition of the Company led by the Chief Executive Officer in partnership with a group of investors. The circumstances surrounding this proposal raise serious concerns about conflicts of interest, governance, the Board's fiduciary responsibilities, and the fairness of the proposed transaction.
We believe the proposal materially undervalues the Company, particularly in light of its long-term potential and intrinsic assets. It is difficult to ignore that this proposal also follows a long period of operational underperformance under the current CEO's leadership. We have previously asked the Board, in a public communication dated May 9, 2025, to replace the CEO precisely because of his sustained underperformance, and that same CEO now appears positioned to benefit from the proposed transaction.1 In our view, these circumstances warrant close scrutiny, and DOMA reserves all of its rights in connection with the proposed transaction.
We strongly believe the proposal would allow management to capitalize on a depressed valuation that developed during its own stewardship and that, in our view, management's performance helped create. Such dynamics are deeply troubling from a governance perspective.
The Board has fiduciary obligations to act in the best interests of all shareholders, not management or any specific investor group. In this context, we urge the Board to take the following actions:
Establish a fully independent special committee with no ties to management to evaluate the proposal. Retain international independent financial and legal advisors to conduct a rigorous valuation and fairness assessment. Conduct a broad and transparent market check inviting public offers to determine whether superior offers exist. Ensure that shareholders are provided with full and fair disclosure regarding the process, assumptions, and any potential conflicts of interest. Any transaction that allows insiders to acquire the Company at a price influenced by their own stewardship must be subject to the highest level of scrutiny. Failure to do so could expose the Company and the Board to significant shareholder value destruction, as well as reputational and legal risk.
Shareholders rely on the Board to uphold strong governance standards and to protect against precisely this type of conflicted transaction. I trust that you will take these responsibilities seriously and act accordingly.
At the current offer of $16.20/share DOMA does not support the proposal and intends to vote against the transaction.
Sincerely,
Pedro Escudero
CEO & CIO
DOMA Perpetual Capital Management LLC
This letter has been prepared by DOMA. The views expressed herein reflect DOMA's opinions and are based on publicly available information regarding the Company. DOMA recognizes that the Company or others may have information not available to DOMA that could lead them to disagree with DOMA's views or conclusions. DOMA reserves the right to change or modify its views, opinions, intentions, or positions at any time and for any reason, and disclaims any obligation to update or revise the information contained herein, except as may be required by applicable law.
This letter was not prepared by, and has not been endorsed by, InMode Ltd. This letter is provided for informational purposes only and is not intended to be, and should not be construed as, an offer to sell or a solicitation of an offer to buy any security, or as a recommendation to purchase or sell any security. DOMA is not currently soliciting proxies, consents, authorizations, or voting commitments with respect to any securities of the Company. One or more funds managed by DOMA currently beneficially own shares of the Company.
Certain statements in this letter may constitute forward-looking statements. These statements reflect DOMA's current views and expectations, speak only as of the date hereof, and are subject to risks, uncertainties, and assumptions that could cause actual results or developments to differ materially from those expressed or implied.
PR Newswire, May 9, 2025, DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program (urging the Board, among other actions, to replace the Chief Executive Officer), https://www.prnewswire.com/news-releases/doma-perpetual-sends-letter-urging-board-of-directors-of-inmode-ltd-to-resume-share-repurchase-program-302451097.html SOURCE DOMA Perpetual
Biogen po akvizici Apellis za 5,6 miliardy USD pozastavil nebo ukončil financování většiny výzkumných programů a zrušil část míst ve výzkumu. Firma přesouvá zdroje k Empaveli a Syfovre.
Biogen logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab
CompaniesJune 26 (Reuters) - Biogen (BIIB.O), opens new tab said on Friday it had either paused or discontinued funding for most of Apellis Pharmaceuticals' research programs as it integrates the rare-disease drugs specialist it purchased for $5.6 billion earlier this year.
The U.S. drugmaker has also cut a small number of roles within the research organization as it shifts resources toward Empaveli and Syfovre, the approved therapies acquired through the deal.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
"As part of the integration of Apellis, Biogen is conducting a comprehensive review of the former Apellis clinical & preclinical portfolio to further evaluate strategic fit," a Biogen spokesperson said.
The company did not offer details on the number of roles or the specific programs impacted by the decision.
Biogen has suspended two trials evaluating Empaveli in two separate kidney-related conditions, according to updates posted earlier this month on the U.S. government's clinical trials database.
The Apellis deal, Biogen's largest since its 2023 buyout of Reata Pharmaceuticals, is expected to support the company's near-term growth as demand for its key multiple sclerosis franchise declines and sales of Alzheimer's drug Leqembi lag expectations.
Empaveli is approved for two rare kidney diseases and a rare blood disorder while Syfovre is authorized to treat geographic atrophy, an advanced eye condition that is a leading cause of blindness.
The two drugs generated a combined revenue of about $689 million last year and are expected to grow at a mid-to-high-teens rate at least through 2028, the companies had said when the deal was announced in March.
Reporting by Mariam Sunny in Bengaluru; Editing by Sriraj Kalluvila
Our Standards: The Thomson Reuters Trust Principles., opens new tab
